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Abstract 
 
Cardiovascular disease is the primary cause of global mortality (Naghavi, 2015). 
Given the global health issues associated with poor cardiovascular function, 
interventions that help reduce the severity and prevalence of these diseases would 
not only have economic implications, but would also improve health, wellbeing and 
quality of life. Epidemiological studies have suggested that polyphenol-rich foods 
can exert positive cardiovascular health benefits and as a result could reduce the 
severity of the primary pathology and increase the capacity to stay physically and 
mentally active (Joshipura et al., 1999; Bazzano et al., 2002; Hung et al., 2004).  
One of most studied polyphenol-rich, functional foods in recent years, in both the 
clinical and exercise domains, has been tart cherries. Tart cherries and their 
derivatives are high in numerous polyphenols (Wang et al., 1999; Seeram et al., 
2001; Seymour et al., 2014; Bell et al., 2014) that include the flavonoids 
isorhamnetin, kaempferol, quercetin, catechin, epicatechin, procyanidins, and 
anthocyanins (Kim et al., 2005; Kirakosyan et al., 2009).   Indeed, there has been 
an enormous research effort over the past decade to delineate the physiological 
and biochemical effects that tart cherries (and its constituents) might afford, and 
how these effects could be exploited to improve health outcomes.  There is now 
strong evidence that tart cherries attenuate inflammation (Wang et al., 1999), 
oxidative stress (Howatson et al., 2010; Bell et al., 2014) and accelerate exercise 
recovery (Howatson et al., 2010; Bowtell et al., 2011; Bell et al., 2014; 2016).  
Furthermore, cherry extracts have been shown, in cell and animal models, to exert 
a range of cardioprotective effects that include increasing nitric oxide production 
and antioxidant (AOX) status, reducing lipid oxidation and inhibiting inflammatory 
pathways (Wang et al., 1999; Seeram et al., 2001).  However, data from human 
trials are not always consistent.  Furthermore, it is yet to be explored whether MC 
concentrate can be used for performance enhancement. Thus, the overarching 
aim of this thesis was to elucidate the effects of Montmorency, a specific cultivar of 
tart cherry, (MC) supplementation on vascular function and exercise performance 
in humans.   
The series of investigations that set out to address this aim have led to many novel 
and interesting findings.  To begin, study 1 was the first to show that 
protocatechuic and vanillic acid were identified in the plasma post MC 
consumption.  Furthermore, a combination of PCA and VA increased cell migration, 
4 
but had no effect on the proliferation of vascular smooth muscle cells.  Secondly, 
and perhaps the most novel finding of this thesis was that MC supplementation 
showed promise as an effective adjuvant in the management of hypertension.  
This was a consistent finding throughout the thesis; in all instances MC 
supplementation was able to significantly reduce systolic blood pressure.  Another 
important finding was that MC supplementation resulted in an acute modulation of 
cerebral blood flow parameters in the front cortex during task performance with no 
changes in cognition or mood.  Finally, the final study of this thesis demonstrated 
that MC supplementation can improve aspects of exercise performance with no 
changes in V̇O2 kinetics, NO2- concentrations or muscle oxygenation.  All of these 
findings suggest that circulating phenolic metabolites derived from MC juice are at 
least partly responsible for these effects.   
Collectively, findings of this thesis provide novel information to literature 
surrounding the application of MC in health maintenance and exercise 
performance.  In addition to identifying and quantifying some of the primary 
downstream metabolites of the principal anthocyanins contained in the 
concentrate, this research is the first to provide efficacy for the use of MC 
supplementation to acutely modulate various aspects of vascular function 
including systolic blood pressure, total and oxy-Hb during a cognitively challenging 
task.  The underlying mechanisms that govern these effects remain elusive, 
although data from study 1, 2 and 4 would suggest that it is not likely to be 
attributed to NO, at least systemically.   A more likely idea by which MC 
supplementation improves factors associated with CVD is based on the uptake of 
polyphenols that possess cardio-protective properties.  To conclude, this thesis 
highlights the ability of MC to improve aspects of cardiovascular function and 
exercise performance.  Circulating phenolic metabolites derived from MC are at 
least partly responsible for these acute improvements. Further work is required to; 
fully elucidate the mechanisms by which MC exerts its protective effects, 
determine whether the effects reported would be amplified using chronic 
supplementation and demonstrate effects of MC supplementation within habitual 
dietary practices. 
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1.1 Introduction  
 
Cardiovascular disease (CVD) is the primary cause of global mortality (Naghavi, 
2015).  In the United States, one in four deaths can be attributed to a 
cardiovascular related event, equating to roughly 610,000 people per annum 
(Centers for Disease Control and Prevention, 2015).  In Europe, CVD is the major 
cause of death in adults and is responsible for nearly half (48%) of all annual 
deaths (Allender et al., 2008; Centers for Disease Control and Prevention, 2015).  
Risk factors for the development of atherosclerosis and CVD can be classified as 
modifiable, including obesity, dyslipidemia, hypertension, physical inactivity, and 
smoking, or non-modifiable, including age, sex and family history (Nelms et al., 
2011).   
A diet high in fruit and vegetables has been associated with a decreased 
prevalence of CVD (Hu et al., 2000; Ye et al., 2012; Oyebode et al., 2014) this is 
thought to be due to their high polyphenolic content.  Despite extensive research 
efforts, the precise mechanism of polyphenols is not yet completely understood. 
Initially, the focal reason for this interest was based on their potential antioxidant 
(AOX) properties. Whilst this concept is no longer accepted, evidence suggests 
they may have several properties which make them potentially important 
compounds for the prevention of multiple diseases (cardiovascular, 
neurodegenerative, obesity and cancer) (Baur et al., 2006; de Pascual-Teresa et 
al., 2010; Feng et al., 2007; Hooper et al., 2008; Ramassamy, 2006).  
One of most studied functional foods in recent years, in both the clinical and 
exercise domains, has been tart cherries.  Tart cherries and their derivatives are 
high in numerous polyphenols (Wang et al., 1999; Seeram et al., 2001; Seymour 
et al., 2014; Bell et al., 2014) that include the flavonoids isorhamnetin, kaempferol, 
quercetin, catechin, epicatechin, procyanidins, and anthocyanins (Kim et al., 2005; 
Kirakosyan et al., 2009).   Indeed, there has been an enormous research effort 
over the past decade to delineate the physiological and biochemical effects that 
tart cherries (and its constituents) might afford, and how these effects could be 
exploited to improve health outcomes.  There is now strong evidence that tart 
cherries attenuate inflammation (Wang et al., 1999), oxidative stress (Howatson et 
al., 2010; Bell et al., 2014) and accelerate exercise recovery (Howatson et al., 
2010; Bowtell et al., 2011; Bell et al., 2014; 2016). The significant decrease of 
markers of inflammation and oxidative stress afforded by cherry compounds and 
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derivatives may have implications for the management of clinical pathologies 
associated with high levels of inflammation and oxidative stress and suggests that 
their consumption may have the potential to reduce cardiovascular or chronic 
diseases in humans.   In agreement, cherry extracts have been shown, in cell and 
animal models, to exert a range of cardio-protective effects that include increasing 
nitric oxide production and AOX status, reducing lipid oxidation and inhibiting 
inflammatory pathways (Wang et al., 1999; Seeram et al., 2001).  However, data 
from human trials is uncertain.  These protective effects are thought to be 
mediated by the high number of phenolic compounds in tart cherries (Ferretti et al., 
2010). However, as with the aforementioned physiological effects of tart cherries, 
additive and synergistic effects with nitrate, cannot be ruled out.  Furthermore, 
nitrate, via its conversion to NOx, has been shown to demonstrate potent anti-
inflammatory effects independent of any interactions with phenolic compounds 
(Jädert et al., 2012; Justice et al., 2015). 
In addition, polyphenol-rich food and supplements, in the form of grape seed 
extract (Wang et al. 2008), resveratrol (Giliberto et al. 2010) and red wine (Chen et 
al. 2009) have specifically demonstrated the ability to offer protection against the 
brain-aging processes leading to Alzheimer’s disease in rodent models. On the 
other hand, evidence of polyphenol benefits on the young has been focused on 
various insults to the brain i.e. hypoxic ischemic brain injuries (Loren et al. 2005; 
West et al. 2007; Liu and Yu 2008). Few have demonstrated hard data in support 
of benefits to neuronal growth and brain development in healthy models (Scott et al. 
2011). Considering the potential for brain bioactive nature of these polyphenols, it 
is not surprising that interest in research addressing the benefits for both young 
and old is growing, however research in tart cherry supplementation has been 
paradoxical with inconsistent results reported (Caldwell et al., 2015; Kent et al., 
2015). 
From an exercise perspective, while tart cherries, via a juice beverage, has 
emerged as an effective and popular recovery aid from exercise induced muscle 
damage (Howatson et al., 2010; Bell et al., 2014; 2015; 2016), it is yet to be 
explored whether they can be used for performance enhancement. However, the 
proposed relationship between oxidative stress, inflammation and exercise makes 
the expectation tenable that a polyphenol-rich tart cherry rich supplement has the 
potential to improve performance.   Consequently the overarching aim of this 
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thesis was to investigate the application of Montmorency, a specific cultivar of tart 
cherry, supplementation in both health and exercise paradigms.  Specifically, the 
course of research is broken in to five aims that are systematically addressed in 
four experimental chapters 
 
1) Establish the polyphenol content of a commercially available 
Montmorency tart cherry juice, and the plasma bioavailability of principal 
downstream metabolites. 
2) Examine the effects of phenolic acids on vascular smooth muscle cells 
in vitro. 
3) Examine whether MC supplementation can improve indices of vascular 
function in males with early hypertension.  
4) Examine whether MC supplementation can improve cerebral blood flow 
and cognition in middle aged adults.  
5) Examine the effects of MC supplementation on V̇O2 kinetics and 
exercise performance. 
 
 
 
 
 
 
 
 
 
 
 
 
 
24 
 
 
 
 
 
 
2 Literature Review 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
25 
2.1 Introduction  
 
Given the diverse nature of this thesis which focuses on the application of tart 
cherries in health and exercise paradigms, this review will examine the literature 
pertaining to the following areas:  
 Polyphenol structure and function with particular emphasis on those present 
in tart cherries.  
 The bioavailability and the factors that affect the bioavailability of phenolic 
compounds in tart cherries.  
 The potential mechanisms of action of polyphenols. 
 The effects of tart cherry supplementation on various aspects of health and 
exercise.  
 
Traditional medicines of ancient cultures like the Chinese, Egyptian, Asian, and 
Native Americans demonstrated an early knowledge of the use of plant 
constituents for preventing and curing diseases, and maintaining good health 
(Parkins, 2001; Higdon, 2007).  In the past two to three decades there has been a 
growing awareness of the role of diet in the aetiology of chronic diseases, notably 
cardiovascular disease and cancer (World Health Organisation, 2016). A wide 
range of bioactive substances, including polyphenols have been identified in food 
and beverages, and it is likely that many more exist.  Epidemiological studies have 
suggested that there is an inverse relationship between the consumption of foods 
rich in polyphenolic compounds, and the incidence of the aforementioned chronic 
diseases, indicating that these dietary polyphenols are involved in enhancing long 
term health (Scalbert et al., 2005).   
 2.2 Functional foods 
 
The term “functional foods” was first introduced in Japan in the 1980s.  The British 
Nutrition Foundation gave its own definition of functional foods in one of its expert 
reports. It states that functional foods deliver additional or enhanced benefits over 
and above their basic nutritional value (British Nutrition Foundation, 2016).  Other 
respected agencies in the world, such as the Mayo Clinic in the United States, 
have similar definitions describing functional foods as food that are similar in 
appearance to a conventional food, consumed as part of the usual diet, with 
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demonstrated physiological benefits, and/or to reduce the risk of chronic disease 
beyond basic nutritional functions. 
Research into functional foods supplementation in health and exercise science 
has gained momentum in recent years.  This interest stems from the observation 
that functional foods contain a variety of naturally occurring polyphenols, (i.e.., 
flavonoids, anthocyanins) (Myburgh, 2014). These polyphenols appear to exhibit a 
broad range of beneficial physiological effects that include, but are not limited to, 
AOX and anti-inflammatory properties (Nikolaidis et al., 2012a; Sousa et al., 2013; 
Urso, 2013).  Beetroot juice (Bailey et al., 2009b; 2010, Vanhatalo et al., 2010b, 
Lansley et al., 2011a; 2011b, Ferreira and Behnke, 2010, Clifford et al., 2016), 
purple sweet potatoes (Chang et al., 2007; 2011), blueberries (McAnulty et al., 
2011, Sanchez-Moreno et al., 2008), pomegranate juice (Trombold et al., 2010; 
2011), green tea (Jowko et al., 2011, Eichenberger et al., 2010), lychee extract 
(Kang et al., 2012, Nishizawa et al., 2011) and tart cherries (Connolly et al., 2006b, 
Howatson et al., 2010; 2012a; 2012b) Bowtell et al., 2011, Kuehl et al., 2010, 
Ducharme et al., 2009; Bell et al., 2015;2016) have received varying degrees of 
attention in relation to their purported applications in both health and exercise.  
The last of these, cherries, have provided several avenues for research because 
of the high levels of polyphenols present within them and compare favourably with 
other functional foods (Clifford, 2000, Table 1).   
Tart cherries, also known as sour cherries, specifically the cultivar Montmorency 
tart cherry is a variety of cherry native to the United States, Canada and France 
that is very high in polyphenols.  Montmorency cherries are widely available and 
are consumed in their raw state, cooked, dried, powdered, juiced and used as 
concentrated extracts.  Montmorency tart cherry supplementation has received 
widespread attention for its application in both health and exercise, which will be 
discussed in more detail in sections 2.5 and 2.6 of this review. These exercise and 
health-related benefits have been postulated to arise from the high anthocyanin 
content (Kim et al., 2005). The major anthocyanin constituents of tart cherries are 
cyanidin 3-glucosylrutinoside, followed by cyanidin 3-rutinoside, cyanidin 
sophoroside, and peonidin 3-glucoside (Kirakosyan et al., 2009).  However, tart 
cherries and their processed products have been shown to be high in numerous 
other polyphenolic compounds (Wang et al., 1999; Seeram et al., 2001). Amongst 
the 20 most commonly consumed fruits, cherries appear to have the fifth highest 
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total phenol content (Vinson et al., 2001). Data supports the presence of several 
other polyphenols in Montmorency tart cherries including the flavonoids 
isorhamnetin, kaempferol, quercetin, catechin, epicatechin and procyanidins (Kim 
et al., 2005; Blando et al., 2004) and non-flavonoid phenolic acids (Jakobek et al., 
2007). The following section will attempt to classify these compounds with 
particular emphasis on those present in tart cherries.    
Table 1 - Anthocyanin concentration of various fruit juices.  Adapted from Clifford 
(2000). 
Food 
Anthocyanin content 
(mg.L-1) 
Montmorency Tart Cherry Juice 
9117 (Biosciences, 
2010) 
Blackberry 1150 
Blueberry 825-4200 
Grape (Red) 300-7500 
Sweet cherry 20-4500 
Strawberry 150-350 
Cranberry 600-2000 
 
2.2 Polyphenols or secondary metabolites in plants 
 
Plants synthesise a vast range of organic compounds that traditionally are 
classified as primary and secondary metabolites, although the precise boundaries 
between the two groups can, in some instances, be blurred.  Primary metabolites 
are compounds that have essential roles in photosynthesis, respiration, growth 
and development (Heldt, 2005) that include acyl lipids, nucleotides and amino 
acids, amongst others.  Secondary metabolites, which accumulate in large 
quantities in certain species, are diverse structurally.  Although long ignored, the 
function of these compounds is now attracting widespread attention (Goldberg, 
2003).  Unlike the other nutrients i.e.. carbohydrates and protein, they appear not 
to be essential for short-term well-being, but there is increasing evidence that long-
term intakes may have favourable impacts on various health markers. 
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Based on their biosynthetic origins, plant secondary metabolites can be divided 
into three major groups as seen below.  Of the three, phenolic compounds are of 
most interest in this review as they and their subclasses are found in abundance in 
tart cherries. 
1. Terpenoids 
2. Nitrogen-containing alkaloids and sulphur containing compounds  
3. Phenolic compounds 
2.2.1 Terpenoids 
 
Terpenoids represent the most structurally varied class of polyphenols with more 
than 30,000 compounds identified.  The name terpenoid derives from the fact that 
the first members of the class were isolated from turpentine (Croteau et al., 2000).  
All terpenoids are derived by repetitive fusion of branched five-carbon units based 
on an isopentane skeleton.  Carotenoids are an example of tetraterpenoids, a 
family of C40 compounds, which carry out essential functions in the life cycle of 
green plant.  They also play a role in human health by virtue of their metabolism to 
vitamin A (retinol) which is involved in sight, growth and development process and 
its deficiency in humans can have serious consequences for long-term health 
(Beyer et al., 2002).  Tart cherries have been shown to be high in beta carotene, 
containing roughly 770 µg (Ferretti et al., 2010), however terpenoids are not of 
particular interest in the current thesis.  
2.2.2 Nitrogen-containing alkaloids and sulphur containing compounds 
 
Alkaloid compounds have a 3000-year history of human use.  They are nitrogen 
containing compounds synthesized principally, but not exclusively, from amino 
acids.  Because of their various pharmacological activities, alkaloids have 
influenced human history profoundly, for both good and ill.   Atropine, chloroquine, 
heroin, cocaine, caffeine, nicotine are some of the alkaloids that have influenced 
medicine, societies and even geopolitics (Zulak et al., 2006).  The main sulphur 
compounds in the human diet are the glucosinolates found in cruciferous crops 
like cabbages, broccoli, watercress, and the allium compounds in Allium crops 
including garlic, onions and leeks (Mithen, 2006).  Tart cherries have not been 
shown to possess any of these compounds.  
 
29 
2.2.3 Classification of phenolic compounds 
 
Phenolics are secondary metabolites characterized by having at least one 
aromatic ring with one or more hydroxyl group attached.  In excess of 800 phenolic 
structures have been reported and they are widely dispersed throughout the plant 
kingdom (Strack & Wray, 1994; Strack, 1997).  Accounting for about 40% of 
organic carbon circulating in the biosphere, these phenolics are primarily derived 
from the phenylpropanoid and phenylpropanoid-acetate pathways in which p-
coumaric acid is a key compound (Crozier et al., 2006).  Phenolics range from 
simple, low molecular weight, single aromatic-ringed compounds to large and 
complex tannins and derived polyphenols.  Phenolic compounds are concentrated 
in the skin and contribute to sensory and organoleptic qualities of fruits and 
vegetables, such as taste and astringency. They can be classified into two main 
groups: flavonoids, a structurally diverse group of C15 compounds arranged in a 
C6-C3-C6 configuration and non-flavonoids which include condensed and 
hydrolysable tannins, stilbenes, phenolic acids and hydroxycinnamates.  The term 
polyphenol is therefore very much an umbrella term for this abundance of 
compounds which can be subcategorised into smaller and more appropriate 
groups. Figure 1 provides a simplified diagram of these groups and some 
examples of dietary sources. 
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Figure 1- Main sub-groups of polyphenols and examples of dietary sources. Phenolic acids are included for completeness 
but are not technically ‘poly’phenols due to the presence of only 1 phenol group. Chemical structures in diagram are 
adapted from Kennedy et al. (2010) 
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2.2.3.1 Flavonoids 
 
Flavanoids are the most abundant of the phenolics and are found throughout the 
plant kingdom.  The flavonoids are compounds based upon a C6-C3-C6 structure.  
This structure is the product of two separate biosynthetic pathways formed by two 
aromatic rings, linked together by three carbon atoms forming oxygenated 
heterocycle.  This basic flavonoid structure can have numerous substituents as a 
function of the type of heterocycle (the C ring), and as a results can be further 
divided into several sub-classes.  It has previously been reported that tart cherries 
are very high in flavonoids (Blando et al., 2004) which is discussed in the following 
sub-sections. Figure 3 provides a general overview of the polyphenols that have 
been identified in tart cherries to date; each will be discussed in more detail in the 
forthcoming sections. 
 
Figure 2 – What is in a tart cherry? A summary of the main polyphenols present in 
tart cherries 
2.2.3.1.1 Flavonols  
 
Flavonols are arguably the most widespread of the flavonoids.  The distribution 
and structural variations of flavonols have been well documented (Williams & 
Harbone, 1992; Wollenweber, 1992).  They have a double bond between C2 and 
C3, with a hydroxyl group in the C3-position.  Querectin is the most represented 
flavonol, alongside myricetin, isorhamnetin and kaempferol, all of which are 
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commonly found as O-glycosides.  The main dietary sources are onions, curly kale, 
broccoli and blueberries (D’Archivio et al., 2007).  With that said, various 
kaempferol and quercetin glucosides have been identified in Montmorency tart 
cherries (Shrikhande & Francis, 1973; Schaller & Von Elbe, 1970) 
2.2.3.1.2 Flavones 
 
In terms of their structure, flavones are very similar to flavonols, differing only in 
the absence of hydroxylation at the 3-position in the C-ring.  However, flavones 
are far less distributed.  Most flavones occur as 7-O-glycosides (Bohm, 1998).  
The only edible dietary sources include parsley and celery, with some 
polymethoxylated flavones contained in citrus species (Ooghe et al., 1994) and 
chrysin, a naturally occurring flavone, and tectochrysin, a chemical compound, 
have both been reported from the bark of tart cherries (Geibel et al., 1990), but not 
in the whole fruit.   
2.2.3.1.3 Flavan-3-ols 
 
Flavan-3-ols (also known as flavanols) are the most complex subclass of 
flavonoids as they exist as both the monomer (catechins) and the polymer 
(proanthocyanidins) form.  They contain a saturated 3-carbon chain with a 
hydroxyl group in the C3, however any further information on their structure is 
unknown.  Unlike the majority of other flavonoid subclasses, flavan-3-ols are not 
glycosylated in foods.  The main dietary sources of flavan-3-ols are fruit.  Tart 
cherries belong to a group of fruits with the highest content of catechins 
(Czyzowska & Pogorzelski, 2004).  Other common dietary sources of flavan-3-ols 
are tea (Arts et al., 2000) and red wine (Sun et al., 1999).  
2.2.3.1.4 Anthocyanidins 
 
Anthocyanidins are widely dispersed in the plant kingdom, especially in fruit and 
flower tissues where they are responsible for the red, blue and purple colours 
(Mazza, 2004).  They have an important role for attracting insects to flowers to 
facilitate pollination and are involved in protecting the plant against UV light 
(Crozier, 2003).  However, interest in anthocyanins has recently intensified 
because of their possible health benefits (Blando et al., 2004) discussed in section 
2.6. They are found primarily as glycosides of their respective aglycones form, 
anthocyanins.  Cyanidin, malvidin, peonidin, delphinidin, pelargonidin, petunidin 
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are the most common anthocyanidins.  The main dietary sources are cereals, 
vegetables, with the highest concentrations present in fruits (D’Archivio et al., 
2007).  Tart cherry fruits and their relevant processed food products have already 
been shown to be a rich source of dietary anthocyanins with cyanidin and peonidin 
the two major contributors (Ou et al., 2012; Kirakosyan et al., 2009).  However it is 
important to note that a large proportion of ingested anthocyanins may also be 
degraded into phenolic acids and aldehyde, discussed later. Yet there is still 
considerable uncertainty as to what occurs in vivo. In one paper, protocatechuic 
acid was reported to be a major metabolite of cyanidin glycoside in humans 
(Vitaglione et al., 2007), yet subsequent papers have failed to detect 
protocatechuic acid in rat blood plasma, stating protocatechuic acid is not a major 
intestinal metabolites of cyanidin glycosides (Ichiyanagi et al., 2007). Reasons for 
these discrepancies may be due to substantial degradation reactions within the 
small intestine and colon and further conjugation reactions occurring in the 
intestine, kidneys or liver which is discussed in later sections of this review. 
2.2.3.1.5 Flavanones 
 
A few decades ago, flavanones were considered as only minor flavonoids (Bohm, 
1994) However, more recently the total number of known flavanones has 
increased to the point that they are now considered a major flavonoid class 
(Grayer and Veitch, 2006).  Flavanones are first products of the flavonoid 
biosynthetic pathway and are characterized by the absence of the C2-C3 double 
bond and the presence of a chiral centre at C2.  These structures have been found 
to be highly reactive and undergo hydroxylation, glycosylation and O-methylation 
reactions.  The main dietary sources of flavanones are citrus fruits, with the 
highest concentrations found in peel (Nogata et al., 2006).  Flavanones such as 
naringenin, prunin and sakuranin have been reported from the bark of tart cherries 
(Geibel, 1995; Geibel & Feucht, 1991; Wang et al., 1999) but not yet in the whole 
fruit. 
2.2.3.1.6 Isoflavone 
 
Similar to flavanones, isoflavones are also derived from the flavonoid biosynthetic 
pathway.  In terms of their structure, they have been likened to estrogen in that the 
hydroxyl groups are located in C7 and C4 positions, like estradiol (D’Archivio et al., 
2007).  As with the majority of the flavonoid family, they undergo several reactions 
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including hydroxylation, glycosylation and methylation (Dewick, 2002). Isoflavones 
are distributed throughout the plant kingdom but the main dietary sources are 
legumes i.e. soya bean (Eisen et al., 2003), however certain variations of genistein 
and prunetin have been found from the tart cherry bark (Geibel, 1995; Wang et al., 
1999).   
2.2.3.2 Non – flavonoids 
 
The main non-flavonoids of dietary significance are subdivided into stilbenes, 
hydroxycinnamates, phenolic acids and other minor families. Both 
hydroxycinnamates and phenolic acids have been found in tart cherries and will be 
discussed in more detail in the forthcoming sections.  
2.2.3.2.1 Stilbenes 
 
Members of the stilbene family have a C6-C2-C6 structure, and as a result are 
considered polyphenolic compounds.  Stilbenes are produced in plants as a 
defence response to stress, microbial infection and UV irradiation (Fremont, 2000).  
Very low quantities are present in the human diet, mainly found in red grapes, 
wines and cranberries (Mulat et al., 2014), with resveratrol (3,5,4′- 
trihydroxystilbene) the most widely representative of the group.  Resveratrol is a 
phytoalexin found in red wine that has received attention in recent years for its 
potential beneficial effects on human health (Smoliga, 2011). Salimi et al. (2014) 
reported that sour cherry seed kernel extract is composed of 1% stilbenes, 
however to date; stilbenes have not been identified in whole Montmorency tart 
cherries. 
2.2.3.2.2 Phenolic acids 
 
The C6-C1 phenolic acids (also commonly known as hydroxybenzoates) have 
gallic acid as their principal component and are produced in plants via shikimic 
acid through the phenylpropanoid pathway, as by-products of the monolignol 
pathway and as breakdown products of lignin and cell wall polymers in vascular 
plant (Harkin, 1973)   These provide unique taste, flavour and health-promoting 
properties and are found in many vegetables and fruits (Tomas-Barberan & Espin, 
2001). Tart cherries, for one have been shown to contain very small quantities of 
phenolic acids (Kim et al., 2005).  Interestingly, as mentioned in Section 2.2.3.1.4, 
the concentrations of these compounds in vivo are often higher than the quantity 
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ingested, as the majority agree that they represent the major human metabolites of 
anthocyanins (Scalber and Williamson, 2000) (Figure 3).  This has been verified 
with anthocyanins such as cyanidin-3-glucoside, the most represented 
anthocyanin in tart cherries (Vitaglione et al., 2007).  This degradation occurs 
normally as a result of exposure to neutral pH, temperature or enzymes (β-
glucosidase) i.e.. the warm, basic physiochemical conditions found in the 
gastrointestinal tract (Seeram et al., 2001; Kay et al., 2009; Woodward et al., 2009) 
and will be discussed in more detail in section 2.3 and 2.4 of this review.  Figure 3 
demonstrates the degradation of all primary anthocyanins into their respective 
phenolic acids. 
 
 Anthocyanidin Phenolic Acid R1 R2 
Cyanidin Protocatechuic acid -OH -H 
 Delphinidin Gallic acid -OH -OH 
 Malvidin Syringic acid -OCH3 -OCH3 
 Pelargonidin 4-Hydroxybenzoic 
acid 
-H -H 
 Peonidin Vanillic acid -OCH3 -H 
 Petunidin 3-Methylgallic acid -OH -OCH3 
Figure 3 - Degradation of anthocyanidins into phenolic acids and aldehyde.  R1 
and R2 represent functional groups. Adapted from (Keppler and Humpf, 2005; 
Fleschhut et al., 2006). 
 
2.2.3.2.3 Hydroxycinnamates 
 
Hydroxycinnamates are derivatives of cinnamic acid, a C6-C3 compound produced 
by phenylalanine ammonia lyase-catalysed deamination of the amino acid 
phenylalanine.  The most common types are caffeic, p-coumaric, ferulic and 
sinapic acids.  These are produced by the phenylpropanoid pathway via a series 
of hydroxylation and methylation reactions.  Hydroxycinnamates are very rarely 
found in their free form, tending to accumulate as glycosylated conjugates in most 
plant tissues including pollen (Harborne, 1993).  The main dietary sources are 
coffee, fruit and cereal grains (Sosulski et al., 1982).  Chlorogenic and 
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neochlorogenic acid (Wang et al., 1999), p-coumaric (Kim et al., 2005) and 
isomers of caffeic and ferulic acid have all been identified in tart cherries (Schaller 
and Von Elbe, 1970) 
To summarise, the structure and function of some of the polyphenols present in 
tart cherries, particularly in relation to anthocyanin content have been well 
documented (Blando et al., 2004; Kirakosyan et al., 2009; Ou et al., 2012 Bell et 
al., 2014).  However, a detailed investigation of other phenolic compounds in tart 
cherries would be beneficial and although recent literature has shed some light on 
the downstream metabolites and bioavailability of these compounds, further 
research is needed. 
2.3 Bioavailability of phenolics 
 
When we consume a food or drink, the nutrients contained are released from the 
matrix, absorbed into the bloodstream and transported to their respective target 
tissues. However, not all nutrients can be utilised to the same extent. In other 
words, they differ in their bioavailability. This section will provide an overview of 
the bioavailability of polyphenols and describe the different steps of the metabolic 
pathway where changes in bioavailability may occur.  Moreover, this section will 
examine the literature on Montmorency tart cherry bioavailability as well as 
highlighting key factors that affect the bioavailability of these compounds and as a 
result, their biological action.   
For a food component to be considered beneficial for health it must be bioavailable 
in vivo, that is, following ingestion, the active compounds are absorbed through the 
gastro-intestinal tract and made available in the circulation, in sufficient quantities, 
to be utilized by cells (Toutain & Bousquet-Melou, 2004). There are several 
definitions of bioavailability but the one that is most appropriate in nutrition 
research was described by Pandey and Rizvi (2009) as the proportion of the 
nutrient that is digested, absorbed and metabolised through normal pathways and 
distribution to target tissue.  However, in vivo activity is largely dependent on the 
extent and manner of metabolism, with colonic microflora, the rate of excretion and 
the degree of retention in body tissues also playing a large part.  As a result, Holst 
and Williamson, (2004) extended the classical pharmacological definition of 
bioavailability as a series of linked and integrated processes including liberation, 
absorption, distribution, metabolism and excretion. 
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The pharmacokinetic profile of a food or compound can be determined 
experimentally by the oral administration of a single dose of a phenolic-rich food or 
a pure compound to animals or humans.   The peak plasma levels (cmax), the time 
to reach the peak plasma concentration (tmax) and the area under the curve (AUC) 
of plasma concentration vs time are then calculated.  The chemical structure of 
polyphenols which was previously discussed in section 2.2.3, will inevitably 
determine their rate and extent of intestinal absorption and the nature of the 
metabolites circulating in the plasma (D’Archivio et al., 2007).  A detailed review 
on the bioavailability of polyphenols in humans was published in 2005 (Manach et 
al 2005a) that showed large variability in polyphenol and flavonoid bioavailability 
(Figure 4). In this example, expressed by urinary excretions (as % of intake), 
ranging from 0% (epigallocatechin gallate; EGCG) to above 60% (daidzin).   
 
Figure 4 - Recoveries of different groups of phenolics in urine (Manach et al., 
2005). 
 
The route of absorption and metabolism of phenolics is shown in Figure 5.  The 
polyphenol chemical transformation in the oral cavity has not yet been fully 
elucidated due to the limited number of published studies (Vacek et al., 2010).  
Based on the short interaction time, the impact of enzymatic digestion on 
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polyphenol release is assumed to be low (Laurent et al., 2007).  Nevertheless, 
there is some existing evidence to suggest a partial participation in glycoside 
hydrolysis by the salivary enzymes (Ice and Wender, 1953), microbiota or oral 
epithelial cells (Walle et al., 2005). Furthermore, catechol containing compounds 
such as chlorogenic acid and (+)-catechin, have been shown to increase nitric 
oxide bioavailability when exposed to saliva (Peri et al., 2005).  Dietary phenolics 
then pass through the stomach where they are reduced to even smaller particles 
thus enhancing the release of phenolic compounds from the food matrix (Scalbert 
et al., 2002). Polyphenols are extensively modified during the absorption period, 
with the hydrolysis of the glycosides continued by the intestinal enzyme systems 
[lactase phlorizin hydrolase (LPH) or β-glucoside (CBG) in the small intestine, 
however not all of ingested dietary polyphenols are metabolized in the stomach or 
small intestine and may reach the colon where they can be metabolized by the 
colonic bacteria, α-rhamnosidases, resulting in a conjugated derivatives (Lampe, 
2003).  This metabolic process of deglycosylation is named phase I metabolism. 
This phase also includes other chemical reactons namely oxidations, reductions 
and/or hydrolytic pathways adding a function group (e.g., OH, SH, NH2) to the 
phenolic molecule (Parkinson, 1996).   
During the course of absorption, these modifications means that the forms 
reaching the blood and tissues are different from those present in the food and it is 
very difficult to identify all the metabolites and evaulate their biological activity (Day 
et al., 2001).  Certain compounds are never glycosylated i.e.. (-)-epicatechin, and 
are absorbed at enterocyte level without any deconjugation or hydrolysis. Once a 
final derivative has been absorbed, either in the small intestine or the colon, it 
undergoes some degree of phase II metabolism.  On entering the circulatory 
system, they are transported to the liver via the portal vein where they may undero 
further phase II metabolism (conjugation reactions, including methylation, 
glucuronidation and/or sulphastion) which occurs in the brush border of the 
epithelial cells (Vacek et al., 2010) and transported to the bloodstream until they 
are secreted.   Some of the liver conjugates are then excreted as bile components 
back to the small intestine (enterohepatic recirculation) and deconjugated 
compounds are regenerated by gut microbial enzymes before being reabsorbed 
again (Aura, 2008).  The unabsorbed compounds and metabolites are excreted via 
faeces.   
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To summarise, the concept of bioavailability integrates several variables including 
intestinal absorption, distribution, microflora metabolism, nature of circulating 
metabolites and excretion.  The evaluation of polyphenol bioavailability has 
recently been gaining increasing interest as the health benefits of polyphenols are 
largely dependent upon their bioavailability (Koli et al., 2010). Despite this sudden 
popularity and the amount of available data, definitive conclusions on 
bioavailability of most polyphenol compounds are difficult to obtain and further 
studies are necessary. There is no single approach recommended but techniques 
like radiolabelled compounds, microflora composition, in vitro fermentation or 
intervention studies with ileostomy volunteers could provide new insights into the 
metabolism of polyphenols.  This is a fundamental part to fully understanding the 
potential role of polyphenols in human health and exercise performance. 
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Figure 5 - Absorption and metabolism routes for dietary polyphenols and their derivatives in humans. 
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2.3.1 Bioavailability of tart cherries 
 
It is critically important that any alleged health benefit of a food source be firstly 
verified with well-designed bioavailability studies that characterise the extent of its 
in vivo absorption (Rein et al., 2013). In recent years, there has been an attempt 
made to identify the bioavailability of polyphenolic compounds in tart cherries.   A 
previous pharmacokinetic study on whole tart cherry intake in humans showed that 
the consumption of whole fruit tart cherries resulted in the appearance of two 
unmodified anthocyanins in plasma: cyanidin 3-glucosylrutinoside and cyanidin-3-
rutinoside, and three modified anthocyanins in urine: cyanidin-xylosylxyloside, 
pelarogonidin-xylosylxyloside, and methylated peonidin-xylosyloside (Uhley et al., 
2009).   More recently, Seymour and colleagues (2014) investigated anthocyanin 
pharmacokinetics in 12 healthy humans following intake of either 45 or 90 cherries.  
Similiar to the finding reported previously, LC-MS/MS identified cyanidin-3-
glucosylrutinoside and cyanidin-3-rutinoside in plasma and also cyanidin glycoside, 
peonidin glycoside or methylated cyanidin glycoside and a pelargonidin metabolite 
with an undetermined conjugate moiety in urine post tart cherry consumption.  
Interestingly, there were no significant differences between the low and high 
cherry dose, the only noticable difference was the times the compounds needed to 
achieve maximum plasma concentrations (tmax), this differed by compound 
detected (Figure 6).  
 
Figure 6 - Plasma anthocyanins cyanidin-3-glucosylrutinoside (C3GR) and 
cyanidin rutinoside (C3R) (representative plasma sample). 90 CHE = 90 cherries; 
45 CHE = 45 cherries. 
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This same group also confirmed and identified the presence of tart cherry 
anthocyanins in several target tissues of healthy rats (Kirakosyan et al., 2015).  
They showed that four native anthocyanins were located in the bladder, kidney, 
liver, heart and brain of the rats post consumption.  The detection of these native 
anthocyanins in the heart, brain and other tissues may correlate with some of the 
health-enhancing benefits of tart cherries particurily in relation to  transcription 
factors and AOX and anti-inflammatory defence (Seymour et al., 2009; 2013).   
However, it is not yet known if tart cherry anthocyanins accummulate  in skeletal or 
smooth muscle. 
Taken together, the results of the aforementioned studies provide a good base of 
evidence that tart cherries are a bioavailable source of bioactive compounds 
(particularly anthocyanins) in humans and animals. With that said, anthocyanins 
have a very short half life which indiciates that their concentration in the body is 
decreased by half the original value very quickly and as a result future work should 
focus on the bioavailability of other polyphenolic compounds.  Findings from these 
extended pharmacokinetic studies with tart cherries would reveal their breadth of 
bioavailability and potential health-enhancing properties.  
 
2.3.2 Factors affecting bioavailability of tart cherries 
 
There are several factors that affect the bioavailability of polyphenol compounds, 
these are summarised in Table 2. As previously mentioned, one of the major 
factors affecting bioavailability is the chemical structure of the compound, with the 
type of the sugar in the glycoside also determining the rate and extent of intestinal 
absorption.  External factors or “pre-harvest” factors such as environmental ones 
i.e. rainfall, temperature, sun exposure and light intensity (Manach, 2004) can 
have a massive bearing on the polyphenol content and nutritional value of cherries.  
It has previously been shown that high temperature growing conditions (25/30ºC) 
significantly enhances the total phenolic content of cherries (Wang et al., 2006).  
Furthermore, the degree of ripeness can affect both the concentration and 
proportion of various polyphenols, more often than not phenolic acid 
concentrations decrease during ripening, whilst anthocyanin concentrations 
increase (Macheix et al., 1990).  For all cherry cultivars, during this stage the 
ripening process advances, acidity decrease and colour intensity increases due to 
the elevation in anthocyanins (Ferretti et al., 2010).   
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“Post-harvest” factors such as food processing related factors, transport and 
storage can also affect the polyphenolic content of cherries and other foods.  
Thermal processing methods can reduce the total phenol content and, 
consequently, the AOX activity of foods (Xu & Chang, 2009).   During canning, it 
has been reported that roughly half the anthocyanins and polyphenolics leach from 
the fruit into the syrup.  Heat processing did not result in a loss of total 
anthocyanins, total phenolics, and AOX activity when the values for syrup and 
cherries were combined. In fact, samples show an apparent slight increase in total 
anthocyanin content with canning. This might be due to increased extraction 
efficiency in the softened fruits. 
Additionally, cooking and the methods of food preparation can also have a 
remarkable effect on polyphenol content (Ferracan et al., 2008), with boiling, 
steaming and frying all having different effects (Miglio et al., 2008).  A decrease in 
polyphenol content is typically associated with storage duration.  More than 75% of 
anthocyanins in frozen Bing cherries were destroyed after 6 months of storage at -
23°C (Chaovanalikit & Wrolstad, 2004). However, during postharvest storage the 
ripening process advances, acidity decreases and anthocyanins as well as colour 
intensity increases.  During cold storage and subsequent shelf-life, a general 
increase (over 40 – 60% on average) in phenolic compounds was reported 
(Serrano et al., 2009; Goncalves et al., 2004).  Direct interaction between 
polyphenols and other food components have been shown to effect bioavailability 
with the capacity of polyphenols and their metabolites to bind to proteins been 
often highlighted (Manach et al., 2004).  
Effects of the harvest year and the harvest time on anthocyanin concentrations 
also have been reported (Poll et al., 2003).  The highest levels of nutrients and 
bioactive food components were found in the year characterized by the highest 
temperature and greatest solar radiation exposure.  The cyanidin-3-glucoside 
equivalent anthocyanin concentrations in the harvested cherry juice varied from as 
low as 500 mg/L to as high as 2300 mg/L. In fact, ultra violet light (UV-light) has 
reportedly increased anthocyanin concentrations of sweet cherries (Arakawa, 
1993).  Although tart cherries are a bit easier than sweet cherries to cultivate, as 
they are more tolerant of frost as well as humidity and precipitation, there are still 
big differences in annual crops which may have implications for the proposed 
health benefits of tart cherries.  
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Finally, host related factors can be subdivided into intestinal factors (arguably the 
most important) and systemic factors.  Intestinal factors include variations in 
enzyme activity and colonic microflora, for examples; only 30-40% of the 
occidental people excrete significant quantities of equol after the consumption of 
isoflavones (Setchell et al., 2002), while the Japanese excrete up to 60% (Morton 
et al., 2002). Bioavailability can also depend on systemic factors including genetic 
characteristics, gender and age. The main factors that affect polyphenol 
bioavailability are summarised in Table 2. 
Table 2  - Main factors affecting the bioavailability of dietary polyphenols in 
humans. 
Polyphenol related 
factors 
Chemical structure; concentration in food; amount 
administered 
Food processing related 
factors 
Thermal treatments; storage; homogenization, food 
preparation 
Food related factors Food matrix; presences of positive or negative 
effectors of absorption (i.e.., fat, fibre) 
Interaction with other 
compounds 
Bonds with proteins (i.e.., albumin) or with 
polyphenols with similar mechanism of absorption 
Growing conditions Weather, radiation exposure 
Host related factors Intestinal factors (i.e.., variations in enzyme activity; 
colonic microflora) Systemic factors (i.e.., gender; 
age; genetics; disorders) 
 
Bioavailability studies are often difficult to accomplish due to several complexities 
involved in the biological system, 1) variation in food materials and the human 
subjects or surrogate models which are not always representative; 2) complex 
interactions amongst huge chemicals/food components during post-harvest, 
storage, processing, digestion, and absorption that may alter health benefits; and 
3) mechanism pathways (Epriliati & Ginjom, 2012), the last of which will be 
discussed in the forthcoming section.  
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2.4 Mechanism of action of flavonoids and phenolic acids  
 
Tart cherries, specifically polyphenols are receiving increasing interest from 
consumers and food manufacturers as epidemiological studies have suggested 
associations between the consumption of polyphenol-rich foods and the 
prevention of diseases including cancers and heart disease (Yang et al., 2001; 
Nobili et al., 2009).  However, many studies often report biological effects of food 
polyphenols, without elucidating the underlying molecular, cellular, and 
physiological mechanisms due to their complex mechanistic nature. Despite 
difficulties in defining the mechanisms, previous work has shed light on more 
detailed underlying bioactive actions of polyphenols and thus, the potential 
protective and health-enhancing properties of tart cherries.  Initially, the focal 
reason for this interest was the identification of the potential AOX properties 
associated with polyphenol compounds.  This section will present the original AOX 
hypothesis and the more recently presented competing hypotheses that go 
beyond the AOX theory.    
 
2.4.1 The AOX Hypothesis  
 
The AOX hypothesis has its origins in 1954 when Harman published his free 
radical theory of aging (FRTA) and the simultaneous discovery of the free radicals 
in endogenous metabolic reactions.  The FRTA considered reactive oxygen 
species to be one of the main reasons for the ageing process, including age 
related disorders such as cancers, diabetes and cardiovascular diseases.  
Consequently, it was felt there was an important need for the protection against 
these species by means of a high intake of exogenous AOX.  The AOX properties 
of plant phenolics are due to the hydrogen of the phenoxyl groups that is prone to 
be donated to a radical, and by the ensuing structure that is chemically stabilized 
by resonance (Bors et al., 1997).  As mentioned previously, most polyphenols are 
modified during absorption from the small intestine, through conjugation and 
metabolism, and by the large intestine, mainly through the action of colonic 
bacteria and by subsequent hepatic metabolism. Thus, flavonoid metabolites that 
reach the cells and tissues are chemically, biologically and probably functionally 
different from the ingested dietary form (Kroon et al., 2004). In terms of AOX 
activity, glucuronidation or sulphation of quercetin, for example, reduces its free 
radical scavenging activity (Morand et al., 1998).   
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Tart cherries have previously been shown to possess high amounts of AOX, and 
as a result reduce inflammation and oxidative stress (Howatson et al., 2010; Bell 
et al., 2013; 2014; 2016). The AOX hypothesis has been substantiated greatly by 
many investigations in the past fifty years, which have demonstrated that a high 
intake of AOX- and polyphenolic-rich fruit and vegetables have an inverse 
relationship with the incidence of many chronic disorders (Yang et al., 2001; 
Chong et al., 2010); therefore making it a plausible mechanism by which tart 
cherries could improve cardiovascular function.  
However, accumulating evidence has shown that not all polyphenolics are readily 
bioavailable, reaching only low µM concentrations in plasma, despite a large 
intake.  Additionally, most of these compounds are also extensively metabolized in 
vivo (see Section 2.3), and this can adversely affect their “natural” AOX activity 
(Lottito and Frei, 2006).  As a result, it would now appear that the AOX concept is 
an oversimplified view of the polyphenol mode of action (Azzi et al., 2004).   
 
2.4.2 Other mechanisms beyond the AOX hypothesis  
 
As previously mentioned, the AOX view is being challenged by recent research 
and far more complex actions are under investigation (Chiva-Blanch and Visioli, 
2012; Watson et al., 2014).  In the past few years, research on polyphenols has 
expanded remarkably and is unveiling several nutrition pharma-biological activities 
of these compounds, most of which extend beyond AOX activity. 
 
2.4.2.1 Cellular signalling pathways 
 
The possibility that polyphenols may also modulate cellular signalling arose from 
the failure to explain the anti-inflammatory, antitumor, and anti-atherogenic abilities 
of polyphenols solely on the basis of their AOX properties.  Polyphenols merely do 
not act as free radical scavengers, but may also modulate cellular signalling 
processes during inflammation or may themselves serves as signalling agents 
(Rahman et al., 2006).   Cellular signal transduction refers to any process by which 
a cell convert one kind of signal or stimulus into another, most often involving 
ordered sequences of biochemical reactions inside the cell, that are carried out by 
enzymes and linked through second messengers resulting in what is known as a 
second messenger pathway.  There is now evidence that polyphenols may play a 
role as modulators of cascade signalling mechanisms (Williams et al., 2004).   It is 
47 
likely that cells respond to polyphenols mainly through direct interactions with 
receptors or enzymes involved in signal transduction, which may result in 
modification of the redox status of the cell and may trigger a series of redox-
dependent reactions (Halliwell et al., 2005; Moskaug et al., 2005; Forman et al., 
2002).   
Some reports indicate that polyphenols can selectively regulate multiple signalling 
pathways at the level of transcription, especially those involving nitrogen-activated 
protein kinases (Frigo et al., 2002). Furthermore, polyphenols such as resveratrol, 
epigallocatechin gallate, gingerol, phytosterol, and myricetin directly influence 
various molecular signal transduction pathways like inflammation cascade, cell 
proliferation/migration, oxidative stress, and metabolic disorders, which are 
involved in the development of several noncommunicable diseases (Upadhyay & 
Dixit, 2015).  Therefore, it is possible that the polyphenols present in tart cherries 
may have similar effects.  
2.4.2.2 Modulation of gut microbiota  
 
Polyphenols have the ability to modulate microbiota composition; however the 
mechanisms of modulation are largely unknown.  In addition to the accepted 
beneficial effects of polyphenols on human physiology, it would appear the offer 
added health benefits via modulation of gut microecology (Parkar et al., 2008).  
Metabolites released into the lumen may influence the growth of the microbiota, 
which transformed them whilst affecting other neighbouring microflora species.  A 
recent review suggested that polyphenol metabolites are able to enhance some 
beneficial probiotic species while inhibiting the growth of non-beneficial species. In 
support of this idea, green tea extracts have been reported to have general 
inhibitory effects on intestinal bacteria (Lee et al., 2006).  Similar findings have 
been reported with cocoa and a by-product of pomegranate (Bialonska et al., 
2010).   
There are a range of additional mechanisms that have been proposed and studied 
to explain the decrease in CVD risk from consumption of polyphenols. These 
include anti-inflammatory, antithrombotic or anti-atherogenic action, inhibition or 
promotion of signalling pathways related to the maintenance of vascular health, 
and changes to the expression of genes related to those pathways (Quiñones et al. 
2013; Tangney & Rasmussen 2013). However, linking the in vitro or animals 
experiments which investigate these mechanisms to the human studies that 
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demonstrate the health benefits of polyphenols is generally quite difficult.  It must 
also be noted that recent speculation has suggested that the health effects 
associated with polyphenols may simply be because it limits other potentially 
noxious foods.  Even though this is disputable, many believe the exclusion of other 
foods, namely those rich in animal protein and saturated fat that would increase 
the risk of disease, rather than plants and their polyphenols providing a protective 
effect (Chiva-Blanch & Visioli, 2012), although a combination is also conceivable.   
2.4.2.3 Mechanism by which polyphenols could improve exercise 
performance 
 
Polyphenols could potentially improve exercise performance either directly or 
indirectly.  Indirect effects could include enhancement of training, reduction of 
physiological stressors that negatively impact on training (illness or the training 
response itself), or improvement in the ability to recover from training. Given that 
tart cherries have already been shown to attenuate exercise induced muscle 
damage (Howatson et al., 2010; Bell et al., 2013; 2014; 2016).  This is a plausible 
mechanism.   
Directly, polyphenols have been purported to improve performance by increasing 
mitochondrial biogenesis. Firstly, they stimulate stress-related cell signalling 
pathways that increase expression of genes encoding cytoprotective proteins such 
as nuclear respiratory factor 2 (Nrf2) (Eynon et al., 2010). Nrf2 plays an important 
role in mitochondrial biogenesis, and variants of the Nrf2 gene have been 
associated with endurance performance (Stevenson, 2012).  Secondly, select 
polyphenols such as quercetin, resveratrol and curcumin, some of which are 
present in tart cherries, have been reported to modulate muscle function and 
mitochondrial biogenesis by activating sirtuins (SIRT1) and increasing peroxisome 
proliferator-activated receptor c coactivator (PGC-1a) activity (Malaguti et al., 
2013).  In addition, evidence shows that various polyphenols improve flow-
mediated dilatation and endothelial function in humans by increasing endothelial 
nitric oxide synthesis (Nicholson et al., 2008; Ghosh & Scheepens, 2009). In 
sports where the rate of blood flow and maximum cardiac output are important 
determinants of cardiovascular performance, by acting on endothelial function, 
polyphenols could aid overall athletic performance. 
It is pertinent to sound a word of caution concerning the interpretation of 
mechanistic studies in which purified compounds have been examined as putative 
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modifiers of pathophysiological processes.  Many such studies have been 
undertaken by classical biochemical methods in which little attention has been 
paid to the physiological relevance of the concentrations at which the compounds 
have been examined.  To summarise, the proposed beneficial health and exercise 
effects (see section 2.5 and 2.6) associated with tart cherries and general 
polyphenol intake are the results of a series of complex actions from polyphenols 
that likely extend beyond mere AOX actions.  It would appear that polyphenols are 
important metabolic modulators and influence several cellular processes such as 
signalling, proliferation, apoptosis, redox balance and differentiation.   
2.5 Tart cherries and exercise 
 
While tart cherry supplementation has been shown to improve exercise recovery 
(Howatson et al., 2010; Bowtell et al., 2011; Bell et al., 2014), decrease markers of 
inflammation and oxidative stress (Wang et al., 1999; Bell et al., 2014; Howatson 
et al., 2010), studies investigating the effects of tart cherries on exercise 
performance are limited and equivocal.  Therefore, this review will aim to critically 
evaluate these studies and also look at how other fruits with comparable 
polyphenol content and how some of the individual phenolic compounds in tart 
cherries affect exercise performance.  Although exercise and tart cherry 
supplementation studies in animals are uncommon, the majority of the literature on 
polyphenols and exercise performance has been carried out in animal models.  
This chapter will also attempt to briefly summarise these findings. 
 
2.5.1 Tart cherries and exercise recovery 
 
Tart cherries have been shown on numerous occasions to be of benefit in exercise 
recovery.  A series of studies have investigated the use of Montmorency cherries 
in influencing recovery from running (Howatson et al., 2010), heavy eccentric 
contractions (Bowtell et al., 2011) cycling (Bell et al., 2013; 2014) and prolonged 
intermittent exercise (Bell et al., 2016).  Specifically, these studies have 
demonstrated that tart cherries can restore muscle function quicker following an 
exercise induced muscle damaging protocol. Bowtell and colleagues (2011) 
demonstrated faster recovery of isokinetic knee extensor force following tart 
Montmorency cherry juice consumption relative to an iso-energetic placebo.  
These results have been substantiated in recent years (Bell et al., 2013; 2014; 
2016).  Moreover, given the potential deleterious actions of reactive oxygen and 
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nitrogen species on recovery and performance, attenuating such indices has 
received attention in the literature (Gomez – Cabrera et al., 2006; Powers and 
Jackson, 2008).  Tart cherries have been shown to alleviate indices of oxidative 
stress including thiobarbituric acid reactive substances (Howatson et al., 2010) 
and lipid hyperperoxides (Bell et al., 2016) in the days following intense exercise.  
Tart cherries, more specifically their anthocyanins were first shown to inhibit pain 
in the days following intense physical activity by Tall et al., (2004).  Several of the 
studies already alluded to and others reported lower pain scores post tart cherry 
supplementation (Howatson et al., 2010; Kuehl et al., 2010; Bell et al., 2014; 2016).  
Collectively, there appears to be a great deal of literature that supports the use of 
tart cherry supplementation as an efficient and effective recovery method.  All 
studies demonstrated that using a loading phase of 3-16 days is effective.  
However, it must be noted that one should be cautious when adaptation (rather 
than recovery) is the priority as high doses might diminish training benefits. Indeed, 
there is a growing concern that dampening exercise-induced oxidative stress 
and/or inflammation could actually mitigate or at least lessen some of the 
physiological adaptations evoked by training (Gross & Baum, 2015).  To date, 
there has not been the same interest invested in the investigation of tart cherry 
supplementation and exercise performance. 
 
2.5.2 Tart cherries and exercise performance  
 
During highly intense exercise, the capacity for aerobic metabolism is a major 
factor in determining an individual’s performance (Mortensen et al., 2008). During 
intense aerobic exercise and the resulting dramatic increases in oxygen 
consumption, production of free radicals can exceed the intrinsic AOX defence 
capacity, leading to both muscle fatigue and oxidative stress in the circulatory 
system, which is responsible for delivery of oxygen (Allen et al., 2008; Machefer et 
al., 2004; Davies et al., 1982). Many AOXs have been evaluated and shown to 
have some favourable effects alone or in combination in reducing oxidative stress 
generated during intense exercise (Baskin et al., 2000; Margaritis et al., 2003; 
Powers & Hamilton, 1999). More recently, several studies reported the significant 
beneficial AOX effects of natural polyphenols, in exercise-induced oxidative stress 
and performance (Panza et al., 2008; Morillas-Ruiz et al., 2006). Surprisingly, 
beside the possibility to partially prevent exercise-induced muscle damage and 
inflammation markers, very few studies (n=2) have been performed to analyse the 
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possibility that tart cherry supplementation could improve exercise performance in 
humans.   
2.5.2.1 Tart cherries and exercise performance - in vivo human studies 
 
Clifford and colleagues (2014) first examined the effect of tart cherries on exercise 
performance.  This study examined the influence of 200 mg of CherryActive® 
capsules containing 216 mg of polyphenols on sub-maximal cycling and time trial 
performance.  Participants supplemented 2 days before and on the day of each 
experimental trial. The experimental trials consisted of four 5 minute stages at 
40%, 50%, 60%, and 70% maximal power output (Wmax), followed by a 20 km 
time trial (TT). Results showed that no significant differences between trials were 
found for heart rate, respiratory exchange ratio, gross mechanical efficiency, 
oxygen consumption, or blood lactate, at any of the intensities completed during 
the initial 20 minute phase of the trial (P > 0.05).  Not surprisingly, final 20 km TT 
times were not different between trials (P = 0.115).  However, this study had no 
control group and a low sample size which may have confounded the results, as 
VO2, respiratory exchange ratio and gross mechanical efficiency data was only 
available for 6 participants.  Contrastingly, a recent addition to the literature 
investigated the effects of powdered Montmorency tart cherry supplementation on 
acute endurance exercise performance in 27 aerobically trained individuals 
(Levers et al., 2016).  Participants were randomly assigned, in a double- blind 
manner, to either capsules containing 480 mg of a rice flour placebo (n = 16) or 
powdered tart cherries [CherryPURE®] (n = 11) group. The authors speculated 
based of analysis carried out in 2012, that the 480 mg CherryPURE supplement 
contained 991 mg of phenolic compounds and 66 mg of anthocyanins. Results of 
this study revealed that short-term supplementation of Montmorency powdered tart 
cherries not only attenuated markers of muscle damage, but also increased 
performance in aerobically trained individuals.  Participants in the tart cherry 
averaged 13 % faster half-marathon race finish times (P = 0.001) and tended to 
have smaller deviations from predicted race pace (P = 0.091) compared to their 
placebo counterparts. Although participants in this study were matched based on 
average reported race pace, fat free mass, body mass and age, differences in 
aerobic state of training beyond the study inclusion/exclusion criteria may have 
been a source of variability in study cohort. 
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The majority of studies demonstrating an advantageous effect of polyphenols on 
performance have utilized whole polyphenolic compounds.  Quercetin has a 
relatively long half-life in circulation, and most attention has been paid to this 
polyphenol in exercise-related studies.  A recent meta-analysis (Kressler et al., 
2011) reported that on average, quercetin provided a statistically significant benefit 
in human endurance exercise capacity (V̇O2max and endurance exercise 
performance). In the quercetin 
Interestingly most of the studies examining quercetin use a dose of around or 
greater than the average intake of 688 mgday-1.  Achieving this intake of quercetin 
from the diet, would involve consuming either 2.4 kg of dark chocolate or 72 L of 
red wine daily, both unrealistic for an athlete, supporting the notion of specific 
quercetin supplementation. This increased performance benefit leads to two 
proposed theories: firstly that quercetin may have a greater performance increase 
compared with other polyphenols, and/or secondly that a greater performance 
improvement may be associated with increased daily polyphenol supplementation. 
Accordingly, further research needs to be conducted around varying doses of 
quercetin within a food matrix to determine if this is a specific polyphenol effect or 
a dose alone effect.  Quercetin has also been reported in relatively high amounts 
in tart cherries as mentioned in earlier sections of this review (Shrikhande & 
Francis, 1973; Schaller & Von Elbe, 1970).   
Although quercetin is the most studied flavonoid in relation to exercise, other 
molecules are under investigation for their ability to prevent exercise-induced 
muscle damage and to affect physical performance. Among them are catechins, 
which have also been identified in tart cherries (Czyzowska & Pogorzelski, 2004), 
have been shown to exert some positive effects at least in animal models, 
discussed in the next section (2.5.2.2).  Nowadays, a considerable amount of data 
is available in humans.  Dulloo and colleagues (1999) showed that green tea 
extract increased daily energy expenditure in humans.  It has also been shown 
that an acute dose of green tea extracted improved fat oxidation and insulin 
sensitivity during moderate exercise in healthy males (Venables et al., 2008).  
Other recent findings reported that EGCG (primary polyphenol present in green 
tea) increased V̇O2max in humans (Richards et al., 2010).  In contrast, several 
studies have reported no significant effects following catechin or green tea 
consumption (Dean et al., 2009; Eichenberger et al., 2009; Jowko et al., 2012), 
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perhaps suggesting that catechins can improve physical performance particularly 
in terms of endurance capacity and V̇O2max in untrained subjects, but the same 
results cannot be reached in physically active people and well-trained athletes. 
Other studies examining whole foods have highlighted the performance-enhancing 
benefits of grape extract, chokeberries and blueberries (McAnulty et al., 2011; 
Pilaczynska – Szczesniak et al., 2005).  In a randomized, double-blind, crossover 
design, Lafay et al (2009) supplemented with a grape extract containing several 
polyphenols (400 mg/day taken in capsule format), however the variation of sports 
in which the volunteers participated (handball, basketball, sprint and volleyball) 
resulted in large inter-individual variations for most parameters tested.  Handball 
players (n=10), a homogenous sub group of the same study improved jump 
performance over 45 seconds following one month of grape extract 
supplementation when compared to the placebo. More recently, in another 
randomized, double-blind, crossover design, Cook et al. (2015) reported that 
following a seven-day intake of New Zealand blackcurrant extract, there was a 
significant improvement in cycling time-trial by 2.4% performance, coupled with an 
increase in fat oxidation when compared to the placebo. The authors of both 
studies speculated that this improvement may have been as a result of improved 
endothelial function and increased peripheral blood flow. Similar findings have 
been reported in other studies where polyphenolic content of a fruit – derived 
supplement is similar to tart cherries (Kang et al., 2012).  Kang and colleagues 
reported that oligomerized lychee fruit extract significantly increased the anaerobic 
threshold by 7.4% (1.8, 13.0).  Interestingly, these results suggest that a 
polyphenol-containing supplement and typical AOXs may have different 
mechanisms of action and that the endurance-promoting effect of oligomerized 
lychee fruit extract may not directly come from the scavenging of free radicals but 
may be attributed to other non-AOX properties of polyphenols, which were 
discussed in Section 2.4.2.   
 
2.5.2.2 Tart cherries and exercise performance - in vivo animal studies 
 
The majority of early studies investigated the effect of polyphenol supplementation 
on exercise performance in animal models.  Previous literature has demonstrated 
the performance enhancing properties of polyphenols extracted from pomegranate 
peel (Swamy et al., 2011) green tea (Swamy et al., 2011) cocoa (Nogueira et al., 
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2011) amongst others. Swamy and colleagues (2011) reported increased 
swimming time, reduced lipid peroxidation and lactic acid levels in tissues 
following polyphenol extract supplementation.  Four groups of rats group 1 
sedentary, group 2 sedentary but force fed with predetermined concentration of 25 
mg polyphenol equivalent extract/day/rat, group 3 and 4 were subjected to force 
swimming but force fed water and with 25 mg equivalent extract of green tea, for 7 
days after pre feeding the animals for 21 days with same dietary treatment. 
Concentration of polyphenols decreased in blood, liver and muscle suggesting the 
utilization of these polyphenols which enhanced the swimming time more than 
twice in group 4 than group 3, reduced lipid peroxidation and LDH activity and 
increased the activity of creatine phosphate kinase. Higher glycogen content was 
found in muscle and liver in group 4 than group 3 with no change in the fat content. 
Murase et al., (2005) have also demonstrated that green tea extract improves the 
time to exhaustion in a dose dependent manner, in mice undergoing a swimming 
test after 7 weeks of supplementation.  Similar results were reported with 
pomegranate peel extract (Swamy et al., 2011). Both of these studies 
demonstrated the possible anti-fatigue role of pomegranate peel and green tea 
extract.  
Additionally, 12 weeks of resveratrol supplementation has been shown to prevent 
the decline in running time to exhaustion, oxygen consumption and lipid oxidation 
in senescence-accelerated mice model.  Data shown in this study demonstrate 
that the resveratrol induction of mitochondrial biogenesis is responsible for the 
prevention of ageing-related performance impairment (Murase et al., 2009). 
Accordingly, Dal-Ros et al. (2011) have recently demonstrated that chronic red 
wine polyphenols intake prevents aging-induced performance decline in rats.  
Moreover, dark-chocolate polyphenols have been ascribed to be responsible for 
some positive effects of dark-chocolate consumption during exercise. Results 
suggest that (–)-epicatechin increases the capacity for muscle aerobic metabolism, 
thereby delaying the onset of fatigue (Nogueira et al., 2011). Data showed that 
when mice were fed for 15 days with (–)-epicatechin (present in dark chocolate), 
they had improved exercise performance accompanied by: (1) an increased 
number of capillaries in the hind limb muscle; and (2) an increased amount of 
muscle mitochondria as well as signalling for mitochondrial biogenesis.  
Contrastingly, although dark-chocolate consumption was associated with lower 
oxidized low-density lipoprotein levels before and after exercise and with an 
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increase in free fatty acids levels during exercise, the time to exhaustion was not 
significantly affected (Allgrove et al., 2011). 
Although it is clear that polyphenol supplementation in a variety of forms and 
doses is able to increase the capacity to quench free radicals, at least in the 
circulation, and enhance exercise performance in animal models, as the studies 
discussed differ in study design, subject population, supplementation regimen and 
testing protocols, there is insufficient evidence to conclude that polyphenol 
supplementation can improve endurance performance in humans. Interestingly, 
there are also insufficient negative data to discourage polyphenol supplementation 
use actively for purposes other than endurance performance (Myburgh, 2014). In a 
recent review (Somerville et al., 2017), the authors speculated that in relation to 
polyphenols and performance publication bias is also a potential issue. Very little 
studies are published showing a null or negative effect.  This could either be due 
to polyphenols consistently having a performance benefit effect, or conversely that 
those papers were not published. Consequently, although based on the papers 
identified in the comprehensive search there is an overall positive effect, the 
authors acknowledge there is a potential that select papers may not have been 
published that could alter the overall improvement effect and/or size. 
 
2.6 Tart cherries and health 
 
Research on the effects of dietary polyphenols on human health has developed 
considerably in the past 10 years. It strongly supports a role for polyphenols in the 
prevention of several diseases. The literature on the health benefits of tart cherry 
has generally focused on their role in the prevention, treatment, and recovery of 
soft tissue injuries and pain remediation.  The anti-inflammatory and anti-oxidative 
capacity of cherries has led to focus on supplementation for a number of 
pathologies.  Inflammation and oxidative stress are commonly associated with 
several pathologies including cancer, arthritis (Fillippin et al., 2008), cardiovascular 
disease (Wu et al., 2014) and with acceleration of the aging process (Lau et al., 
2005).  Tart cherry supplementation has been previously shown to enhance sleep 
quality (Pigeon et al., 2010; Howatson et al., 2012), alleviate arthritic pain and gout 
(Jacob et al., 2003; Zhang et al., 2012) and inhibit intestinal tumor development in 
mice (Kang et al., 2003).  This section will focus on the tart cherry supplementation 
and their effect on both cardiovascular and cognitive function.  
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2.6.4 Cardiovascular function 
 
 In Europe, CVD is the major cause of death in adults and is responsible for nearly 
half (48%) of all annual deaths (Allender et al., 2008; Centres for Disease Control 
and Prevention, 2015).  Epidemiological studies have suggested that polyphenol-
rich foods can exert positive cardiovascular health benefits (Joshipura et al., 1999; 
Bazzano et al., 2002; Hung et al., 2004). Oxidative stress and ROS have been 
vastly implicated in endothelial damage, progression to atherosclerosis, and injury 
in sustained myocardial infarction, as well as in ischemia reperfusion (Dhalla et al., 
2000; Sugamura et al., 2011).  Given the proposed relationship between tart 
cherries, inflammation and oxidative stress which has been well documented, and  
evidence demonstrating that cherry extracts exert a range of cardio-protective 
effects that include increasing nitric oxide production and AOX status, reducing 
lipid oxidation and inhibiting inflammatory pathways in cell and animal models 
(Wang et al., 1999; Seeram et al., 2001), it makes the rational expectation that 
Montmorency tart cherry consumption could exert positive cardiovascular health 
benefits. However, data from human trials are ambiguous.   
 
2.6.4.1 Tart cherries and CV function - in vitro cell and in vivo animal studies 
 
As previously mentioned, cherry extracts have been shown to exert a range of 
cardio-protective effects.  Tart cherries as described in earlier sections are rich 
sources of anthocyanins (Chandra et al., 1992, 1993; Wang et al., 1997). These 
compounds, in particular cyanidin, have previously been reported to exhibit in vitro 
AOX and cyclooxygenase inhibitory activities comparable to those of commercial 
products (Wang et al., 1999).  The best COX-I and COX-II inhibitory activities were 
observed in the anthocyanins from raspberries and sweet cherries, respectively.  It 
has also been shown that the consumption of freeze dried tart cherries (1% w/w in 
the diet) by the Dahl-SS animals for 90 days, enhanced hepatic peroxisome 
proliferator-activated receptors (PPAR) and improve the condition of 
hyperlipidemia and hyperinsulinemia in rats (Seymour et al., 2008).  The authors 
concluded that physiologically relevant tart cherry consumption had the ability to 
reduce several phenotypic risk factors associated with metabolic syndrome and 
type 2 diabetes mellitus.   
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Likewise, in 2009 a study examining the in vivo AOX efficacy, lipid peroxidation 
and anti-inflammatory properties of sour cherry juices reported similar findings 
(Šarić et al., 2009).  Male CBA/Hr mice were randomly split into a control group 
(fed with commercial food pellets) and 2 experimental groups (fed with commercial 
food pellets with 10% or 50% of cherry juice added).   Sour cherry juice 
supplementation resulted in increased SOD and GPx activity and decreased lipid 
peroxidation (LPO) concentrations.  Similar to the studies mentioned earlier, this 
highlights cherry juice as a potent COX-2 inhibitor and might potentially be used as 
an AOX and anti-inflammatory product with beneficial health-promoting properties. 
 
2.6.4.2 Tart cherries and CV function - in vivo human studies 
 
The potential cardio-protective effects of cherries have not been investigated in 
humans to the same degree.  Earlier observations reported indirect links between 
tart cherry supplementation and cardiovascular risk.  Elevated levels of high-
sensitivity C-reactive protein has been linked to increased cardiovascular disease 
risk (Koenig et al., 2013).  Previous studies, which were discussed in earlier 
sections demonstrated the ability of tart cherry juice to attenuate inflammatory 
response to a series of exercise stresses (Howatson et al., 2010; Bell et al., 2014; 
2016).  Moreover, Kelley and colleagues (2006) reported that 280 g/day of sweet 
cherries (supplying approx. 100 mg/day anthocyanins) reduced CRP by 8 % after 
two weeks of supplementation and by 25 % after four weeks of supplementation.  
In 2008, a pilot study investigated the effects of sour cherry juice on blood glucose 
and some cardiovascular risk factors improvements in diabetic women (Ataie-
Jafari et al., 2008).  In this study, 19 diabetic women were asked to consume 40g 
of concentrated sour cherry juice daily for 6 weeks.  Results found that significant 
reductions in body weight, blood pressure (Table 3a) and hbA1c were observed 
post supplementation period.  In addition, total cholesterol and LDL-C decreased 
in a sub group (n=12), with LDL-C less than 100mg/dl.  The authors attributed 
these improvements in blood pressure and blood lipid profiles to the high 
anthocyanin content of sour cherries.  In particular, endothelial nitric oxide 
synthase (eNOS) plays an important role in maintaining blood pressure 
homeostasis and vascular integrity. Cyanidin-3-glucoside, the most abundant 
anthocyanin in cherries, has been shown to induce eNOS expression and escalate 
NO production in the vascular endothelial cells (Xu et al., 2004).  One big limitation 
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of this study is that there was no control group included and therefore results 
should be interpreted with a certain degree of caution. Despite this, these findings 
are in accordance with many similar studies on hypocholesterolemic effects of 
polyphenol rich foods (Reshef et al., 2005; Hobbs et al., 2012). 
Contrastingly, a more recent study (Lynn et al., 2014) examining the effect of tart 
cherry juice supplementation on arterial stiffness and inflammation in healthy 
adults reported no significant differences in arterial stiffness, BP, CRP or risk 
markers for cardiovascular disease following supplementation (Table 3b), but 
evokes a minor increase in AOX status.  In this study, 47 healthy adults consumed 
30 ml of cherry concentrate diluted to a volume of 250 ml with water or the same 
volume of an energy matched control drink daily for six weeks, the same duration 
as the previous study.  At the end of the intervention, there was no significant 
differences in arterial stiffness (P = 0.218), CRP (P = 0.220), systolic blood 
pressure (P = 0.163), diastolic blood pressure (P = 0.121), total cholesterol 
(P = 0.342) and high density lipoprotein cholesterol (P = 0.127). However, the 
authors speculated that this was due to numerous limitations including their 
sample size, blood sampling technique and population.  Therefore, it cannot rule 
out the possibility that cherry juice may be more effective in individuals with 
existing hypertension or cardio-metabolic disease, as demonstrated by the 
obvious higher baseline blood pressure values and blood lipid profile between the 
two set of participants highlighted below. 
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Table 3 - Change in cardiovascular outcome variables following tart cherry juice 
consumption. 
 (a) 
 Cherry Juice  
 Baseline End P value 
SBP               
(mmHg) 
129 ± 16 123 ± 13 P < 0.01 
DBP                
(mmHg) 
82 ± 8 76 ± 9 P < 0.01 
Cholesterol          
(mmol/L) 
11.9 ± 0.50 10.7 ± 0.22 P < 0.05 
Adapted from Ataie-Jafari et al. (2008) 
(b) 
 Cherry Juice Placebo  
 Baseline End Baseline End P value 
SBP            
(mmHg) 
111 ± 14 110 ± 13 110 ± 12 113 ± 12 P = 0.163 
DBP            
(mmHg) 
70 ± 10 69  ± 10 67 ± 8 70 ± 8 P = 0.121 
Cholesterol  
(mmol/L) 
4.25 ± 0.5 4.22 ± 0.8 3.76 ± 0.7 4.12 ± 0.7 P = 0.342 
Adapted from Lynn et al. (2014) 
In addition, polyphenols have garnered attention for their ability to modulate blood 
flow in both clinical and non-clinical populations.  Grapes, cocoa, beetroot and 
blueberries have all been shown to modulate peripheral blood flow using 
techniques such as flow mediated dilation and laser Doppler imaging.  In one such 
study (Stein et al., 1999), patients with coronary artery disease were 
supplemented with 4 ml/kg/body weight of purple grape juice twice daily for 14 
days.  Flow-mediated vasodilation was increased by 6.4% following 
supplementation indicating an overall improvement in endothelium dependent 
vasodilation.  This observation was also reported with healthy participants 
(Rodriguez-Mateos et al., 2013) whereby following 766 mg of blueberry 
supplementation, a significant increase in endothelium-dependent brachial artery 
vasodilation was observed relative to the placebo group.  Similarly, the 
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incremental area under the curve (0–6 h post ingestion) for endothelium 
dependent vasodilation as assessed by laser Doppler was greater (P = 0.017) 
after beetroot bread ingestion compared to the control trial.  These effects 
occurred in conjunction with increases in plasma and urinary nitrate (P < 0.0001) 
and nitrite (P < 0.001) (Hobbs et al., 2013).  To date, no research has looked at 
the effect of tart cherry juice supplementation on blood flow using these methods.    
 
2.6.5 Cerebral haemodynamics and cognitive function  
 
Aging is associated with deficits in motor function, which include decreases in 
balance, muscle strength, coordination, and cognitive function, especially in tasks 
that require the use of spatial learning and memory. This has been suggested to 
be caused by a concurrent decline in cerebral blood volume and metabolism of 
oxygen which also occurs as a result of aging (Machal et al., 1992).  These 
decrements have been reported in numerous studies in both animals (Joseph et al. 
1983; Shukitt-Hale et al., 1998) and humans (Brayne et al. 1995; Hofer et al. 2003).  
A large number of dietary interventions using polyphenol-rich foods or beverages, 
in particular those using tea (Chan et al., 2006), Gingko Biloba (Birks & Evans, 
2009), cocoa (Scholey et al., 2010) and blueberry (Shukitt-Hale et al., 2008), have 
demonstrated beneficial effects on memory and learning in both animal and 
human models (See Lamport et al., 2012 for full review).  Although it is not clear 
whether tart cherries decreases the risk of neurodegenerative aging or diseases 
such as Parkinson’s and Alzheimer in humans, studies with animal models are 
more positive and suggest that the phenolic compounds found in tart cherries, may 
exert their beneficial effects through their ability to lower oxidative stress and anti-
inflammatory properties or by altering directly the signalling involved in neuronal 
communication, calcium buffering ability, stress signalling pathways among others 
(Shukitt-Hale et al., 2008; Shukitt-Hale et al., 2006). The foregoing literature 
provides a brief synopsis of how tart cherries and their isolated components 
influence cognitive function in both animal and human models.    
 
2.6.5.1 Cerebral haemodynamics and cognitive function - in vivo animal 
studies 
 
As previously alluded to, the majority of literature supporting the use of tart 
cherries to improve various aspects of cognition has been demonstrated in animal 
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models.  Seymour et al. (2013) showed that intake of 1% tart cherry diet 
significantly reduced stroke-related phenotypes in rats. Tart cherry intake also 
reduced brain NFκB activity and the related pro-inflammatory transcripts.  
Interestingly in 2015, Kirakosyan and colleagues confirmed that tart cherry 
anthocyanins cross the blood-brain barrier (Kirakosyan et al., 2015).  A more 
recent addition to the literature examined thirty 19-month-old male Fischer 344 
rats who received either a control diet or a diet supplemented with 2% tart cherry 
for six weeks.  Results showed that although there were no changes on motor 
performance, tart cherry supplementation significantly improved working memory 
of aged rats (Thangthaeng et al., 2016).  The authors attributed this finding to the 
high polyphenols content of tart cherries and the subsequent reduction in 
inflammatory markers (GFAP, NOX-2, and COX-2) and improvement in autophagy 
function (phosphorylated mTOR, Beclin 1, and p62/SQSTM).   
This is not the first study to demonstrate that fruits high in polyphenols can exert 
positive influences on cognitive function and memory.  Ramirez and colleagues 
(2005) supplemented twenty 12-month-old male Wistar rats with a dried blueberry 
extract per day for a month.  Results demonstrated an increase in short-term 
memory, improvements in working memory and an overall reduction in anxiety 
following blueberry supplementation.  Moreover, in another study twenty-eight 19-
month-old rats were supplemented with a reconstituted plum juice beverage or 
water for eight weeks.  Results showed improvements in spatial working memory.  
Rendeiro and colleagues (2013) supplemented eight 18-month-old male Wistar 
rats with one of four diets for six weeks.  The diets included a control, a 2% 
blueberry diet, a high anthocyanin diet and a flavanol-enriched.  They too, reported 
that spatial working memory scores increased in all conditions with the exception 
of the control diet.   This improvement was coupled with increased levels of BDNF 
mRNA expression in the hippocampus.  In addition, a study examining the effects 
of cyanidin on cognition reported that cyanidin 3-O-glucoside (Cy3G) (one of the 
main anthocyanins in tart cherries) is protective against the Aβ-induced 
impairment of learning and memory, but has no effect on normal learning and 
memory. Moreover, they found that Cy3G attenuated the Aβ-induced tau 
hyperphosphorylation and GSK-3β hyperactivation observed in Alzheimer’s 
disease. Taken together, these results demonstrated that Cy3G can rescue the 
cognitive impairments that are induced by Aβ via the modulation of GSK-3β/tau, 
suggesting a potential therapeutic role of Cy3G in Alzheimer’s disease. 
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2.6.5.2 Cerebral haemodynamics and cognitive function - in vivo human 
studies 
 
Following the recent finding by Kirakosyan and colleagues (2015) where it was 
shown that tart cherry anthocyanins accumulated in the brain of young rats 
following 3 weeks of supplementation with either 1 or 10 % tart cherry diets, there 
has been more literature focusing on the use of tart cherries to improve cognitive 
function with mixed findings.  Caldwell et al., (2015) previously demonstrated that 
regardless of dose, cherry juice had no acute impact on cognitive function in 
young people, older people or dementia patients.  They concluded that although 
cherry juice may have an acute impact on cardiovascular function, there was no 
change in cognitive performance 6 h post consumption.  Contrastingly, a chronic 
supplementation study (Kent et al., 2015) reported that the daily consumption of 
sweet cherries for 12 weeks improved cognitive performance across almost all 
tasks in older adults with mild-to-moderate dementia; this group showed 
improvements for category verbal fluency and tasks relating to verbal learning and 
memory and concluded the positive changes have clinical relevance for these 
cognitive improvements.  However, the former study used sweet cherries as an 
intervention, it has been speculated that sweet cherries are not as rich in 
polyphenol compounds as tart/sour cherries (Kim et al., 2005).  These inconsistent 
findings have also been reported with other functional foods where Kelly et al., 
(2013) and Thompson et al., (2014) showed that after acute beetroot 
supplementation, there were no changes in cognitive performance for 
concentration, memory, attention or information processing ability.  However, 
when older type 2 diabetics were supplemented with beetroot juice for 14 days, 
they experienced a significant improvement in simple reaction time compared to a 
control group (Gilchrist et al., 2004).   It would seem that the cerebrovascular 
response required to elicit measurable changes in cognitive function can only be 
achieved with longer term dosing strategies that have the potential to induce 
sustained modifications to cerebrovascular function (Clifford et al., 2015).   
Although there have only been a handful of studies that investigated the 
relationship between tart cherry intake and cognitive function, far more studies 
have looked at individual phenolic compounds and other fruits and their impact on 
various aspects of cognition with positive results.   It has been shown that an 
increased intake of catechins, flavonols and phenolic acids, all present in tart 
63 
cherries, was associated with better verbal memory in a 13-y assessment of 
middle aged adults (Kesse-Guyot et al., 2012).  Moreover, grapes (Krikorian et al., 
2010a), blueberries (Krikorian et al., 2010b) and blackcurrants (Watson et al., 
2015) have all been reported to positively impact cognition function in young and 
old populations.  In a 2012 review, Lamport and colleagues concluded that overall 
findings suggest that polyphenol consumption has the potential to benefit cognition 
both acutely and chronically.   
Polyphenol-rich foods have also been reported to improve cerebral 
haemodynamics assessed by near infrared spectroscopy (NIRS) and functional 
magnetic resonance imaging (fMRI). Wightman and colleagues (2012) assessed 
the effect of EGCG on cerebral blood flow using NIRS in healthy adults.  Results 
suggested that 135 mg of EGCG caused a reduction in total haemoglobin, a proxy 
for cerebral blood flow during cognitive tasks relative to the placebo.  Changes in 
cerebral blood flow has also been demonstrated following resveratrol (Kennedy et 
al., 2010), beetroot (Wightman et al., 2015).  Krikorian et al., (2012) used fMRI to 
examine the effect of Concord grape juice on neurocognitive function.  Sixteen 
adults aged >68 y with mild age-related memory decline were supplemented with 
either a grape juice (444 ml average) containing on average, 209mg of 
polyphenols, or a sugar matched placebo for 16 weeks.  Results found that after 
16 weeks, there were reductions in semantic interference on memory tasks and 
relatively greater activation in anterior and posterior regions of the right 
hemisphere in the grape juice treated group. Similarly, people with mild memory 
complaints, who drank pomegranate juice daily, performed better on memory task 
compared to a placebo and displayed an increase in brain activation measured by 
fMRI (Bookheimer et al., 2013).  Whilst these studies have assessed the impact of 
polyphenol supplementation on cerebral haemodynamics, no attempt has been 
made to examine the haemodynamic response to tart cherries. 
Figure 7 summarises the proposed protective effects of cherry polyphenols and 
their implication in chronic disease management   In conclusion, research using 
animal models has shown that supplementation of tart cherries or tart cherry 
compounds can positively affect working memory and protect against cognitive 
decline (Qin et al., 2013; Thangthaeng et al., 2016).  However, research involving 
humans is not as straight-forward and future research is needed to fully 
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understand the relationship between tart cherry supplementation, cerebral blood 
flow and cognitive function.   
 
Figure 7 - The proposed protective effects of cherry polyphenols and their 
implication in chronic disease management (Adapted from Ferretti et al., 2010). 
 
2.7 Conclusion 
 
The effects of polyphenolic rich foods in various health and exercise paradigms 
have received a great deal of attention in the past 10-20 years. It is generally well 
accepted that a diet high in polyphenols is associated with decreased risk of a 
range of diseases including cardiovascular disease (CVD), specific forms of 
cancer and neurodegenerative disease.   Along with this, reasonable 
understandings of the bioavailability of polyphenols and the mechanisms by which 
they exert such benefits in vivo have been determined.  These mechanisms are 
now believed to involve interactions with a number of cellular signalling pathways, 
which are important in the normal functioning of cells. Such interactions appear to 
modulate these pathways in a way that acts to control various pathogenic 
processes relevant to chronic disease progression. 
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From an exercise perspective, the available literature seems to suggest that 
polyphenols, can provide protection against exercise-induced muscle damage and 
oxidative stress thanks to their AOX and anti-inflammatory properties. However, 
the possibility to improve the exercise performances remains unclear. Tart cherries 
are a functional food that has received substantial attention in recent years for its 
potential benefits for both general health and exercise recovery.  Recent studies 
have provided evidence that tart cherries and its constituents may afford beneficial 
effects for disorders characterize by inflammation, oxidative stress, and aberrant 
vascular function.   
The overall aim of this thesis is to investigate the bioavailability of MC and the 
influence on vascular function in high risk populations.  Furthermore, this thesis 
aims to investigate the effect of MC on exercise performance.  The paucity of tart 
cherry research in these particular areas meant that this review necessarily had to 
begin by providing evidence of the cardiovascular and exercise effects of other 
fruits with similar polyphenol content, and whole polyphenol compounds present in 
tart cherries.  Research reveals that the supplementations of these fruits / 
compounds can improve aspects of vascular and cognitive function and exercise 
performance.  This review of literature has identified a number of areas that 
require further study and consequently some of these will be addressed in the 
subsequent experimental chapters by raising the following questions: 
1) Establish the polyphenol content of a commercially available Montmorency 
tart cherry juice, and the plasma bioavailability of principal downstream 
metabolites. 
2) Examine the effects of phenolic acids on vascular smooth muscle cells in 
vitro. 
3) Examine whether MC supplementation can improve indices of vascular 
function in males with early hypertension.  
4) Examine whether MC supplementation can improve cerebral blood flow and 
cognition in middle aged adults.  
5) Examine the effects of MC supplementation on V̇O2 kinetics and exercise 
performance. 
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3 Polyphenol uptake following 
human consumption of 
Montmorency tart cherry and 
influence of phenolic acids on 
vascular smooth muscle cells 
in vitro 
 
Publication arising from this Chapter: Keane, K.M., Bell, P.G., Lodge, J., Constantinou, 
C., Jenkinson, S.E., Bass, R. and Howatson, G. (2016)  Phytochemical uptake following 
human consumption of Montmorency tart cherry (L. Prunus Cerasus) and influence of 
phenolic acids on vascular smooth muscle cells in vitro.  European Journal of Nutrition, 
1695-705. 
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3.1 Introduction  
Epidemiologic studies have shown that consumption of food and beverages 
containing polyphenols is associated with reduced cardiovascular morbidity and 
mortality (Habauzit & Morand, 2012; Arranz et al., 2012). Amongst the 20 most 
commonly consumed fruits, cherries appear to have the fifth highest total phenol 
content (Vinson et al., 2001). Tart cherries and their processed products are a 
functional food of growing interest and have been shown to be high in numerous 
polyphenols (Wang et al., 1999; Seeram et al., 2001). Data support the presence 
of several polyphenols in tart cherries including the flavonoids isorhamnetin, 
kaempferol, quercetin, catechin, epicatechin, procyanidins and anthocyanins 
(Kirakosyan et al., 2009). 
These polyphenols might be capable of exerting beneficial physiological effects 
and could be used as an effective intervention in health maintenance and exercise 
recovery (Bell et al., 2013). It has been previously shown that tart cherries 
attenuate circulating inflammatory markers (Wang et al., 1999; Howatson et al., 
2010; Bell et al., 2014), improve recovery following exercise (Howatson et al., 
2010; Bell et al., 2016) and improve sleep quality (Pigeon et al., 2010; Howatson 
et al., 2012). Despite previous studies in cell culture and animal models, where 
cherry extracts have been shown to exert a range of cardio-protective effects 
(Wang et al., 1999; Seeram et al., 2001), there has been only two published 
studies illustrating the pharmacokinetics of tart cherry polyphenols and concurrent 
evidence of a biological effect (Bell et al., 2014; Seymour et al., 2014). The health-
related benefits have been postulated to arise from the high anthocyanin content 
of tart cherries; however, the biological effectiveness of tart cherries might be due 
to polyphenol interactions, which accomplish complementary effects. Such 
synergies occur when combinations of bioactive substances exert effects at target 
sites that are greater than the sum of individual components (Lila & Raskin, 2004). 
Furthermore, it has been noted that anthocyanins may not be stable during 
processing or storage (Patras et al., 2010). Thus, it is not surprising that tart cherry 
secondary metabolites could be biologically more active than individual ‘whole’ 
components in cherries. The main non-flavonoid polyphenols of dietary 
significance are the C6–C1 phenolic acids; these provide unique taste, flavour and 
health-promoting properties and are found in many vegetables and fruits (Tomas-
Barberan & Espin, 2001). A human study, feeding blood orange juice, suggested 
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that the phenolic acid degradation product, protocatechuic acid (PCA), was a 
major metabolite of anthocyanins (Vitaglione et al., 2007). In addition, a range of 
phenolic acids, including vanillic acid (VA), syringic acid, caffeic acid and ferulic 
acid, has been identified within human serum, following the consumption of 
anthocyanin-rich berries (Nurmi et al., 2009; de Ferrars et al., 2014), but data on 
the bioavailability of these phenolic acids are very scarce. 
Vascular smooth muscle cells (VSMCs) are responsible for the provision of 
vascular tone in normal, healthy blood vessels, and their behaviour is critical in the 
development of atherosclerotic Plaques (Ross, 1993). The VSMC can be found in 
two states—healthy blood vessels are surrounded by differentiated VSMC in a 
contractile, quiescent state (Owens, 1995). Part of the response to vascular injury 
and the cascade of events that lead to the build-up of an atherosclerotic Plaque 
cause VSMC to de-differentiate into a phenotype that proliferates and migrates 
(Owens, 1995). These de-differentiated cells migrate through the intima and form 
part of the fibrous cap on an atherosclerotic plaque. De-differentiated VSMC in 
these fibrous caps comes into direct contact with metabolites in the circulating 
blood and therefore makes them a biologically relevant cell type to test whether 
metabolites could impact on their behaviour. 
The presence of polyphenol compounds in Montmorency tart cherries that might 
improve vascular health has yet to be fully elucidated, and importantly if these 
compounds can be absorbed and potentially exert a physiological effect. 
Furthermore, metabolites from ingestion of cherries that alter the behaviour of 
VSMC would be of interest to ascertain further applications of this functional food. 
Based on the previous literature, it was hypothesised that Montmorency tart 
cherries would contain vasoactive compounds that would be absorbed and 
detectable in plasma and that these compounds would alter VSMC behaviour in 
vitro. Therefore, this study addresses the specific aim of this thesis, which were (1) 
the time course of selected phenolic compounds following ingestion of a 
Montmorency cherry concentrate and (2) exposure of VSMC to selected phenolic 
compounds would influence cell behaviour in vitro. 
3.2 Methods 
3.2.1 Participants 
Twelve non-smoking males were recruited to take part in the study; the mean ± 
SD age, stature, mass and BMI were 26 ± 3 years, 178.5 ± 7.6 cm, 85.2 ± 11.7 kg 
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and 26.7 ± 3.2 kg/m2, respectively. All participants were in apparent good health 
as assessed by a health-screening questionnaire. Exclusion criteria for the study 
were as follows: food allergy (as discussed with research team), history of 
gastrointestinal, renal or cardiovascular disease and current use of any food 
supplementations. The study was conducted in accordance with the Helsinki 
Declaration and ratified by the University’s Research Ethics Committee. All 
enrolled participants provided written informed consent. This study was registered 
as a clinical trial with clinicaltrials.gov (NCT01825070). 
3.2.2 Study design 
As a first step in the current study, we analysed three analogues of tart 
Montmorency cherries (frozen, dried and concentrated) in order to identify which 
was superior in terms of the total anthocyanin and phenolic content as well as total 
AOX capacity and used in subsequent studies. The second part of the study 
utilised a double-blind, two-phase (separated by at least 10 days), randomised, 
crossover, but counterbalanced design in order to identify the bioavailability of 
specific phenolic acids and their influence on cell behaviour following the ingestion 
of two different doses of Montmorency tart cherry concentrate (MC). Each visit 
was at the same time of day and preceded by an overnight fast (≥10 h). On arrival 
to the laboratory, participants provided a baseline venous blood sample. As 
previously described (Bell et al., 2014), subsequent blood samples were taken at 1, 
2, 3, 5 and 8 h post-MC consumption. No additional food or fluid was provided 
during the study period except for low-nitrate mineral water. 
3.2.3 Treatments and dietary control 
The MC concentrate (CherryActive, Sunbury, UK) was stored at 4 °C prior to use. 
Participants consumed either 30 or 60 mL of MC concentrate diluted with 100 mL 
of water in a double-blind crossover manner. According to the manufacturer’s 
information, a 30 mL dose of concentrate was equivalent to approximately 90 
whole cherries. Participants were instructed to follow a low-phenol diet for 48 h 
prior to each arm of the trial by avoiding fruits and its equivalents (i.e.. juices), 
vegetables, tea, coffee, alcohol, chocolate, cereals, wholemeal bread, grains and 
spices and were asked to refrain from strenuous exercise. Compliance with the 
dietary restrictions was examined with a self-completed standardised 2-day dietary 
record.  
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3.2.4 Montmorency tart cherry analysis 
3.2.4.1Total anthocyanins (TACN) 
The monomeric anthocyanin pigment content of the MC concentrate and aqueous 
Montmorency cherry fruit extracts (whole frozen and dried) was determined using 
the pH differential method (Buckow et al., 2010). The MC concentrate was diluted 
1:20 in 25 M potassium chloride buffer at pH 1.0 and 0.4 M sodium acetate buffer 
at pH 4.5, respectively. The absorbance was measured spectrophotometrically at 
510 and 700 nm (Ultraspec 2000 UV/Vis spectrophotometer, Pharmacia Biotech, 
Sweden). The absorbance difference A was calculated as A = (A510–A700) pH 
1.0 − (A510–A700) pH 4.5. The TACN concentration C (mg/L) was expressed as 
mg cyanidin-3-glucoside equivalents according to the following equation: C = 
A·MW·DF·1000/(ɛ·l), where MW was the molar mass for cyanidin-3-glucoside 
(449.2 g/mol); DF was the dilution factor; 1000 was the conversion from g to mg; ɛ 
was the molar extinction coefficient for cyanidin-3-glucoside (26,900 L/mol); and l 
was the path length (1 cm). 
3.2.4.2 Total phenolic content (TPC) 
Total phenolic content was measured using a modified Folin–Ciocalteu 
colorimetric method (Shahidi, 2007). Samples were diluted in deionised water 
(1:10 or 1:100), and 50 μL of the diluted extract, 50 μL of Folin–Ciocalteu reagent 
diluted in water (1:25) and 100 μL of 6 % (w/v) sodium carbonate were added into 
corresponding sample wells of a 96-well Plate (Greiner Bio-One, Monroe, USA). 
Absorbance readings were taken at 725 nm, at 5-min intervals, over a 30-min 
period at 25 °C (BioTek Synergy HT Multi-Mode MicroPlate Reader, Winooski, 
USA). A stock solution of gallic acid (5.8 mM) was prepared in aqueous methanol 
(80 % (v/v), and quantification was performed on the basis of a standard curve in 
the range 0–50 mg/mL (R2 = 0.99). The analysed samples were measured versus 
a blank sample. All values are expressed as means of gallic acid equivalents per 
gram of sample ±SE for six replications. 
3.2.4.3 Trolox equivalent AOX capacity (TEAC) 
A modified DPPH assay used for AOX activity measurements was adjusted for 
use in the present study (Brand-Williams, 1995). The DPPH solution was prepared 
freshly before analysis, by dissolving the DPPH reagent (2.4 mg) in 80 % 
methanol (100 mL). Then, 10 μL of extract, 40 μL of deionised water and 200 μL of 
DPPH solution were added into each well of the 96-well Plate (CELLSTAR, 
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Greiner Bio-One, Monroe, USA). Absorbance readings were taken at 515 nm, at 
3-min intervals over a 30-min period at 37 °C, using a Multi-Mode MicroPlate 
Reader (BioTek synergy HT, Winooski, USA). A calibration curve using Trolox (0–
500 μM, R2 = 0.99) was plotted. Final values are expressed as means of Trolox 
equivalents per milligram of sample ±SE for six replications. 
3.2.4.4  Individual phenolic analysis 
The levels of individual phenolics (CHL, PCA and VA) were determined by HPLC 
and diode array detection (DAD), using the methods described by Bell and 
colleagues (Bell et al., 2014). These phenolic acids were preferentially selected as 
they are the most abundant degradation products of cyanidin and peonidin, the 
two major anthocyanins detected in the Montmorency whole cherry (Kirakosyan et 
al., 2009) and concentrate (Bell et al., 2014). A 1 % solution of MC juice was 
prepared in 1:1, 0.1 % formic acid: 2 % HCl in methanol (MeOH) filtered with a 
0.2-μm polytetrafluoroethylene (PTFE) filter and analysed by HPLC–DAD using a 
Phenomenex Luna C18, (250 × 2.0 mm × 5 μm). To characterise the major 
phenolics present, a sample of MC concentrate was analysed by LC–MS. All of 
the phenolic acids were identified in the MC concentrate after applying the 
extractive procedure and chromatographic method. The MS chromatogram of CHL 
in MC concentrate is presented in Figure 8 (A: 1-2).  
3.2.5 Blood sampling 
Fasting whole blood samples were collected in a 10 mL EDTA Vacutainer system 
(Becton, Dickinson and Company, Plymouth, New Zealand), inverted to mix the 
anticoagulant and immediately centrifuged at 3000×g for 10 min at 4 °C. Plasma 
was aspirated and pipetted into ~1 mL aliquots and then immediately stored at 
−80 °C for later analysis. 
3.2.6 HPLC analysis 
Under the selected chromatographic conditions, calibration graphs were obtained 
by preparing standard samples of each compound in triplicate, with increasing 
concentration of each analyte. From calibration graphs, the limit of detection and 
linearity were calculated (Table 5). The HPLC– DAD was used to identify plasma 
concentrations of phenolics for the acute phase of the study (pre-supplementation 
through to 8 h post-supplementation). Plasma samples were extracted using a 
solid-phase extraction procedure. Briefly, 1 mL of plasma was mixed with 4 mL 
oxalic acid (10 mM) and 0.1 mL HCl (12.06 M) in 15 mL Falcon tubes and 
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centrifuged at 826×g for 5 min. The supernatant was absorbed on to a primed 
solid-phase extraction cartridge (Waters Sep-Pak C18 plus short cartridge, 360 mg 
sorbent per cartridge, 55–105 μm), conditioned with MeOH with 0.2 % 
trifluoroacetic acid (TFA) followed by 2 × 5 mL of water. The sample was eluted 
with 3 mL of MeOH with 0.2 % TFA, dried under N2 at 45 °C. Samples were then 
reconstituted in 400 μL of dilution solvent (0.1 % formic acid in water: 2 % HCl in 
MeOH) and filtered through a 0.2-μm PTFE filter prior to HPLC analysis. The 
method’s recovery was assessed by analysing separate aqueous solutions of 
each of the AOXs at 1, 25 and 50 μL/mL, as well as blank plasma samples with 
added AOXs at the same three concentrations. The recovery for all sample 
preparations was 99.1–101.4 %.  
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Figure 8 - A (1) LCMS Chromatograms of CHL, extracted ion mode range m/z 
352-256 (RT=4.87 min) (2) MS output of CHL, @ RT = 4.87 min (the m/z at 707 
could be a CHL dimer, formed in the MS) B (1) MC Juice, extracted ion, range m/z 
352-356. The two distinct peaks in the juice (RT=4.37 and 4.87 min) have similar 
MS spectra (m/z 353 main ion) which could indicate the presence of another 
isomer i.e.. crypto- or neo- CHL (2) MC Juice @ RT = 4.87 min C (1) PCA, 
extracted ion range m/z 150-155 (RT=7.17 min) (2) PCA @ RT = 7.17 min D (1) 
Plasma sample (S1-B-Z), extracted ion, range m/z 150-155 (RT=7.17 min) (2) 
Plasma sample (S1-B-Z), @ RT=7.17 min. 
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HPLC–DAD analysis of phenolics was carried out using HPLC equipped with a 
pump, autosampler and UV– Vis detector (UltiMate 3000 HPLC system, Dionex, 
Camberly, UK). Known volumes of model system solutions (0.1–0.3 mL), were 
transferred into an autosampler vial, and deionised water was added to afford a 
final volume of 1.5 mL. Sample aliquots (10 μL) of plasma were injected on a 2.1 
cm × 150 mm i.d., 3-μm particle size reverse-phase column Phenomenex Luna 
C18(2) (250 × 2.0 mm, 5 μm particle size) that was thermostatically regulated at 
30 °C. The mobile phase consisted of water with 1 % acetic acid (solvent A) and 
acetonitrile with 1 % acetic acid (solvent B). After a 5-min equilibration with 20 % B, 
the elution program was as follows: 0–20 min, 10–100 % B, (0.2 mL/min) followed 
by a washing stage (100 % B, 20–28 min, 0.2 mL/min) and re-equilibration at the 
initial conditions for 5 min. Detection was performed at the following wavelengths: 
λ = 260 nm for PCA and VA and λ = 326 nm for CHL. The polyphenolic content of 
plasma extracts was calculated by interpolation from the calibration graph and 
expressed as micrograms per millilitre (μg/mL). 
The total anthocyanin, total phenolic and total AOX capacities for each analogue 
of tart Montmorency cherry are presented in Table 4. Additionally, the individual 
phenolic acid quantities in the concentrate are also provided.  
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Table 4 - Total anthocyanin, phenolics and AOX activity in pitted, frozen, whole, dried and concentrated Montmorency tart cherry. 
 TACN  TPC TEAC Total CHL* Total PCA* Total VA* 
30 mL MC 
Concentrate 
31.24 ± 0.16 71.37± 0.11 0.30±0.01 0.205±0.24 0.020±0.11 0.253±0.84 
60 mL MC 
Concentrate 
62.47 ± 0.31 142.73 ±0.22 0.60±0.03 0.410±0.48 0.040±0.22 0.506±1.68 
Frozen cherries 0.03 ± 0.0009 0.005± 0.0004 0.002±  0.0002 - - - 
Dried cherries 0.008 ± 0.0003 0.006±  0.0005 0.002±  0.0001 - - - 
Values are presented as Mean ± SEM, n = 6 sample preparations per analysis, (*n=3).  TACN, total anthocyanin content, MC = mg 
cyanidin-3-glucoside /L, Whole Food = mg cyanidin-3-glucoside/100 g of cherries; TPC, total phenolic content, MC = mean gallic acid 
equiv/L, Whole Food = mean gallic acid equiv/g of cherries; TEAC, trolox equivalent AOX capacity, MC = mean Trolox equiv /L, Whole Food: 
mean Trolox equiv/g of cherries; CHL, chlorogenic acid; PCA, protocatechuic acid; VA, vanillic acid, MC = µg/m 
 
Table 5 - Retention times (min) and selected UV-Vis wavelengths for quantitation of phenolics by HPLC-UV/Vis 
Compound UV/Vis wavelength (nm) Retention time (min) LOD (µg/mL) 
Range of 
linearity(µg/mL) 
PCA 260 9.263 <0.05 0.5-80 
CHL 326 10.140 <0.04 0.4-80 
VA 260 11.326 <0.04 0.5-100 
LOD, limit of detection 
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3.2.7 LC–MS analysis 
A liquid chromatography–mass spectrometry (LC–MS) method, utilising the same 
chromatographic conditions as the HPLC–DAD analyses, was used for the 
identification of individual compounds in the plasma and juice samples. Briefly, 
LC–MS analyses were carried out on a Dionex UltiMate 3000 RSLC HPLC System 
(Dionex, Camberly, UK) equipped with an UltiMate 3000 RS pump, an UltiMate 
3000 RS autosampler and a QExactive Quadrupole-Orbitrap Mass Spectrometer 
(Thermo Fisher Scientific, Waltham, USA). Electrospray ionisation at both negative 
and positive ion modes was performed with a spray voltage of 2.00 kV and 
capillary temperature of 280 °C. The total ion current (TIC) with a range of 100–
1500 m/z and 70,000 resolution was measured. Sample aliquots (2 μL) were 
injected on an Phenomenex Luna C18(2) (250 × 2.0 mm, 5 μm particle size) 
reverse-phase column thermostatically regulated at 40 °C. The mobile phase 
consisted of water with 1 % acetic acid (solvent A) and acetonitrile with 1 % acetic 
acid (solvent B). The same method as applied for the HPLC analysis was carried 
out on the LCMS. The identification of phenolics in the MC concentrate was 
verified by retention time and spectral data comparison with the corresponding 
reference compounds. 
3.2.8 Vascular smooth muscle cell culture and migration 
Primary human aortic smooth muscle cells (VSMC; Life Technologies, Paisley, UK) 
were cultured in 231 medium supplemented with smooth muscle cell growth 
supplement (Life Technologies, Paisley, UK) including 5 % foetal bovine serum. 
The VSMC cultures were maintained in 75-cm2 tissue culture flasks in a humidified 
incubator at 37 °C. For all experiments, VSMC was used between passages 3 and 
8. Migration of VSMC in response to metabolites PCA and VA was determined 
using xCelligence realtime cell analyser. PCA and VA were dissolved in 100 % 
ethanol, to a concentration of 100 mM. VSMCs were serum-starved for 24 h and 
then detached from the flask with trypsin. The cells were then incubated with PCA 
at a molarity concentration of 32 μM and VA at 4 μM or ethanol only (<0.04 % (v/v)) 
control for 1 h at 37 °C. These concentrations were based on the plasma 
bioavailability concentrations ascertained by the in vivo part of this work and fall 
within the range of values we observed following consumption of the cherry juice. 
The VSMC was Plated onto an xCelligence cell invasion and migration (CIM) Plate 
containing serum-free medium in the top and bottom chambers. The VSMC was 
added to the top chamber at a density of 8000 cells/chamber. Migration of VSMCs 
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was determined by measuring impedance, which is created as cells move from the 
top chamber, through a microporous membrane to the bottom chamber and attach 
to a gold electrode on the underside of the top chamber. Measurements were 
taken every 15 min over a 24-h period. Measurements were then converted to cell 
index values, which were used as a relative measure of cell migration. 
3.2.9 Vascular smooth muscle cell culture and proliferation 
Kinetic proliferation assay—an xCelligence real-time cell analyser—was used to 
monitor cell proliferation in real time (Acea Biosciences Inc, CA, USA). Primary 
VSMCs were seeded onto an xCelligence E Plate at 6000 cells/ well, with 
metabolites or ethanol only as control in normal VSMC growth media. E Plates 
consist of a gold microelectrode, and growth of cells is determined by measuring 
relative electrical impedance across the cell monolayer. Impedance 
measurements were taken every 15 min for up to 72 h to determine cell 
proliferation.  
3.3 Statistical analysis 
Statistical analysis was performed using PASW statistics 21.0 for Windows (SPSS, 
Inc., Chicago, IL.). Descriptive statistics are reported as mean ± SEM. All 
dependant variables were analysed by using a treatment (30 vs. 60 mL) by time 
(baseline, 1, 2, 3, 5 and 8 h) mixed model analysis of variance (ANOVA). 
Mauchly’s test of sphericity was used to check homogeneity of variance for all 
variables; where necessary, any violations of the assumption were corrected using 
the Greenhouse–Geisser adjustment. Significant interaction effects were followed 
up using LSD post hoc analysis. Further analysis was conducted to identify 
maximum plasma concentrations (cmax) and times to achieve maximum plasma 
concentrations (tmax), which were directly obtained from the plasma concentration–
time profiles. As a measure of overall Plasma bioavailability of individual phenolic 
acids, the area under the plasma concentration– time curve (AUC0–8h) was 
estimated by using the linear trapezoidal rule. For the cellular experiments, 
significance was judged using Student’s t test. Results are reported as mean ± 
SEM. The alpha level for statistical significance was set at 0.05 a priori. 
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3.4 Results 
3.4.1 Protocatechuic acid (PCA), vanillic acid (VA) and chlorogenic (CHL) 
acid  
Firstly, all participants (n = 12) complied with the low polyphenolic experimental 
diet according to the food diaries. The MS chromatogram of PCA in plasma is 
presented in Figure 8 (C: 1-2). The PCA (Figure 9) revealed no significant 
treatment effect (F = 0.59, P = 0.810) or treatment by time interaction effect (F = 
0.405, P = 0.845). Following supplementation, there was a significant time effect 
on PCA plasma levels (F = 2.956, P = 0.015). The PCA levels in plasma were 
significantly higher 1 h following consumption of the low (30 mL) and the high dose 
(60 mL) of MC when compared to baseline (P = 0.014 and 0.05, respectively). For 
both the 30 and 60 mL MC dose, the tmax was 1 h for PCA. The Cmax values for 
PCA were not different between the 60 mL (2.75 ± 0.13 μg h/mL−1) and the 30 mL 
(2.76 ± 0.10 μg h/mL−1) dose. Furthermore, AUC0–8h values for PCA were not 
different between the 30 and 60 mL doses, 102.4 ± 0.9 and 106.4 ± 0.1 μg h/mL−1, 
respectively. The presence of PCA was confirmed in plasma by comparison of the 
experimentally determined monoisotopic molecular weights to literature value, in 
which all were within ±1.5 ppm (Table 6). 
 
Figure 9 - PCA responses from baseline to 30 mL and 60 mL Montmorency cherry 
concentrate (MC).  Absolute baseline values were 1.16 ± 0.326 and 1.70 ± 0.435 
ug/mL for 30 mL and 60 mL, respectively.  * indicates a significant time effect (P < 
0.05) (30 mL and 60 mL dose); data presented as mean ± SEM. 
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Plasma VA (Figure 10) revealed no treatment effect (F = 0.004, P = 0.951) or 
treatment by time interaction effect (F = 1.583, P = 0.195). However, following 
supplementation, there was a time effect (F = 3.329, P = 0.008). VA levels were 
higher 1 h after consumption of the higher dose (60 mL) when compared to 
baseline (P < 0.05). Pairwise comparisons revealed increases in VA from 1 to 5 
and 8 h post- 60 mL MC juice consumption (P < 0.05) compared to baseline. 
However, no significant time effects were observed with the lower dose. For VA, 
the tmax differed depending on the dose administered, occurring at 1 h with the 60 
mL dose and 2 h in the 30 mL dose. Cmax values for VA were not significantly 
different between the 60 mL (0.29 ± 0.03 μg h/mL−1) and the 30 mL (0.30 ± 0.01 
μg h/mL−1) dose. Furthermore, AUC0– 8h values for VA were not different 
between the 30 and 60 mL doses, 10.7 ± 0.1 and 11.8 ± 0.1 μg h/mL−1, 
respectively. The presence of VA was confirmed in plasma by comparison of the 
experimentally determined monoisotopic molecular weights to literature value, in 
which all were within ±1.5 ppm (Table 6). The current study did not detect CHL in 
the plasma post-MC consumption (F = 0.148, p=0.704).   
 
Figure 10 - VA responses from baseline to 30 mL and 60 mL Montmorency cherry 
concentrate (MC).  Absolute baseline values were 0.158 ± 0.031 and 0.093 ± 
0.024 ug/mL for 30 mL and 60 mL, respectively.  * indicates a significant time 
effect (P < 0.05) (60 mL dose only); data presented as mean ± SEM. 
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Table 6 - LCMS characterization of phenolic peaks. 
Polyphenol Formula Found Monoisotopic Mass 
   Ionisation Mode 
 
Literature Value1 
 
PCA C7H6O4 154.034 Negative 154.026611 
CHL C16H18O9 354.102 Negative 354.095093 
VA C8H8O4 168.049 Negative 168.042252 
1Royal Society of Chemistry, (2013), Chemspider chemical database. Found at: 
http://www.chemspider.com/. ND, Not Detected. 
 
3.4.2 Cell behaviour 
The maximum mean concentration of PCA measured in plasma was 2.5 μg/mL 
(range 0.33–6.65 μg/mL) (Figure 9) and VA was 0.3 μg/mL (range 0.1–1.32 μg/mL) 
(Figure 10); these correspond to molar concentrations of 16 and 2 μM, 
respectively. The concentrations were doubled to 32 μM PCA and 4 μM VA for the 
cell experiments to fall within the maximum range of concentrations we observed 
in vivo. Both PCA and VA were applied to VSMC in isolation and showed no 
significant increase in migration behaviour in comparison with a control. When 
PCA and VA were combined and added to the culture, there was an increase (P = 
0.038) in migration of VSMC by 36 ± 12 % when compared to the control (Figure 
11 and 12). Finally, there was no effect of the metabolites on VSMC proliferation 
(Figure 13). 
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Figure 11 - % Migration of human vascular smooth muscle cells in vitro in 
response to metabolites PCA (32µM) and VA (4µM) compared to ethanol only 
control, over 24hours. Combined data from three separate experiments. # 
indicates a significant difference between PCA/VA and ethanol (control) condition 
(P < 0.05); data presented as mean ±SEM. 
 
 
 
 
 
 
 
 
 
 
 
Figure 12 - Cell migration over time.  Red = ethanol only (control), green = PCA 
only, blue = VA only and pink = PCA and VA combined. 
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Figure 13 - % Proliferation of human vascular smooth muscle cells in vitro in 
response to metabolites PCA (32µM) and VA (4µM) compared to ethanol only 
control, over 24hours. Combined data from four separate experiments; data 
presented as mean ± SEM. 
3.5 Discussion  
Following the identification of which Montmorency cherry analogue (frozen, dried 
and concentrated) had the greatest AOX activity, total anthocyanin and phenolic 
content, MC concentrate was used to investigate the plasma kinetics of selected 
phenolic acids and their subsequent effect on cell behaviour in vitro. This 
investigation presents new information on the appearance and time course of 
phenolic compounds in plasma following consumption of a lower and higher dose 
of MC concentrate. The hydroxybenzoic acid content of edible plants is generally 
very low, with the exception of certain red fruits, black radish and onions (Brand-
Williams et al., 1995). As a result, very little is known about the metabolism and 
absorption of these compounds. However, this study showed that both PCA and 
VA are most bioavailable in plasma 1–2 h post-MC consumption, whilst other 
hydroxycinnamic acids (CHL) were not present in the plasma. Furthermore, the 
combination of PCA and VA increased cell migration, but had no effect on the 
proliferation of VSMC.  
High concentrations of VA in vivo can be attributed to the large quantity of 
anthocyanins in fruits and vegetables (Nurmi et al., 2009). Ou et al. (2012) 
previously established that the anthocyanins (in order of decreasing prevalence) in 
processed tart cherry products were cyanidin-3-glucosylrutinoside, cyanidin-3-
rutinoside and peonidin-3-rutinoside. These findings concur with those data from 
Balaton cherries (Wang et al., 1997) and Montmorency cherries (Kirakosyan et al., 
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2009). VA is the major degradation product of the parent compound peonidin, and 
this could explain the detection of VA in plasma 1–2 h post-MC consumption in the 
current study. Interestingly, it has been proposed that VA possesses 
chemopreventive properties due to its AOX activity and its ability to scavenge free 
radicals (Kamat et al., 2000). VA has also been shown to exhibit 
immunostimulatory effects in enhancing interferon gamma (IFN-γ) secretion and 
stimulating proliferation of human peripheral blood mononuclear cells (Chiang et 
al., 2003).  
Similar to VA, high concentrations of PCA in vivo are likely to be as a direct result 
of the original anthocyanin content of both fruits and vegetables (Fang, 2014). 
Cyanidin is the main anthocyanin in tart cherry products (Kirakosyan et al., 2009); 
this was recently clarified in the MC concentrate (3.346 mg/mL) where cyanidin 
accounted for the overwhelming majority of anthocyanins with far smaller amounts 
of peonidin and malvidin (Bell et al., 2014). Cyanidin-3-glucoside has been shown 
to readily degrade to cyanidin and then further metabolised to PCA. Vitaglione et 
al. (2007) reported that PCA accounts for almost 73 % of cyanidin ingested. They 
concluded that a high concentration of PCA could explain the short-term increase 
in plasma AOX activity observed after intake of cyanidin-rich food. PCA has also 
been shown to remain in biological tissues for longer periods of time than the 
parent anthocyanin (Azzini et al., 2010). A recent addition to the literature 
(Kirakosyan et al., 2015) examined the tissue bioavailability of cherry phenolic 
compounds in rats following 3 weeks of supplementation. The work showed some 
tissues preferentially store these phenolic compounds, but importantly when 
examined with the data from the current study the transient increase in 
compounds seen in plasma might be the first step to increase tissue bioavailability 
and hence a potential pathway to the proposed health-enhancing benefits of 
cherry phenolics. Consequently, more longitudinal supplementation studies should 
investigate tissue bioavailability in humans to ascertain whether increased tissue 
concentrations of these compounds are possible in a human model. The detection 
of high concentrations of PCA in human plasma 1–2 h post- MC ingestion has the 
potential to exert some physiological potential; for example, previous research has 
shown that PCA possesses antibacterial, AOX, antidiabetic, anticancer, antiulcer, 
antiaging, antiviral, anti-inflammatory,anti-atherosclerotic properties (Kakker & 
Bais, 2014).  
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Despite there being high quantities of CHL in the MC concentrate, it was not 
detected in plasma. Other food and beverage studies administered much higher 
concentrations of CHL; for example, Stalmach et al. (2014) gave participants a 
single serving of a coffee beverage fortified with CHL, the serving consisted of low 
(412 μmol), medium (635 μmol) and high (795 μmol) quantities of CHL.Although 
412 μmol/L represented the low dose, this is still far greater than the amounts 
identified in the MC concentrate in the current study, where 6.8 μg/mL which 
equates to ~22.1 μmol/L. Unlike the previous work, this study utilised an 
ecologically valid quantity of CHL that was found the MC concentrate that 
represents a sensible portion to consume, rather than an artificially derived 
concentration used previously (Stalmach et al., 2009; 2014). In support of this, a 
previous study using comparable concentrations of CHL also failed to detect its 
presence in vivo (rodent plasma) following CHL ingestion (Azuma et al., 2000). 
Given that CHL was present in the MC concentrate, it is quite plausible that CHL 
was metabolised quickly to the downstream metabolites caffeic, quinic and ferulic 
acid. This provides some explanation for the non-detection in plasma; however, 
the possibility remains that CHL become degraded during sample treatment 
process (Farah & Donangelo, 2006). A study (Farah et al., 2008) evaluating the 
pharmacokinetic profile and bioavailability of CHL in plasma and urine of 10 
healthy participants showed a great deal of inter-individual variation in CHL 
absorption, metabolism and kinetics with uptake values ranged from 7.8 to 72.1 % 
amongst participants. Large inter-individual variations in the plasma 
concentrations of all compounds in the current study are not unexpected because 
of the multifaceted factors such as metabolism and genetic disposition to gut 
microbial composition (Mountzouris et al., 2007). 
The effects of the metabolites PCA and VA on the migration of VSMC in vitro were 
also assessed. Migration increased when the cells were treated in concert with 
both metabolites, demonstrating that these metabolites, at a similar level to that 
seen in plasma, can alter VSMC function. Migration of de-differentiated VSMC is 
required for vessel remodelling which occurs from exercise and vascular injury. 
The VSMC migration in advanced atherosclerotic plaques is often considered to 
be protective as it increases stability, protecting against plaque rupture and 
ensuing vascular trauma such as myocardial infarction or stroke (Louis & 
Zahradka, 2010). By increasing VSMC migration, the metabolites may potentially 
be beneficial for blood vessel remodelling, although this would require further 
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investigation. Elsewhere there are conflicting reports of the effects of PCA on cell 
migration; for example, PCA has been shown to increase the migration of adipose 
tissue-derived stromal cells (Wang et al., 2008) and to inhibit the migration of 
gastric cancer cells (Lin et al., 2011), the mechanism of which are thought to 
involve alterations in matrix metalloprotease activity. These conflicting reports are 
likely attributable to the different cell culture models used in each study. It is 
interesting to note that the concentration of PCA used in this study was similar to 
physiological concentration observed in vivo, whereas previous studies required 
between 15 and 47 times greater concentrations to observe an effect on cell 
behaviour (Wang et al., 2008; Lin et al., 2011). VA is less studied, but has been 
reported to have a small effect on lung cancer cell migration in comparison with 
controls, at a concentration 1000 times greater than used in the current 
investigation (Lirdprapamongkol et al., 2009). This is the first study where PCA 
and VA have been examined in concert and show that VSMC migration can be 
influenced at physiologically relevant levels that can be consumed from MC. 
Importantly, the work suggests that the examination of phenolic acids (or other 
polyphenols) in isolation may be of limited value, particularly when whole foods 
and their analogues are far more complex. 
An acknowledged limitation of the current study is that the analysis was not 
exhaustive and so not every polyphenol was analysed; instead, the focus was on 
the degradation products of two of the main anthocyanidins reported in the MC 
juice that could exert a positive effect on vascular function. In addition, we did not 
investigate compounds, for instance procyanidins, which appear to have poor 
bioavailability due to instability, large molecular weight or are quickly excreted. 
Conceivably, these compounds might also contribute to any potential physiological 
effects exerted by MC and cannot be excluded. Furthermore, enterohepatic 
metabolism could predict that the absorption of polyphenols and their metabolites 
are not limited to few hours after intake (Seymour et al., 2014; de Ferrars et al., 
2014). As a result, the timeframe of the analysis in the current study may be 
regarded as a potential limitation. 
In conclusion, these data provide new information on the presence of phenolic 
acids in plasma following MC concentrate consumption in humans. The time 
course of metabolite absorption peaks at 1–2 h post-consumption, and this 
information could inform future in vivo work that examines the health-related 
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benefits associated with Montmorency tart cherries. Lastly, MC concentrate 
provides a bioavailable source of polyphenols that could be helpful in modulating 
vascular function (Broncel et al., 2010; Mudnic et al., 2012) and influencing cell 
behaviour. 
3.6 Perspectives  
This Chapter aimed to identify the polyphenol uptake of polyphenolic compounds 
following human consumption of Montmorency tart cherry and the subsequent 
influence, if any, of these compounds on cell behaviour.  To date, the majority of 
work involving Montmorency tart cherry supplementation focuses on the 
absorption of primary anthocyanins.  Given that the bioavailability of these 
compounds is poor, exploring the absorption time of their primary downstream 
metabolites may be more appropriate when trying to determine the compounds 
eliciting positive health benefits.  This current study is of importance as it is the first 
study to identify both PCA and VA in plasma 1-2 h post MC consumption.  These 
two dihydroxybenzoic acids are the main degradation metabolites of cyanidin and 
peonidin, the most abundant anthocyanins present in MC concentrate.  The 
physiological concentrations of these phenolic acids at peak time points (1-2 h) 
altered VMSC behaviour, specifically cell migration.  By increasing VSMC 
migration, the metabolites may potentially be beneficial for blood vessel 
remodelling, although this would require further investigation.   
Importantly, this work addresses the first and second aim of the thesis 
investigating if the downstream metabolites of the principal anthocyanins in MC 
concentrate are detectable in plasma post consumption and whether these would 
have an effect on cell behaviour.   This work suggests that the examination of 
phenolic acids (or other polyphenols) in isolation may be of limited value, 
particularly when whole foods and their analogues are far more complex.  The 
information provided in this study could inform future in vivo work that examines 
the health-related benefits associated with Montmorency tart cherries.  Future 
chapters will attempt to explore this premise. 
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4.1 Introduction  
The previous Chapter of this thesis provided new information on the appearance 
and time course of phenolic compounds in plasma post Montmorency tart cherry 
consumption, and highlighted the ability of these compounds to modulate vascular 
smooth muscle cell behaviour at physiologically relevant concentrations.  To date, 
the majority of work focusing on the health effects of polyphenols has examined 
phenolic acids (or other polyphenols) in isolation.  Whole foods and their 
analogues are far more complex, the previous chapter has shown that MC 
concentrate consumption leads to the presence of phenolic acids in the plasma at 
concentrations that can physiologically modulate vascular smooth muscle cell 
behaviour.  Therefore, the following study will attempt to further explore the 
cardiovascular benefits of tart cherries in humans.  
Cardiovascular disease (CVD) is the primary cause of global mortality (Naghavi, 
2015).  In the United States, one in four deaths can be attributed to a 
cardiovascular related event, equating to roughly 610,000 people per annum 
(Centers for Disease Control and Prevention, 2015).  In Europe, CVD is the major 
cause of death in adults and is responsible for nearly half (48%) of all annual 
deaths (Allender et al., 2008; Centers for Disease Control and Prevention, 2015).  
Epidemiological studies have suggested that polyphenol-rich foods can exert 
positive cardiovascular health benefits (Joshipura et al., 1999; Bazzano et al., 
2002; Hung et al., 2004) on blood pressure (Taubert et al., 2007), insulin 
resistance (Grassi et al., 2005), cholesterol concentrations (Davies et al., 2002) 
and Platelet activity (Del Rio et al., 2013), which are thought to be attributable to 
the high polyphenol content in fruits and vegetables (Liu, 2003).  Several studies 
have investigated these cardiovascular health benefits of polyphenolic-rich foods; 
for example, George and colleagues (George et al., 2009; 2012a; 2012b) 
examined the acute and chronic effects of a fruit and vegetable puree-based drink 
on vascular function and other CVD risk factors and showed that endothelium-
dependent vasodilation was greatest at 3 h post consumption.  Additionally, 
Dohadwala and colleagues demonstrated improvements in arterial stiffness and 
brachial artery flow mediated dilation 4 h post cranberry juice consumption 
(Dohadwala et al., 2011). 
Tart cherries and their derivatives are high in numerous polyphenols (Wang et al., 
1999; Seeram et al., 2001; Seymour et al., 2014; Bell et al., 2014) that include the 
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flavonoids isorhamnetin, kaempferol, quercetin, catechin, epicatechin, 
procyanidins, and anthocyanins (Kim et al., 2005; Kirakosyan et al., 2009). It has 
been previously shown that tart cherries attenuate inflammation (Wang et al., 
1999), oxidative stress (Howatson et al., 2010; Bell et al., 2014) and accelerate 
exercise recovery (Howatson et al., 2010; Bowtell et al., 2011; Bell et al., 2014; 
2016). Furthermore, cherry extracts have been shown, in cell and animal models, 
to exert a range of cardioprotective effects that include increasing nitric oxide 
production and AOX status, reducing lipid oxidation and inhibiting inflammatory 
pathways (Wang et al., 1999; Seeram et al., 2001). However, data from human 
trials are not clear; recently, it was postulated in the previous Chapter that the 
health-related benefits associated with Montmorency tart cherry consumption 
might, at least in part, be due to the downstream metabolites of the principle 
anthocyanins present in the fruit, as alluded to in Chapter 3. Specifically, this work 
demonstrated an increase in plasma phenolic acids (vanillic and protocatechuic 
acid) following Montmorency tart cherry (MC) consumption in humans. These 
specific phenolic acids are known to improve vascular function (Kamat et al., 2000; 
Kakker & Bais, 2014) and were shown in the preceding Chapter of this thesis to 
modulate vascular smooth muscle cell behaviour in vitro; however it is unclear if 
Montmorency cherry consumption influences in vivo cardiovascular function.  In a 
previous study investigating this premise, Lynn and colleagues (Lynn et al., 2014) 
examined the effect of a tart cherry juice supplement on arterial stiffness and 
inflammation in healthy adults and showed no positive response.  The authors 
speculated that this was due to numerous limitations including their sample size 
and blood sampling technique. 
Although the potential for dietary polyphenols to improve cardiovascular health is 
encouraging, there is a clear need for randomized, placebo-controlled trials with 
appropriate experimental controls to ascertain the role that polyphenols from 
whole foods and their analogues might exert in health maintenance.  Given that 
tart cherries are high in numerous polyphenols, such as anthocyanins, that 
increase the bioavailability of phenolic acids in vivo, it makes the expectation 
tenable they would positively modulate vascular function.  Therefore, this study 
addresses the specific aim of this thesis, which was to examine the acute effects 
of the consumption of Montmorency tart cherries on arterial stiffness, blood 
pressure, microvascular vasodilation in males with early hypertension.  
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4.2 Methods 
4.2.1 Participants  
Sixteen non-smoking males with early hypertension (with SBP ≥130 mmHg, DBP 
≥80 mmHg, or both)   volunteered to participate; baseline characteristics are 
presented in Table 7. For inclusion, the criteria was a resting SBP >130 mmHg. A 
total of 56 participants were screened prior to study commencement. SBP >120 
mmHg is indicative of early hypertension and reflects increased systemic vascular 
resistance and values above 120 mmHg are associated with increased risk of 
coronary heart disease and stroke (Lewington, 2003). Resting BP was measured 
using an automated sphygmomanometer (Omron 70CP, Tokyo, Japan), according 
to British Hypertension Society guidelines following a 10 min rest. Exclusion 
criteria were; food allergy (as discussed with the research team), history of 
gastrointestinal, renal or cardiovascular disease, BP-lowering or anticoagulant 
medication, current use of any food supplements and other risk factors that make 
them eligible for drug treatment of raised BP according to the British Hypertension 
Society guidelines.  All participants were otherwise, in apparent good health as 
assessed by a health-screening questionnaire. The study was conducted in 
accordance with the Helsinki Declaration and ratified by the University’s Research 
Ethics Committee, prior to participants providing written informed consent.  This 
study was registered as a clinical trial with clincialtrials.gov (NCT02234648).  
Table 7 - Baseline characteristics of the study participants (n=15)1 
Characteristic Values 
Age (years) 31 ± 9 
Height (cm) 182.4 ± 7.3 
Mass (kg) 89.7 ± 13.3 
BMI (kg/m2) 27.0 ± 3.8 
SBP (mm Hg) 137 ± 11 
DBP (mm Hg) 82 ± 11 
MAP (mm Hg) 98 ± 11 
HR (bpm) 63 ± 10 
1 Values are presented as means ± SD. BMI, body mass index; SBP, systolic 
blood pressure; DBP, diastolic blood pressure; MAP, mean arterial pressure; HR, 
heart rate.  
 
4.2.2 Study design 
This study employed a randomised, but counter-balanced, placebo-controlled, 
blinded, cross-over, Latin square design with two experimental arms and a 
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washout period of at least 14 days; participants were randomized to receive either 
Montmorency tart cherry concentration (MC) followed by placebo (Pla), or Pla 
followed by MC.  A washout of at least 14 days was chosen based on previous 
literature that suggests these phenolic compounds are quickly absorbed and/or 
excreted, as demonstrated in the previous Chapter.  Each visit was at the same 
time of day and was preceded by an overnight fast (≥10 h).  Participants reported 
to the lab at 8am and provided a baseline venous blood sample.  This was 
followed by baseline microvascular vasodilation by laser Doppler imaging (LDI) 
with iontophoresis, arterial stiffness by pulse wave analysis (PWA) and pulse wave 
velocity (PWV), digital volume pulse (DVP) and blood pressure (BP) were 
performed with the participant in the supine position.  Participants then consumed 
the intervention beverage and subsequent blood samples, LDI, PWV, PWA, DVP 
and heart rate (HR) measures were taken 1, 2, 3, 5 and 8 h post consumption; BP 
was performed every hour.  No food or fluid was provided during the study period 
except for low-nitrate mineral water.  The total amount of water consumed on the 
first study day ad libitum was noted and participants consumed the same quantity 
on the subsequent visit. 
4.2.3 Treatments and dietary control 
The MC concentrate (CherryActive, Sunbury, UK) was stored at 4ºC prior to use.  
Participants consumed either 60 mL of MC concentrate (which according to the 
manufacturer is estimated to be equivalent to ~180 whole cherries) or fruit-
flavoured cordial in a single blind cross-over manner.  The decision to use 60 mL 
was based on previous work that showed a greater uptake of anthocyanin and 
phenolic acids in vivo post-consumption, this was also shown in Chapter 3 of this 
thesis (Bell et al., 2014).  The concentrate was diluted with 100 mL of water prior 
to consumption.  The Pla supplement consisted of a commercially available, low 
fruit mixed berry (<1%) cordial (Kia Ora, Coca Cola Enterprises, Uxbridge, UK) 
with anthocyanins used only for colour, mixed with water, whey protein isolate 
(Arla Foods Ltd., Leeds, UK) and maltodextrin (MyProtein Ltd., Northwich, UK), to 
match the MC concentrate for volume and macronutrient content (Energy = 204 
kcal, volume = 60 mL, carbohydrates = 49 g, protein = 2.2 g and fat = 0 g). The 
Pla also contained small amounts of antioxidants (ascorbic acid).  Prior to study 
commencement, it was explained to participants that the aim of the study was to 
investigate the effect of a fruit juice on vascular function; therefore they were 
unaware which beverage was the experimental drink. Participants were instructed 
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to follow a low phenolic diet for 48 h prior to each arm of the trial by avoiding fruits, 
vegetables, tea, coffee, alcohol, chocolate, cereals, wholemeal bread, grains and 
spices and were asked to refrain from strenuous exercise.  Compliance with the 
dietary restrictions was assessed with a self-reported standardized 2-day dietary 
record.   
4.2.4 Blood sampling 
Fasting whole blood samples were collected at baseline (before supplementation), 
1, 2, 3, 5 and 8 h in a 10 mL ethylenediaminetetraacetic acid vacutainer system 
(Becton, Dickinson and Company, Plymouth, New Zealand), which was inverted to 
mix the anticoagulant and immediately centrifuged at 3000 × g for 10 minutes at 
4°C.  Plasma was aspirated into aliquots and then immediately stored at -80°C for 
later analysis. 
4.2.5 Laser Doppler imaging  
Subjects were placed supine in a quiet, temperature controlled room, where the 
ambient temperature was 23±1ºC for all measures.  Two perspex chambers (ION6, 
Moor Instruments Limited, UK) with an internal platinum wire electrode were 
placed on the volar aspect of the forearm and attached to the skin using adhesive 
discs (MIC-1AD; Moor Instruments Limited, UK) and connected to the 
iontophoresis controller (MIC2, Moor Instruments Limited, UK).  Acetylcholine 
chloride (2.5 ml, 1%; Sigma-Aldrich, UK) in 0.5% NaCl solution was placed in the 
anodal chamber and 2.5 ml of 1% sodium nitroprusside (Sigma-Aldrich, UK) in 0.5% 
NaCl solution was placed in the cathodal chamber. Circular glass coverslips were 
placed over each chamber to prevent loss of solutions. Current delivery was 
controlled by a laser Doppler imager Windows software v.5.1 (Moor Instruments 
Limited, UK). Measurement of skin perfusion was carried out using a moor LDI2-IR 
laser Doppler imager (Moor Instruments Limited, UK). The scanner head was 
positioned 30 cm above the chambers. The laser beam was directed by a moving 
mirror in a raster fashion over both chambers. A total of twenty repeat scans were 
taken; the first set with no current to act as a control, then four scans at 5 µA, four 
at 10 µA, four at 15 µA and two at 20 µA, the final five scans were measured with 
no current. The area under the flux vs. time curve over the twenty scans was 
calculated as a measure of microvascular response to acetylcholine (ACh; 
endothelium-dependent vasodilation) and sodium nitroprusside (SNP; 
endothelium-independent vasodilation). 
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4.2.6 Pulse wave velocity / analysis  
PWV and PWA were determined by using Arterial Tonometry (SphygmoCor CPV 
system, ScanMed Medical, UK).  There is strong association of PWV and PWA 
with incident cardiovascular disease, independently of traditional risk factors 
(Cruickshank et al., 2002; Choi et al., 2007; Buckow et al., 2010). The aortic pulse 
waveform and augmentation index (AIx) were derived at the radial artery; PWV 
was determined between carotid and femoral sites.  A pencil-type probe was used 
for all measurements and was held at the base of the neck over the carotid artery 
and at the inguinal crease over the right femoral artery.  Recordings were taken 
when a reproducible signal was obtained with a high amplitude excursion.  The 
distance between carotid and femoral sites was measured and electrocardiogram 
gating permitted the time lapse between pulse waves at the carotid and femoral 
sites to be calculated.  
4.2.7 Digital volume pulse  
A PulseTrace PCA 2 with a photoplethysmograph transducer transmitting infrared 
light at a wavelength of 940 nm (MicroMedical, Kent, UK) was placed on the index 
finger of the right hand and used to calculate the DVP stiffness index (DVP-SI) and 
DVP reflection index (DVP-RI).  The DVP records the systolic and diastolic 
waveforms of the pulse by measuring infrared-light transmission through the finger.  
The DVP-SI (in m/s) is defined as the height of the subject divided by the time 
between the first and the second wave peaks, and it is usually correlated with the 
stiffness of large arteries.  The DVP-RI is the relative height of the second peak 
compared with the first and is associated with smaller artery stiffness.  Collectively, 
these variables provide an indication of the stiffness of the arterial stiffness for an 
individual.  
4.2.8 Blood pressure  
Blood pressure was measured using a non-invasive digital automatic BP monitor 
(M10-IT Omron Healthcare, UK).  The BP cuff was fitted by the same individual at 
each of the nine time points.  All vascular measurements took place on the non-
cannulated arm.     
4.2.9 Juice analysis 
4.2.9.1 Total anthocyanins (TACN) 
The monomeric anthocyanin pigment content of the MC concentrate and the 
placebo was determined using the pH-differential method (Buckow et al., 2010).  
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The MC concentrate was diluted 1:20 in 25 M potassium chloride buffer at pH 1.0 
and 0.4 M sodium acetate buffer at pH 4.5, respectively.  The absorbance was 
measured spectrophotometrically at 510 and 700 nm (Ultraspec 2000UV/Vis 
spectrophotometer, Pharmacia Biotech, Sweden).  The absorbance difference A 
was calculated as A = (A510-A700) pH1.0 – (A510-A700) pH 4.5.  The TACN 
concentration C (mg/L) was expressed as mg cyanidin-3-glucoside equivalents 
according to the following equation: C=A.MW.DF.1000/(Ɛ.l), where MW was the 
molar mass for cyanidin-3-glucoside (449.2 g/mol); DF was the dilution factor; 
1000 was the conversion from g to mg; ɛ was the molar extinction coefficient for 
cyanidin-3-glucoside (26900 L/mol); and l was the path length (1 cm). The inter- 
and intra-assay %CV for this method were <5%.   
4.2.9.2 Total phenolic content (TPC) 
Total phenolic content was measured using a modified Folin-Ciocalteu colorimetric 
method (Shahidi, 2007).  Samples were diluted in deionised water (1:10 or 1:100) 
and 50 µl of the diluted extract, 50 µl of Folin-Ciocaltea reagent diluted in water 
(1:25) and 100 µl of 6% (w/v) sodium carbonate were added into corresponding 
sample wells of a 96 well Plate (Greiner Bio – One, Monroe, USA).  Absorbance 
readings were taken at 725 nm, at 5 minute intervals, over a 30 minute period at 
25°C (BioTek Synergy HT Multi-Mode MicroPlate Reader, Winooski, USA).  A 
stock solution of gallic acid (5.8 mM) was prepared in aqueous methanol (80% (v/v) 
and quantification was performed on the basis of a standard curve in the range 0-
50 mg/mL (R2 = 0.99).  The analysed samples were measured versus a blank 
sample.  All values are expressed as means of gallic acid equivalents per gram of 
sample ± SE for 6 replications. The inter- and intra-assay %CV for this method 
were <4%.   
4.2.9.3 Trolox equivalent AOX capacity (TEAC) 
A modified DPPH assay used for AOX activity measurements was adjusted for 
use in the present study (Brand-Williams, 1995).  The DPPH solution was 
prepared freshly before analysis, by dissolving the DPPH reagent (2.4 mg) in 80% 
methanol (100 mL).  Then 10 µl of extract, 40 µl of deioned water and 200 µl of 
DPPH solution were added into each well of the 96 well Plate (CELLSTAR, 
Greiner Bio-One, Monroe, USA).  Absorbance readings were taken at 515 nm, at 3 
minute intervals over a 30 minute period at 37°C, using a Multi-Mode MicroPlate 
Reader (BioTek synergy HT, Winooski, USA).  A calibration curve using Trolox (0-
500 µM, R2 = 0.99) was plotted.  Final values are expressed as means of Trolox 
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equivalents per milligram of sample ± SE for 6 replications. The inter- and intra-
assay %CV for this method were <3%.  The total anthocyanin, total phenolic and 
total AOX capacities for the Montmorency cherry concentrate and placebo are 
presented in Table 8.  
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Table 8 - Total anthocyanin, phenolics and AOX activity in 60mL MC concentrate and PLA 
 TACN  
(mg cyanidin-3-glucoside /L) 
TPC 
(mean gallic acid equiv/L) 
TEAC 
(mean Trolox equiv/L) 
 
60 mL MC Concentrate 
 
73.50 ± 0.20 
 
178.75 ± 0.87 
 
0.58 ± 0.01 
Pla ND 10.36 ±0.13 0.01 ± 0.01 
Values are presented as Mean ± SEM, n = 6 per analysis.  TACN, total anthocyanin content; TPC, total phenolic content; TEAC, trolox 
equivalent  AOX capacity. 
 
Table 9 - Retention times (min) and selected UV-Vis wavelengths for quantitation of phenolics by HPLC-UV/Vis 
Compound λex/ λem (nm) Retention time (min) LOD (µg/mL) Range of linearity (µg/mL ) 
Protocatechuic acid 278 / 360 7.07 <0.01 0.05-50 
Chlorogenic acid 260 / 422 7.65 <0.05 0.25-50 
Vanillic acid 260 / 422 9.09 <0.01 0.05-50 
Propyl gallate 278 / 360 11.91 
  
λex/ λem, fluorescence wavelengths; LOD, limits of detection 
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4.2.10 Plasma analysis 
4.2.10.1 High Performance Liquid Chromatography (HPLC) Analysis 
Under the selected chromatographic conditions, calibration graphs were obtained 
by preparing standard samples of each compound in triplicate, with increasing 
concentration of each analyte.  From calibration graphs the limit of detection and 
linearity were calculated (Table 9).  The HPLC-diode array detector (DAD) was 
used to identify plasma concentrations of phenolics for the acute phase of the 
study (pre-supplementation through to 8 h post-supplementation). A method 
previously described by Bell et al., (2014) was adapted for the extraction of 
phenolic compounds from the plasma. 1 mL of plasma and 0.5 mL of propyl 
gallate (internal standard, 50 µg, 100 µL/mL) was mixed with 4 mL oxalic acid (10 
nM) and 0.1 mL HCl (12.6 M) in 15 mL falcon tubes and centrifuged at 3000 rpm 
for 15 minutes.  The supernatant was absorbed on to a primed (washed with 5 mL 
methanol with 0.2% trifluoroacetic acid (TFA) followed by 2 × 5 mL of water) solid 
phase extraction cartridge (Waters Sep-Pak c17,  360 mg sorbent per cartridge, 
55-105 µm).  The sample was eluted with 3 mL of MeOH + 0.2% TFA and dried 
under N2 at 45°C.  Samples were then reconstituted in 400 µl of 0.1% formic acid 
in water: 2% HCl in methanol and filtered through a 0.2µm polytetrafluoroethylene 
filter prior to HPLC analysis. 
A high pressure liquid chromatography-fluorescence (FLD) method for the 
detection and quantitation of selected phenolic compounds in the plasma samples 
and juice was carried out using a Dionex UltiMate 3000 HPLC System (Dionex, 
Camberly, UK) equipped with an UltiMate 3000 RS pump, an UltiMate 3000 
autosampler and a 3000 RS Fluorescence Detector. The filtered samples (20 µL) 
were injected on an Phenomenex Luna C18(2) (250 x 2.0 mm, 5um particle size) 
reverse-phase column thermostat controlled at 30 °C. The mobile phase consisted 
of water with 1% acetic acid (solvent A), and acetonitrile with 1% acetic acid 
(solvent B). After a 5-minute equilibration with 20% A, the elution programme was 
as follows: 0-15 min, 20-100% B, (0.2 mL/min) followed by a washing stage (100% 
B, 15-18 min, 1.0 mL/min) and return at the initial conditions within 2 minutes. 
Detection was performed at the following excitation/emission wavelengths: λex = 
278 nm and λem = 360 nm for protocatechuic acid (PCA) and propyl gallate (PG), 
and λex = 260 nm and λem = 422 nm for chlorogenic acid (CHL) and vanillic acid 
(VA), respectively.  The identification and quantitation of PCA, CHL and VA 
content of plasma samples was based on a combination of retention time and 
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spectral matching of reference standards (Table 9).  Samples were analysed on a 
batch basis, where each batch included standards prepared in 0.1% formic acid in 
water: 2% HCl in methanol, blank control plasma samples, and fortified plasma 
samples at 1 (low), 10 (mid) and 25 (high) ug/mL. The recovery ranges were 
88.73-94.98%, 87.31-103.78% and 89.16-105.98% for low, mid- and high fortified 
levels, respectively. The final results were collected for recovery at the low 
fortification level. Calibration curves were prepared for all AOX compounds and 
final results are expressed as micrograms per milligram (µg/mL). 
4.2.10.2 Liquid Chromatography-Mass Spectrometry (LC-MS) Analysis 
A LC-MS method, utilising the same chromatographic conditions as the HPLC-
DAD analyses, was used for the confirmation of individual compounds in the 
plasma and juice samples. Briefly, LC-MS analyses were carried out on a Dionex 
UltiMate 3000 RSLC HPLC System (Dionex, Camberley, UK) equipped with an 
UltiMate 3000 RS pump, an UltiMate 3000 RS autosampler and a QExactive 
Quadrupole-Orbitrap Mass Spectrometer (Thermo Fisher Scientific, Waltham, 
USA). Electrospray ionization at both negative and positive ion modes was 
performed with a spray voltage of 2.00 kV and capillary temperature of 280°C. The 
total ion current (TIC) with a range of 100-1500 m/z and 70000 resolution was 
measured. Sample aliquots (2 µL) were injected on a Phenomenex Luna C18(2) 
(250 x 2.0 mm, 5um particle size) reverse-phase column thermostatically 
regulated at 40°C. The mobile phase consisted of water with 1% acetic acid 
(solvent A), and acetonitrile with 1% acetic acid (solvent B).  The same method as 
applied for the HPLC analysis was carried out on the LCMS.  The identification of 
phenolics in the MC concentrate was verified by retention time and spectral data 
comparison with the corresponding reference compounds. 
4.2.10.3 Total plasma nitrate/nitrite measurements 
Plasma nitrate/nitrite (NOx) measurements were carried out on plasma samples 
using a nitric oxide (NO) quantification kit (Catalogue No. KGE001, R&D Systems 
Europe, UK).  All reagents, standard dilutions and samples were prepared 
according to manufacturer’s instructions.  Total plasma NOx determination was 
used as a surrogate marker of systemic NO production.  The inter- and intra-
assay %CV for this method were <5%.  It should be noted that this measurement 
is not a reliable index of NO bioactivity in vivo, but may be used as an indicator of 
NO production. 
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4.2.11 Sample size calculation 
Power calculations were performed for the primary outcome: systolic blood 
pressure.  At 80% power and 5% significance, the minimum number of participants 
required to allow detection of a difference of 5 mmHg (clinically relevant outcome) 
between the responses to the two intervention drinks was estimated to be 12.  A 
total of 16 participants were recruited to allow for a 25% drop – out rate.  
4.2.12 Reliability  
Six subjects volunteered to participate; the mean ± SD age, stature, mass and BMI 
was 24 ± 1 years, 180 ± 8.7 cm, 79.6 ± 5.48 kg and 24.8 ± 3.1 kg/m2, respectively.  
Both intra trial reliability (repeat measures made within the same data collection 
session) and inter trial reliability (repeat measures made within three days of each 
other) measures were taken in order to comprehensively test the reliability of the 
blood pressure, digital volume pulse and pulse wave measures.   Reliability for 
these measures was obtained using variance estimates obtained through ANOVA, 
from which an interclass correlation coefficient (ICC) was calculated. The range of 
an ICC may be between 0.0 – 1.0.  Coefficient of variation was calculated for 
these measures.  Reliability for all methods were found to be excellent with the 
lowest ICC reported as 0.934 (>0.75 (Fleiss, 1986)), when the ICC value is high, 
there is little variation expressed.  Coefficient of variation (CoV) was also found to 
be very low <5% for all measures.  See Table 10 for full reliability analysis. 
Table 10 - Inter and inter - reliability data for vascular measures 
 CoV (%) ICC 
 Intra Inter Intra Inter 
Systolic BP 4 2 0.954 0.923 
Diastolic BP 3 3 0.963 0.934 
DVP-SI 1 4 0.988 0.975 
DVP-RI 2 4 0.965 0.944 
PWV 3 4 0.942 0.933 
PWA 2 4 0.934 0.937 
CoV, Coefficient of Variation; ICC, Interclass Correlation Coefficient. 
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4.2.13 Statistical Analysis  
Statistical analysis was performed using PASW Statistics 21.0 for Windows (SPSS, 
Inc., Chicago, IL.). All group characteristics were reported as means ± standard 
errors, unless otherwise stated.  All dependent variables were analysed using a 
within subject, crossover design; treatment, 2 [cherry juice vs placebo] by time, 6 
[pre–supplement, 1, 2, 3, 5 and 8 h post supplement] mixed model analysis of 
variance (ANOVA).  Mauchy’s Test of Sphericity was used to check homogeneity 
of variance for all ANOVA analyses; where necessary, violations of the 
assumption were corrected using the Greenhouse–Geisser adjustment. Significant 
main effects were followed up using LSD post hoc analysis.   As a secondary 
analysis, the AUC was calculated by the trapezium rule, which was subtracted 
from the fasting value to derive incremental AUC (iAUC).  Maximum plasma 
concentrations (cmax) and times to achieve maximum plasma concentrations (tmax), 
were directly obtained from the plasma concentration-time profiles. A correlation 
analysis was performed by using Pearson’s correlation coefficient to examine the 
relationships between indices of vascular function and appearance of phenolic 
metabolites in plasma.  
4.3 Results  
 Sixteen hypertensive men volunteered to take part in the study, but 1 participant 
voluntarily withdrew after the first study day. There were no adverse events 
reported in response to the intervention products. All participants (n = 15) complied 
with the low-polyphenolic experimental diet according to the food diaries. The 
washout period of ≥ 14 d appeared to be sufficient given that the active 
compounds of interest were similar at baseline for both visits.  
4.3.1 Microvascular vasodilation by LDI with iontophoresis  
There was no time, treatment, or treatment × time interaction effect observed for 
acetylcholine (endothelium-dependent vasodilation) or SNP (endothelium-
independent vasodilation). The incremental AUC (1–8 h after ingestion) for 
microvascular vasodilation was not significantly different between groups (P > 0.05) 
(Figure 14). Values are presented in Table 11. 
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Figure 14 - Representative laser Doppler scan showing both the SNP (left) 
acetylcholine (right) response before (top) and 1 h post (bottom) MC consumption 
in a single subject.  The illuminated regions indicate areas of increased blood flow. 
 
4.3.2 Blood pressure 
SBP exhibited a significant time (F = 7.885, P = 0.001) and treatment × time 
interaction effect F = 3.478, P = 0.003) with the MC concentrate trial. A post hoc 
least significance difference test indicated that this difference occurred at 1, 2, and 
3 h after supplementation in the MC group, with peak reductions of 7 ± 3 mmHg at 
2 h after MC consumption relative to the placebo. Individual responses to 60 mL 
MC consumption and placebo at the relevant time points are illustrated in Figure 
15 (A and B). Absolute values are presented in Table 12. DBP showed a 
significant time effect (F = 6.060, P = 0.01) but no treatment or treatment × time 
interaction effects. Mean arterial pressure demonstrated a significant time (F = 
10.389, P = 0.001) and treatment × time interaction effect (F = 2.500, P = 0.01).  
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Figure 15 - Individual responses to 60 mL MC concentrate (A) and placebo (B) 
consumption at relevant time points. The mean individual response is highlighted 
in bold. MC, Montmorency tart cherry; SBP, systolic blood pressure. 
 
No other vascular variables (HR, DVP-SI, DVP-RI, PWV, AIx, and AIx corrected 
for HR at 75 beats/min) were altered after consumption of the MC concentrate 
compared with the placebo treatment. The absolute values for all variables are 
presented in Tables 11 and 12. 
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Table 11 - Acute effects of tart Montmorency cherry juice polyphenols on vascular function 
 Baseline 1 h 2 h 3 h 5 h 8 h   ANOVA iAUC (0-8 h) 
 
LDI ACh (PU) 
60mL MC 
Pla 
 
 
 
1409 ± 183 
1671 ± 275 
 
 
2017 ± 356 
1647 ± 207 
 
 
1397 ± 226 
1178 ± 187 
 
 
1373 ± 232 
1242 ± 171 
 
 
1442 ± 189 
1168 ± 115 
 
 
 
1231 ± 157 
1180 ± 133 
 
Effect 
 
T 
T × T 
P 
 
0.060 
0.530 
 
 
7459 ± 348 
6415 ± 237 
 
LDI-SNP (PU) 
60mL MC 
Pla 
 
 
1666 ± 206 
1891 ± 228 
 
1616 ± 283 
1847 ± 233 
 
_ 
 
1453 ± 206 
1552 ± 221 
 
1559 ± 241 
1636 ± 140 
 
1424 ± 178 
1690 ± 187 
 
T 
T × T 
 
0.240 
0.976 
 
8543 ± 209 
8475 ± 202 
PWV (m/s) 
60mL MC 
Pla 
 
 
6.0 ± 0.2 
5.9 ± 0.2 
 
5.7 ± 0.2 
5.8 ± 0.2 
 
5.9 ± 0.2 
5.9 ± 0.3 
 
5.9 ± 0.2 
6.2 ± 0.2 
 
5.8 ± 0.2 
6.1 ± 0.2 
 
5.9 ± 0.2 
6.2 ± 0.2 
 
T 
T × T 
 
0.029 
0.211 
 
_ 
AIx (%) 
60mL MC 
Pla 
 
 
11.0 ± 1.7 
10.8 ± 2.2 
 
8.4 ± 1.9 
10.8 ± 2.0 
 
9.7 ± 1.8 
10.0 ± 1.8 
 
8.6 ± 1.9 
10.4 ± 2.0 
 
8.4 ± 1.9 
9.0 ± 2.0 
 
9.5 ± 2.1 
10.9 ± 2.6 
 
T 
T × T 
 
0.582 
0.182 
 
_ 
DVP–SI (m/s) 
60mL MC 
Pla 
 
5.7 ± 0.2 
6.1 ± 0.3 
 
5.7 ± 0.2 
6.0 ± 0.2 
 
5.8 ± 0.2 
6.2 ± 0.3 
 
6.0 ± 0.3 
6.3 ± 0.2 
 
5.9 ± 0.3 
6.2 ± 0.3 
 
6.1 ± 0.3 
6.3 ± 0.2 
 
T 
T × T 
 
 
0.068 
0.957 
 
_ 
DVP–RI (%) 
60mL MC 
Pla 
 
47.2 ± 2.8 
50.6 ± 3.5 
 
50.1 ± 2.8 
51.7 ± 3.0 
 
54.6 ± 3.2 
58.2 ± 4.3 
 
55.5 ± 3.6 
57.9 ± 3.7 
 
53.1 ± 2.9 
52.9 ± 3.5 
 
59.0 ± 3.7 
63.4 ± 3.5 
 
T 
T × T 
 
0.001 
0.938 
 
_ 
All values are means ± SEM (n=15). There were no significant difference between Placebo and cherry concentrate treatment. LDI, laser Doppler 
imaging; PWV, pulse wave velocity; AIx, augmentation index; DVP-SI, digital volume pulse stiffness index; DVP-RI, digital volume pulse reflection 
index; MC, Montmorency cherry concentrate; Pla, Placebo; T, time effect; T × T, time × treatment interaction effect. 
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Table 12 - Acute effects of tart Montmorency cherry juice on blood pressure and heart rate  
 Baseline 1 h 2 h 3 h 4 h 5 h 6 h 7 h 8 h         ANOVA 
 
PSBP (mmHg) 
60mL MC 
Pla 
 
 
 
137 ± 3 
134 ± 2 
 
 
125 ± 3b,y 
130 ± 3a 
 
 
121 ± 3b,y 
128 ± 3b 
 
 
123 ± 3b,y 
127 ± 2b 
 
 
124 ± 3b 
127 ± 2b 
 
 
125 ± 4b 
128  ± 2b 
 
 
128 ± 3b 
129 ± 1a 
 
 
128 ± 3b 
129 ± 2a 
 
 
131 ± 3b 
131 ± 3 
Effect 
 
T 
T × T 
 
P 
 
0.001 
0.003 
PDBP (mm Hg) 
60mL MC 
Pla 
 
82 ± 3 
79 ± 3 
 
76 ± 3 
76 ± 3 
 
75 ± 3 
76 ± 2 
 
76 ± 2 
75 ± 2 
 
76 ± 2 
76 ± 2 
 
76 ± 3 
75 ± 2 
 
78 ± 2 
76 ± 2 
 
78 ± 2 
76 ± 3 
 
80 ± 2 
81 ± 3 
 
T 
T × T 
 
 
0.010 
0.779 
MAP (mm Hg) 
60 mL MC 
Pla 
 
101 ± 3 
97 ± 2 
 
92 ± 3b 
94 ± 2b 
 
91 ± 3b 
93 ± 2a 
 
91 ± 3b 
93 ± 2b 
 
92 ± 2b 
93 ± 2b 
 
93 ± 3b 
93 ± 2 
 
95 ± 2a 
94 ± 2 
 
95 ± 2a 
94 ± 2 
 
97 ± 2 
97 ± 2 
 
T 
T × T 
 
 
0.001 
0.014 
Heart Rate (bpm) 
60mL MC 
Pla 
 
63 ± 3 
59 ± 2 
 
61. ± 2 
60 ± 2 
 
60 ± 3 
58 ± 2 
 
62 ± 3 
58 ± 2 
 
_ 
 
62 ± 3 
60 ± 2 
 
_ 
 
_ 
 
61  ± 2 
61 ± 3 
 
T 
T × T 
 
 
 
0.702 
0.184 
All values are means ± SEM (n=15).  a,b Significant difference between baseline and post intervention (1, 2, 3, 5 or 8 h) (repeated – measures 
ANOVA): a P < 0.05, b P < 0.01.  y Significant difference between Placebo and cherry concentrate treatment (2-factor repeated measures 
ANOVA): y P < 0.05.   PSBP, peripheral systolic blood pressure; PDBP, peripheral diastolic blood pressure; MAP, mean arterial pressure; MC, 
Montmorency cherry concentrate; Pla, Placebo; T, time effect; T × T, time × treatment interaction effect. 
105 
4.3.3 Plasma nitrite and nitrate 
Because of a sampling error, blood was analyzed in 13 participants. There was no 
time, treatment, or time × treatment interaction effect for plasma nitrate or nitrite 
(P > 0.05). 
4.3.4 PCA, VA, and CHL  
Plasma PCA (Figure 16 A) revealed a time (F = 30.595, P < 0.001), treatment (F = 
444.637, P < 0.001), and treatment × time interaction effect (F = 29.814, P < 
0.001). PCA in plasma was higher after MC consumption across all time points 
relative to the placebo (P < 0.001). For the 60-mL MC dose, the tmax was 1 h after 
consumption, yielding a cmax value of 2.35 ± 0.08 µg/mL. AUC0–8 h values for PCA 
were different between the 60-mL dose and the placebo (93.7 ± 2.3 μg · h · mL-1 
and 4.2 ± 0.3 μg · h · mL-1, respectively; P = 0.005). The presence of PCA was 
confirmed in plasma by comparing the experimentally determined monoisotopic 
molecular weights to the literature values, all of which were within ±1.5 parts per 
million. Plasma VA (Figure 16 B) revealed a significant time (F = 8.575, P = 0.001), 
treatment (F = 24.610, P = 0.001), and treatment × time interaction effect (F = 
11.561, P = 0.001). VA was markedly higher in plasma for ≤ 5 h after MC 
consumption than after the placebo trial. Similar to PCA, the tmax for VA was 1 h 
after consumption, yielding a cmax value of 0.20 ± 0.01 µg/mL. AUC0–8 h values for 
VA were statistically significant between the 60-mL dose and the placebo (39.6 ± 
2.5 μg · h · mL-1 and 0.5 ± 0.1 μg · h · mL-1, respectively; P = 0.026). The 
presence of VA was confirmed in plasma by comparing the experimentally 
determined monoisotopic molecular weights to literature values, all of which were 
within ±1.5 parts per million. The CHL concentrations in plasma after consumption 
were below the limits of detection in this study. Peak plasma PCA (1 h) negatively 
correlated with SBP at 1 and 2 h after MC consumption (r = -0.182 and -0.131, 
respectively). Peak VA in the plasma (1 h) negatively correlated with SBP at 2 h 
after MC consumption (r = -0.095). However, these correlations were not 
statistically significant. There were no negative correlations, significant or 
otherwise, observed in the placebo trial. 
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Figure 16 A: Time course of protocatechuic acid and B: vanillic acid (mean ± SEM) 
response after consumption of MC concentrate- and macronutrient – matched 
control (n=15).  Data was analysed by using a 2-factor repeated – measures 
ANOVA with time and treatment as the 2 factors [significant effects of time (P = < 
0.001), treatment (P < 0.001), and the interaction between time and treatment (P < 
0.001) were observed for both variables].  Significantly different from the Placebo 
drink: * P < 0.05 *** P < 0.001.    
0.0
0.5
1.0
1.5
2.0
2.5
0 1 2 3 4 5 6 7 8
60mL MC Concentrate
Placebo
***
***
*
* *
P
C
A
 C
o
n
c
e
n
tr
at
io
n
 (
u
g
/m
L
)
0.00
0.05
0.10
0.15
0.20
0 1 2 3 4 5 6 7 8
***
*
* *
Time  (h)
V
A
 C
o
n
c
e
n
tr
at
io
n
 (
µ
g
/m
L
)
A
B
107 
4.4 Discussion 
To our knowledge, this study is the first to investigate the acute effects of MC 
consumption on arterial stiffness, BP, and microvascular vasodilation in men with 
early hypertension. In support of our hypothesis, this study presents new 
information that consuming 60 mL MC reduced SBP ≤ 3 h post-prandially. This 
improvement in BP occurred at the same time points as peak increases in plasma 
phenolic acid uptake.  
BP is a modifiable but nonetheless major risk factor for CVD (Lewington et al., 
2002), and diet is believed to play an important contributing factor in the advent of 
hypertension. Relatively small reductions (2–5 mm Hg) in BP have been reported 
to have an important impact on cardiovascular mortality (Collins et al., 1990). To 
our knowledge, this is the first study to report a positive modulation of SBP after 
MC consumption. Previous studies have demonstrated that other polyphenol-rich 
foods such as cocoa, beetroot, and grape extract can have a positive effect on BP 
(Grassi et al., 2005; Hobbs et al., 2013; Draijer et al., 2015). This study is 
particularly noteworthy because data from prospective observational studies have 
shown a reduction in mean SBP of 5–6 mm Hg over a 5-y period was associated 
with 38% and 23% reduction risk of stroke and coronary artery disease, 
respectively (Collins et al., 1990). Herein, we reported peak reductions in 
postprandial SBP of 7 ± 3 mm Hg relative to the placebo. Previously, Lynn et al., 
(2014) did not detect any changes in BP after tart cherry consumption in 
normotensive participants (~111/70 mm Hg). This discrepancy might be 
attributable to suggestions that the magnitude of change in the BP response is 
directly related to baseline BP (Kapil et al., 2010), making it possible that a higher 
baseline BP will likely experience a greater change after an intervention. In 
addition, Lynn et al., (2014) had little control over the supplement timing in free-
living participants. It is therefore conceivable that any vaso-modulatory effects 
from the cherries were missed. This is especially evident given that measures of 
vascular function were assessed after an overnight fast; this work clearly 
demonstrates that any positive effects are transient and return to baseline after 4 h. 
The magnitude of BP-lowering effects observed in this study is comparable to 
those achieved by a single antihypertensive drug in mildly hypertensive patients 
(MRC, 1985) and highlights the potential importance of MC supplementation as an 
adjuvant in the management of hypertension. In this study, the greatest 
improvements in SBP occurred in association with peak plasma PCA and VA, 
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indicating that both of these metabolites could be partly responsible for the effects 
observed, particularly given that these hydroxybenzoic acids were shown in the 
previous Chapter to modulate vascular smooth muscle cell behaviour in vitro.  
To our knowledge, only one study has investigated the effect of a tart cherry juice 
supplement on arterial stiffness (Lynn et al., 2014). PWV is emerging as an 
important measure of vascular function that relates to CVD risk and has been 
shown to be a stronger predictor of arterial stiffness than AIx and central pulse 
pressure (Mitchell et al., 2004). We did not observe any significant differences in 
PWV between the MC concentrate and placebo across the 8-h trial. These 
findings are in agreement with Lynn et al., (2014), in which no effect was observed 
on arterial stiffness in healthy subjects. Notwithstanding the aforementioned 
limitations of that study, there are several possible explanations for these results 
that could be applicable to our findings. Lynn et al., (2014) speculated that arterial 
stiffness is less responsive to a short-term increase in polyphenols in healthy 
populations. Similar to BP, it might be the case that the magnitude of change is 
directly related to PWV at baseline, although this is speculative. In this study, the 
mean value at baseline was 5.9 m/s, which, according to the reference values for 
arterial stiffness collaboration (Mitchell, 2009), is well within the normal ranges for 
this population.  
The pivotal role vascular dysfunction Plays in the progression of atherosclerosis 
has been increasingly recognized; therefore, the vasculature has emerged as an 
important target for dietary therapies (Armah et al., 2008). We assessed 
microvascular vasodilation with the use of LDI, which measured the response to 
cutaneous perfusion of the forearm with acetylcholine and SNP (Turner et al., 
2008). Contrary to our expectations, we did not observe any change in 
microvascular vasodilation after the intervention. It was somewhat surprising that 
no change was evident given that an increase in endothelium-dependent 
microvascular reactivity after high flavonoid (Macready et al., 2014) and fruit and 
vegetable intake (McCall et al., 2011) has been previously observed. However, 
these data are not in isolation; a study by Jin et al., (2011) showed no change in 
acetylcholine or SNP response after blackcurrant consumption. However, it is 
particularly noteworthy that in this study certain individuals had a far higher 
endothelium-dependent vasodilator response than others in the same cohort. 
Perhaps similar to what George et al., (2012) previously demonstrated, there is a 
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differential response to the MC concentrate that is potentially based on genotype. 
They showed that acute consumption of a flavonoid-rich drink resulted in a 
considerable increase in dilation of the microcirculation in the forearm in response 
to acetylcholine after 180 min in GG individuals alone. However, there was no 
effect of the same beverage on endothelium-dependent vasodilation in the GT 
genotype or on endothelium-independent vasodilation in response to SNP in either 
genotype. However, this analysis was outside the remit of this study. These 
variables might be modulated after chronic supplementation and are certainly 
worth future investigation. In addition, the assessment of endothelial function by 
LDI is specific to the region examined and therefore may not provide a fuller 
picture of global vascular function.  
Peripheral PWA is frequently used to measure the AIx, an index of arterial 
stiffness (Wilkinson et al., 1998). Increased arterial stiffness results in a faster 
propagation of the forward pulse wave as well as a more rapid reflected wave. 
Therefore, a high AIx has been previously linked with greater arterial stiffness and 
has been shown to be a predictor of adverse cardiovascular events in a variety of 
patient populations (Shimizu, 2008). In this study, there were no noteworthy 
changes in AIx or AIx when corrected for an HR of 75 beats/min after acute 
ingestion of MC concentrate. Similarly, Hobbs et al., (2013) failed to detect any 
meaningful changes in AIx after beetroot bread ingestion. Although we reported 
marked improvements in SBP following the consumption of MC concentrate, there 
were no changes in microvascular vasodilation, arterial stiffness, DVP, and HR; it 
has previously been reported that concurrent improvements in all measures of 
vascular function are not always observed (Hobbs et al., 2013).  
There are 2 proposed mechanisms by which tart cherries are thought to improve 
indexes of cardiovascular function. The first is via the NO pathway, which 
increases the bioavailability of NO via its potential to inhibit NADPH oxidase. 
Cyanidin-3-glucoside, an anthocyanin found in abundance in tart cherry products 
(Kirakosyan et al., 2009; Bell et al., 2014), has also been shown to increase 
endothelial NO synthase (eNOS) expression (Xu et al., 2004) and decrease 
inducible NO synthase expression (Wang et al., 2008). Such changes in the 
balance between eNOS and inducible NO synthase expression/abundance/activity 
would favour the bioavailability of the vasoactive NO. However, this study 
measured plasma total NOx concentration, often used as a surrogate marker of 
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eNOS activity (Moncada & Higgs, 1991), and found no changes in the plasma 
NOx. The second and perhaps more likely idea by which MCs improve factors 
associated with CVD is based on the uptake of polyphenols that possess cardio-
protective properties. An analysis of the MC juice revealed larger amounts of total 
anthocyanins and phenolic content than in the placebo.  To investigate a cause-
and-effect relation between improvements in cardiovascular function and the 
intake of cherry polyphenols, we examined plasma concentrations of anthocyanin 
metabolite profiles after consumption. In line with BP, we observed a peak 
increase in plasma phenolic metabolites at 1 h after MC consumption. This also 
supports previous observations in the earlier Chapter that showed that PCA and 
VA peaked between 1 and 2 h after MC consumption in healthy men. These 
phenolic acids have previously been observed in plasma after blueberry, cranberry, 
and blackcurrant consumption (Rechner et al., 2002; Zhang et al., 2004; Stalmach 
et al., 2009) and may be responsible for driving the beneficial vascular response 
observed. Both compounds have been shown to modulate vascular function in 
isolation (Kamat et al., 2000; Kakker & Bais, 2014) and in concert can influence 
vascular smooth muscle cell behaviour in vitro as demonstrated in the previous 
Chapter. Concentrations of these acids gradually decreased after peaking at 1 h, 
indicating further chemical or microbial degradation (Keppler & Humpf, 2005), 
excretion, or tissue uptake (Kirakosyan et al., 2015) of these compounds. 
In conclusion, these data provide the first evidence to our knowledge that 
circulating phenolic metabolites derived from MC juice are at least partly 
responsible for acute improvements in SBP in men with early hypertension. This 
study provides further evidence that diets containing polyphenolic-rich foods have 
the potential to exert positive effects on vascular function. In particular, tart 
cherries, which contain a high concentration of bioactive polyphenols, can 
modulate human physiological function. This study also provides information on a 
new application of tart cherries in health maintenance, particularly in positively 
modulating SBP. 
 4.5 Perspectives  
Following on from Chapter 3 and the significant effects tart cherries imposed on 
vascular smooth muscle cell behaviour, this Chapter aimed to explore the 
cardiovascular benefits of tart cherries in humans.  The results from this Chapter 
add further application to the findings reported earlier, demonstrating that tart 
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cherries may be an adjuvant in the management of hypertension.  In males with 
early hypertension (SBP ≥130 mmHg, DBP ≥80 mmHg, or both), SBP was 
reduced by up to 7 ± 3 mmHg relative to the placebo in the hours following 
consumption. In the UK, about half of people aged over 65, and about 1 in 4 
middle-aged adults, have high blood pressure.  Raised blood pressure is the 
greatest risk factor for cardiovascular disease and even small reductions in blood 
pressure can have a big impact on mortality rates.  Therefore, the findings from 
this Chapter potentially extend the application of MC supplementation to a much 
wider group of individuals.  Furthermore, this Chapter demonstrated that the 
circulating phenolic metabolites (VA and PCA) derived from Montmorency tart 
juice are, at least in part, responsible for this modulation of SBP.  Importantly, 
regardless of the mechanism, this improvement in blood pressure is of most 
interest to clinical nutritionists, dieticians, clinicians, researchers, applied 
nutritionists and also the wider population in furthering our understanding of the 
health benefits associated with tart cherries. 
Conceptually, in light of the vaso-modulatory effects of polyphenol-rich foods, and 
the findings of this Chapter which highlight the ability of MC juice to modulate 
aspects of vascular function, it is possible that Montmorency cherries might also 
be capable of conferring a positive vascular effect by improving blood flow and 
human performance.  Resultantly, the following Chapters of this thesis will 
investigate the effects of MC supplementation on 1) cerebral blood flow, cognitive 
function and mood in middle-aged adults, and 2) on exercise performance in 
trained cyclists.  
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5 Tart Montmorency cherries 
modulate vascular function 
acutely, in the absence of 
improvement in cognitive 
performance 
 
Publication arising from this Chapter: Keane, K.M., Haskell-Ramsay, C.F., 
Veasey, R.C. and Howatson, G. (2016) Montmorency Tart cherries (Prunus 
Cerasus L.) modulate vascular function acutely, in the absence of improvement in 
cognitive performance.  British Journal of Nutrition, 1-10. 
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5.1 Introduction  
Tart cherries and their derivatives are a functional food that are high in numerous 
polyphenols (Wang et al., 1999; Seeram et al., 2001; Seymour et al., 2014; Bell et 
al., 2014) that include the flavonoids isorhamnetin, kaempferol, quercetin, catechin, 
epicatechin, procyanidins, and anthocyanins (Kim et al., 2005; Kirakosyan et al., 
2009). It has been previously shown that tart cherries attenuate inflammation 
(Wang et al., 1999), oxidative stress (Howatson et al., 2010; Bell et al., 2014) and 
improve aspects of vascular function as demonstrated in Chapter 4.  One property 
underlying the potential vascular effects of tart cherries is an ability to modulate 
blood flow parameters.  Cherry extracts have been shown, in cell and animal 
models, to exert a range of cardio-protective effects that include increasing nitric 
oxide production and AOX status, reducing lipid oxidation and inhibiting 
inflammatory pathways (Wang et al., 1999; Seeram et al., 2001).  In Chapter 2 of 
this thesis, an increase in plasma phenolic acids (vanillic and protocatechuic) was 
observed following Montmorency tart cherry consumption in humans; these 
compounds were also shown to modulate vascular smooth muscle cell behaviour 
in vitro.  Moreover, in Chapter 4, it was demonstrated that circulating phenolic 
metabolites derived from Montmorency tart cherry juice are, at least in part, 
responsible for an acute reduction in systolic blood pressure in men with early 
hypertension. 
Aging is associated with deficits in motor function, which include decreases in 
balance, muscle strength, coordination, and cognitive function, especially in tasks 
that require the use of spatial learning and memory. This has been suggested to 
be caused by a concurrent decline in cerebral blood volume and metabolism of 
oxygen which also occurs as a result of aging (Marchal et al.,1992).  These 
decrements have been reported in numerous studies in both animals (Joseph et 
al., 1983; Shukitt-Hale et al., 1998) and humans (Ajmani et al., 2000; Hofer et al., 
2003).  A large number of dietary interventions using polyphenol-rich foods or 
beverages, in particular those using tea (Chan et al., 2006), Gingko Biloba (Birks & 
Evans, 2009), cocoa (Scholey et al., 2010) and blueberry (Shukitt-Hale et al., 
2008), have demonstrated beneficial effects on memory and learning in both 
animals and humans.  Although it is not clear whether tart cherries can decrease 
the risk of neurodegenerative aging or diseases such as Parkinson’s and 
Alzheimer in humans, studies with animal models are more positive and suggest 
that the phenolic compounds found in tart cherries, may exert their beneficial 
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effects through their ability to lower oxidative stress and anti-inflammatory 
properties or by altering directly the signalling involved in neuronal communication, 
calcium buffering ability, stress signalling pathways among others (Shukitt-Hale et 
al., 2006; 2008).  
Seymour et al., (2013) showed that intake of 1% tart cherry diet significantly 
reduced stroke-related phenotypes in rats. Tart cherry intake also reduced brain 
NFκB activity and the related pro-inflammatory transcripts.  Interestingly in 2015, 
Kirakosyan and colleagues (Kirakosyan et al., 2015) confirmed that tart cherry 
anthocyanins cross the blood-brain barrier.  In a more recent addition to the 
literature, thirty 19-month-old male Fischer 344 rats who received either a control 
diet or a diet supplemented with 2% tart cherry for six weeks were examined.  
Results showed that although there were no changes on motor performance, tart 
cherry supplementation significantly improved working memory of aged rats 
(Thangthaeng et al., 2016).  However, there is a paucity of data from human trials 
to extrapolate these findings to hominids.   
Caldwell et al., (2015) previously demonstrated that regardless of dose, cherry 
juice had no acute impact on cognitive function in young people, older people or 
dementia patients.  Oxygen radial absorbance capacity of the cherry juice was 
58.99 μmol Trolox equivalent/g and the anthocyanin content was 18.6 mg/100 ml, 
there was no mention of the total phenolic or flavonoid content of the juice. They 
concluded that although cherry juice may have an acute impact on cardiovascular 
function, there was no change in cognitive performance 6 h post consumption.  
Contrastingly, a chronic supplementation study (Kent et al., 2015) reported that the 
daily consumption of sweet cherries for 12 weeks improved cognitive performance 
across almost all tasks in older adults with mild-to-moderate dementia; this group 
showed improvements for category verbal fluency and tasks relating to verbal 
learning and memory and concluded the positive changes have clinical relevance 
for these cognitive improvements.  It would therefore appear that the 
cerebrovascular response required to elicit measurable changes in cognitive 
function can only be achieved with longer term dosing strategies (Clifford et al., 
2015). Contrary to this theory, two recent additions to the literature suggest that 
acute supplementation has the ability to improve aspects of cognitive function.  
Acute blackcurrant supplementation was shown to improve both digit vigilance and 
rapid visual information processing in healthy younger humans (Watson et al., 
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2015).  Similarly, acute wild blueberry supplementation was shown to improve final 
immediate recall, delayed word recognition, and accuracy on cognitively 
demanding incongruent trials in the interference task in in children (Whyte et al., 
2016).  Therefore, it is possible that Caldwell and colleagues reported no impact of 
cherry supplementation on cognitive function as they used sweet cherries as an 
intervention.  It has previously been speculated that sweet cherries are not as rich 
in polyphenol compounds as tart cherries (Kim et al., 2005).    
Polyphenol-rich foods have also been reported to improve cerebral 
haemodynamics assessed by near infrared spectroscopy (NIRS) and function 
magnetic resonance imaging (fMRI). Wightman and colleagues (Wightman et al., 
2012) assessed the effect of EGCG on cerebral blood flow using NIRS in healthy 
adults.  Results suggested that 135 mg of EGCG caused a reduction in total 
haemoglobin, a proxy for cerebral blood flow during cognitive tasks relative to the 
placebo.  Changes in cerebral blood flow has also been demonstrated following 
resveratrol (Kennedy et al., 2010) and beetroot supplementation (Wightman et al., 
2015).  Krikorian et al., (2012) used fMRI to examine the effect of Concord grape 
juice on neurocognitive function.  Sixteen adults aged >68 y with mild age-related 
memory decline were supplemented with either a grape juice (444 ml average) 
containing on average, 209mg of polyphenols, or a sugar matched placebo for 16 
weeks.  Results found that after 16 weeks, there were reductions in semantic 
interference on memory tasks and relatively greater activation in anterior and 
posterior regions of the right hemisphere in the grape juice treated group. Similarly, 
people with mild memory complaints, who drank pomegranate juice daily for four 
weeks, performed better on memory task compared to a placebo and displayed an 
increase in brain activation measured by fMRI (Bookheimer et al., 2013). In a 
recent addition to the literature, Lamport et al., (2017) investigated the effects of 
flavanone – rich citrus juice consumption on cognitive function and cerebral blood 
flow using fMRI.  They reported that the citrus juice was associated with 
significantly increased regional perfusion in the inferior and middle right frontal 
gyrus at 2 h relative to baseline and the control drink. Furthermore, the citrus juice 
was associated with significant improvements in cognition, namely the digit symbol 
substitution test at 2 h relative to baseline and the control drink. 
Very little has been reported on the effect of acute polyphenol supplementation on 
cerebral haemodynamics, with the majority of this work carried out with flavanol-
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rich cocoa (Francis et al., 2006; Sorond et al., 2008).  At present, no attempt been 
made to examine the haemodynamic response to acute tart cherry 
supplementation. 
Notwithstanding, given that Montmorency tart cherries are capable of modulating 
human vascular function (particularly in relation to blood pressure and vascular 
smooth muscle behaviour), we hypothesised that cerebral blood flow could also be 
acutely modulated and consequently improve cognitive performance in humans.  
Therefore, this study addresses the specific aim of this thesis, which was to 
assess the impact of Montmorency tart cherry juice consumption on pre-frontal 
cortical haemodynamics, cognitive function and blood pressure in middle aged 
adults. 
5.2 Methods 
5.2.1 Participants  
Thirty healthy middle aged (defined as 45-60 years) adults (10 female, 20 male, 28 
right-handed, 2 left-handed) were recruited to take part in the study; the mean ± 
SD age, stature, mass and BMI were 50 ± 6 years, 170.7 ± 9.1 cm, 76.0 ± 16.0 kg 
and 26.1 ± 4.9 kg/m2, respectively.  All participants were in apparent good health 
as assessed by a health-screening questionnaire.  This questionnaire was 
administered to highlight any contraindications to taking part in the study. 
Exclusion criteria included those who had suffered a head injury, neurological 
disorder or neuro-developmental disorder. In addition, those who had any relevant 
food allergies or intolerances, smoked tobacco, drank excessive amounts of 
caffeine [>6 cups coffee/d (>450 mg caffeine/d)], or took illicit social drugs were 
also identified as contraindications to participation.  All exclusion criteria were self-
reported.  The study was conducted in accordance with the Helsinki Declaration 
and ratified by the University’s Research Ethics Committee. All enrolled 
participants provided written informed consent. This study was registered as a 
clinical trial with clinicaltrials.gov (NCT02381860). 
5.2.2 Study Design 
This study employed a placebo-controlled, double blinded, cross-over, randomised 
Latin square design with two experimental arms and a washout period of at least 
14 days (mean ± SD, 15 ± 2 days); participants were randomly allocated to receive 
a 60 mL dose of a Montmorency cherry (MC) concentrate or a placebo (PLA). 
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Fourteen participants received the MC concentrate on the first visit, with the 
remainder receiving the PLA. A washout of at least 14 days was chosen based on 
findings from Chapters 3 and 4 as well as previous literature that suggests these 
phenolic compounds are quickly absorbed and/or excreted (Manach et al., 2005).  
Each participant was required to attend the laboratory on three separate occasions.  
Each visit was at the same time of day (within participant) and was preceded by an 
overnight fast (≥10 h). The first visit was an initial screening and familiarisation visit 
during which, participants were screened with regards to the study 
exclusion/inclusion criteria, briefed with regards to compliance requirements, 
provided written informed consent and given full training and familiarisation on the 
cognitive tasks. On the subsequent experimental days, participants reported to the 
lab between 7 and 9am and a baseline blood pressure (BP) reading was taken.  
This was followed by a baseline cognitive assessment and cerebral blood flow 
measures by near infrared spectroscopy (NIRS) and transcranial Doppler (TCD).  
Participants then consumed the intervention beverage (either MC or PLA), 
following which, they sat quietly, watching one of a selection of non-arousing 
DVDs, during a 1 hour “absorption period”.   Subsequent cognitive assessments 
and blood flow measures were taken 1, 2, 3, and 5 h post consumption; BP was 
performed hourly.  Between cognitive test sessions, participants continued to 
watch a selection of non-arousing DVDs.  No additional food or fluid was provided 
during the study period except for low-nitrate mineral water, which was consumed 
ad libitum.  The total volume of water consumed on the first experimental day was 
recorded and participants consumed the same volume on the second visit.  The 
reason for this was to accurately examine the efficacy of the intervention.   
5.2.3 Treatments and dietary control 
A MC concentrate (CherryActive, Sunbury, UK) was stored at 4º C prior to use.  
Participants consumed either 60 mL of MC concentrate (which according to the 
manufacturer is estimated to be equivalent to ~180 whole cherries) or fruit-
flavoured cordial in a double blind, cross-over manner.  This estimate is based on 
the brix value of sucrose in 100 g of solution. The decision to use 60 mL was 
based on previous literature and Chapter 3 of this thesis that showed a greater 
uptake of anthocyanin and phenolic acids in vivo post-consumption when 
compared to a 30 mL dose (Bell et al., 2014).  Additionally, Chapter 3 identified 
that of the three Montmorency cherry analogue studied (frozen, dried and 
concentrated), the MC concentrate had the greatest AOX activity, total 
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anthocyanin and phenolic content. The MC concentrate was examined for total 
anthocyanins, total phenolic content and Trolox Equivalent AOX Capacity using 
techniques previously described in Chapter 4.  The MC concentrate was found to 
contain 68.0 ±0.26 mg cyanidin-3-glucoside /L, 160.75 ± 0.55 mean gallic acid 
equiv/L and 0.59 ± 0.02 mean Trolox equiv/L, respectively.   The concentrate was 
diluted with 100 mL of water prior to consumption.   
The Pla supplement consisted of a commercially available, low fruit (<1%) cordial 
(Kia Ora, Coca Cola Enterprises, Uxbridge, UK) mixed with water, whey protein 
isolate (Arla Foods Ltd., Leeds, UK) and maltodextrin (MyProtein Ltd., Northwich, 
UK), to match the MC concentrate for volume and macronutrient content (Energy = 
204 kcal, volume = 60 mL, carbohydrates = 49 g, protein = 2.2 g and fat = 0 g). 
The total anthocyanin content (used for colour purposes only) and total AOX 
capacity of the PLA were lower than the limits of detection, with trace amounts of 
phenolics (8.26 ± 0.04 mean gallic acid equiv/L).  All drinks were prepared and all 
bottles were covered in tape prior to the study by a third party.  Prior to study 
commencement, it was explained to participants that the aim of the study was to 
investigate the effect of a fruit juice on vascular function; therefore they were 
unaware which beverage was the experimental drink. Participants were instructed 
to follow a low phenolic diet for 48 h prior to each arm of the trial by avoiding fruits, 
vegetables, tea, coffee, alcohol, chocolate, cereals, wholemeal bread, grains and 
spices and were asked to refrain from strenuous exercise.  Compliance with the 
dietary restrictions was assessed with a standardised, self-reported 2-day dietary 
record.  All participants complied with the low phenolic diet and this was confirmed 
via visual inspection of the food diaries.   
5.2.4 Cognitive tasks 
All cognitive and mood measures were delivered using the Computerised Mental 
Performance Assessment System (COMPASS, Northumbria University, Newcastle 
upon Tyne, UK), a purpose-designed software application for the flexible delivery 
of randomly generated parallel versions of standard and novel cognitive 
assessment tasks. This assessment system has previously been shown to be 
sensitive to nutritional interventions following both acute (Dodd et al., 2015) 
including acute supplementation with phenolics (Watson et al., 2015) and chronic 
supplementation (Stonehouse et al., 2013). At each of the aforementioned time 
points, a cognitive assessment test was completed. This assessment was a 
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collection of three tasks that lasted 9 minutes; this was performed twice, which 
equated to 18 minutes in total.  The tests were performed twice in order to induce 
some level of cognitive fatigue.  This was followed by a series of visual analogue 
scales to assess perceptions of fatigue and difficulty.  The types of tests chosen 
have been previously used to detect changes in cognitive function following 
nutritional interventions (Scholey et al., 2010; Kennedy et al., 2010; Watson et al., 
2015). In order to assess the relationship between specific brain regions and any 
changes in CBF, a selection of tasks that engender either higher or lower 
activation of the frontal cortex were employed. The “low activation” tasks 
comprised of a sustained attention test (digit vigilance).  The “high activation” tasks 
(Rapid Visual Information Processing and Stroop tasks) entail a higher cognitive 
workload and have been shown to increase activity in the pre frontal cortex 
(Drummond et al., 1999; Lawrence et al., 2002).  The battery of cognitive tasks is 
described in more detail below.   
Digit Vigilance 
The DV task is a measure of sustained attention and psychomotor speed (Coull et 
al., 1996).  A single target digit was randomly selected and constantly displayed on 
the right hand side of the screen.  A series of single digits appeared on the left 
hand side of the screen, one at a time, at the rate of 150 per minute.  The 
participant was required to press the target button on the response pad as quickly 
as possible every time the digit in the series matched the target digit.  The task 
lasted three minutes in total.  Task outcomes included accuracy (%) and reaction 
time for correct responses (ms) 
Rapid Visual Information Processing (RVIP) 
The RVIP task is a measure of sustained attention and working memory (Coull et 
al., 1996).  This task requires the participant to monitor a continuous series of 
single digits for targets of three consecutive odd or three consecutive even digits.  
The digits are presented on the computer screen one at a time at the rate of 100 
per minute in pseudo-random order, and the participant responds to the detection 
of a target string by pressing the target button on the response pad as quickly as 
possible. The task lasted three minutes in total.  Task outcomes included number 
of target strings correctly detected (%) and average reaction time for correct 
detections (ms). 
120 
Stroop 
The Stroop test is a measure of attention, inhibition and cognitive flexibility 
(Homack & Riccio, 2004).  In this task, participants were presented with a colour 
name.  The colour name presented was written in a coloured font, either the same 
“congruent” or a different “incongruent” font.  Participants had to identify the colour 
of the font the word was written in, rather than the colour that the word was 
describing, via a response pad with coloured keys.   Participants were presented 
with 90 stimuli in total taking ~3 minutes to complete. Task outcomes included 
number of correct responses (%) and the average response time for congruent 
and incongruent stimuli (ms).   
Visual Analogue Scales  
Participants were required to rate how “alert”, “concentrated” and ‘mentally 
fatigued’ they felt and how ‘difficult’ they had found the tasks after each cognitive 
assessment repetition by indicating on a 100 mm line with the cursor (“not at all” at 
one end of the line and “extremely” at the other end) for alertness, fatigue and 
level of difficulty and (“very low” to “very high”) for concentration.  The VAS were 
scored as % along the line denoting more of the relevant adjective. 
5.2.5 Blood pressure  
Blood pressure was measured using a non-invasive digital automatic BP monitor 
(M10-IT Omron Healthcare, UK).  The BP cuff was fitted by the same researcher 
at each of the six time points. The inter- and intra-trial %CV for this method was 
4.2 and 1.3% respectively.  
5.2.6 Cerebrovascular responses 
5.2.6.1 Transcranial Doppler imaging 
Cerebral blood flow velocity in the middle cerebral artery (CBFV) was determined 
using transcranial Doppler sonography (Doppler-Box, Compumedics DWL, Singen, 
Germany). A 2 MHz Doppler probe was positioned over the right middle cerebral 
artery using previously described search techniques (Aaslid et al., 1982), and 
secured with an adjustable headset (DiaMon, Compumedics DWL). The mean 
depth for Doppler signals was 62 ± 3 mm. All data were sampled at 200 Hz 
(PowerLab 16/30, ADInstruments Ltd, Oxfordshire, UK), and processed offline 
(LabChart version 5.4.2, ADInstruments Ltd).   
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5.2.6.2 Near Infrared Spectroscopy (NIRS)  
The NIRS is a non-invasive brain imaging technique in which two nominal 
wavelengths of light, which are differentially absorbed by oxygenated (oxy-Hb) and 
deoxygenated haemoglobin (deoxy-Hb), respectively, are introduced through the 
skull via a laser emitter.  They are then measured, following transit through the 
upper surface of the cortex, by an optode placed at a pre-set distance from the 
light source. NIRS has been used extensively as a technique for multiple-channel 
imaging of task-related brain activity over relevant areas of the head, including 
groups suffering from potential declines in CBF (Schecklmann et al., 2008).  In the 
current study, cerebral oxygenation was assessed using near-infrared 
spectroscopy (NIRS; NIRO-200NX, Hamamatsu Photonics K.K., Japan). Two 
near-infrared sensors were placed over the left and right frontal lobe region of the 
forehead corresponding to the International 10–20 system Fp1 and Fp2 EEG 
positions; these signals were averaged to determine cerebral oxygenation. The 
sensors were secured to the skin using double-sided adhesive tape and shielded 
from ambient light using an elastic bandage. The sensors alternately emit two 
wavelengths of near-infrared light (≈765 and 855 nm) with an emitter/optode 
separation distance of 4 cm. The NIRS data were acquired continuously and 
output every 5 s and recorded for later offline analysis.  The NIRS data output was 
time stamped at the start of each task segment to assure that data corresponded 
to the relevant period of task performance. Relative concentration changes in oxy-
Hb, deoxy-Hb and total-Hb were calculated. The experimental set up on study 
days is shown in Figure 17.   
5.2.6 Statistical Analysis  
Cognitive performance, BP and CBFV data were analysed by using a treatment × 
time point mixed model analysis of variance (ANOVA).  Mauchly’s Test of 
Sphericity was used to check homogeneity of variance for all ANOVA analyses; 
where necessary, violations of the assumption were corrected using the 
Greenhouse–Geisser adjustment. Significant main effects were followed up using 
LSD post hoc analysis.  Planned comparisons were made between the MC and 
placebo condition for each variable at each of the time points [pre-supplement, 1, 
2, 3 and 5 h].   The analysis of NIRS data was conducted with Minitab 15 for 
Windows (Minitab Inc, State College, PA).  Prior to the primary analysis, a within 
subjects Analysis of Variance (ANOVA) was carried out with left/right optode 
included as a factor (hemisphere x treatment group) for each task. As there were 
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no treatment related interactions involving hemisphere the data from the 2 
channels were averaged across hemispheres for the analysis and figures reported 
below.  For each variable (oxy-Hb, deoxy-Hb and total Hb), data were converted to 
“change from baseline” (calculated from baseline pre-treatment period). Task 
length was fixed for the DV (180 s) and RVIP (180 s), but NIRS data from the 
Stroop test were truncated so that the same amount of data was analysed for all 
participants during each task period.  Data from the ‘resting/absorption’ period 
(minutes 1-60) and the task performance were analysed separately for all time 
points [pre–supplement, 1, 2, 3 and 5 h].  Data from the ‘resting/absorption’ period 
was averaged across 6 equal 10-min epochs and analysed by two – way repeated 
measures analysis of variance (ANOVA) (epoch × treatment).  Data from the task 
period data was averaged across 6 equal 3-min epochs.  This data was analysed 
by a three-way repeated measures ANOVA (task (epoch) × treatment × time point).   
In the absence of any directly relevant data, it was suggested that a sample size of 
twenty – four would be adequate to have greater than an 80% chance of detecting 
the medium effect sizes demonstrated in previous research assessing the effect of 
polyphenols on NIRS parameters (Wightman et al., 2014).  The resultant sample 
size of 27 (for a within-subjects, crossover design) was in excess of the typical 
sample sizes for NIRS investigations. 
 
 
Figure 17 - The experimental set up on study days.  Participants were fitted with a 
headpiece that continuously monitored cerebral blood flow velocity (TCD) and 
haemoglobin levels (NIRS) whilst performing several cognitive tests (COMPASS). 
COMPASS 
assessment 
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Transcranial 
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pad 
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5.3 Results  
Thirty male and female participants volunteered to take part in the study, but three 
participants voluntarily withdrew after the first study day (n=27).  There were no 
adverse events reported in response to the intervention products. All participants 
complied with the low-polyphenolic diet according to the food diaries.  
5.3.1 Cognitive performance and mood 
No significant treatment-related differences were observed for any of the cognitive 
or mood measures (P > 0.05).   The absolute values for task scores and mood 
ratings are given in Tables 13 and 14, respectively.  
5.3.2 Blood pressure 
Systolic blood pressure (SBP) exhibited a time (F = 15.856, P < 0.001), and 
treatment × time interaction effects (F = 4.825, P = 0.002).  A post-hoc LSD test 
indicated that this difference occurred at 1, 2, 3 h post supplementation in the MC 
group, with peak reductions from baseline in postprandial SBP of 6 ± 2 mmHg at 1 
h post MC consumption (Figure 18). There was no time, treatment or treatment × 
time interaction effects observed for diastolic blood pressure (DBP) (P > 0.05).     
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Figure 18 - Time course of systolic blood pressure (mean ± SEM) response after 
consumption of MC concentrate- and macronutrient – matched control (n=27).  
Significantly different from the placebo drink: * P < 0.05 
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Table 13 - Effects of MC concentrate and Pla on various aspects of cognitive performance in healthy middle aged adults. 
  Task battery repetition   
  Baseline 
 
1 
 
2 
 
3 
 
5 
 
ANOVA 
 
Measures Treatment  Mean SEM Mean SEM Mean SEM Mean SEM Mean SEM Effect F P 
DV (%) 60 mL MC 94.2 1.1 94.3 1.4 93.6 1.4 92.3 1.7 92.3 2.0 T 0.087 0.771 
Pla 95.2 0.9 94.5 1.2 94.1 1.3 92.6 1.8 92.1 2.0 T × R 0.137 0.890 
DV RT (ms) 60 mL MC 455.4 8.1 461.9 9.0 464.0 8.0 472.1 8.9 470.1 9.4 T 3.793 0.062 
Pla 455.5 8.2 461.0 8.6 465.8 9.1 454.6 11.1 444.0 16.2 T × R 2.109 0.135 
RVIP (%) 60 mL MC 53.4 5.0 52.9 4.2 51.2 5.1 51.8 5.0 52.3 4.8 T 0.027 0.870 
Pla 51.7 4.3 55.1 4.7 51.3 4.9 53.5 4.5 52.2 4.7 T × R 0.391 0.759 
RVIP RT(ms) 60 mL MC 491.6 32.2 517.1 12.1 522.4 11.0 528.0 11.0 504.4 11.8 T 0.269 0.608 
Pla 526.1 11.6 520.0 12.0 483.8 29.1 505.6 17.1 507.0 15.7 T × R 1.145 0.316 
Stroop (%) 60 mL MC 98.7 0.2 98.8 0.3 98.7 0.2 98.8 0.2 98.7 0.3 T 0.960 0.414 
Pla 98.6 0.2 98.7 0.3 98.9 0.2 99.0 0.2 99.0 0.2 T × R 0.667 0.298 
Stroop RT 
(ms) 
60 mL MC 789.0 30.7 774.6 26.9 778.1 36.0 754.0 26.7 761.1 24.5 T 0.214 0.648 
Pla 814.9 37.5 764.0 29.2 764.0 29.2 763.4 29.8 805.3 68.2 T × R 0.677 0.487 
All values are means ± SEM (n=27) T, treatment; R, repetition; DV, digit vigilance; RVIP, rapid visual information processing; RT, reaction 
time; Pla, Placebo. 
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Table 14 - Effects of MC concentrate and Pla on mood in healthy middle aged subjects. 
  Task battery repetition   
  Baseline 
 
1 
 
2 
 
3 
 
5 
 
ANOVA 
 
Measures Treatment  Mean SEM Mean SEM Mean SEM Mean SEM Mean SEM Effect F P 
Alert 60 mL MC 35.67 4.55 35.39 3.55 40.31 4.11 42.91 4.41 45.22 4.44 T 0.415 0.525 
Pla 35.10 3.91 34.76 3.49 43.13 3.70 45.30 3.94 49.85 4.37 T × R 0.763 0.477 
Concentration 60 mL MC 57.19 4.83 52.50 3.68 52.39 3.69 50.94 3.49 47.96 3.42 T 0.287 0.597 
Pla 51.75 3.61 57.02 3.19 48.80 3.44 49.15 3.50 46.93 3.52 T × R 1.417 0.250 
Mental fatigue 60 mL MC 60.74 4.29 61.54 3.76 60.94 4.13 58.69 3.97 57.20 4.21 T 0.163 0.690 
Pla 61.65 3.95 63.44 3.32 55.76 3.82 54.30 4.09 56.85 4.08 T × R 1.281 0.288 
Difficulty  60 mL MC 38.41 3.91 38.94 3.46 40.50 4.21 41.57 4.21 44.59 3.81 T 0.014 0.907 
Pla 40.73 3.69 36.65 3.41 39.78 3.08 38.96 3.43 44.96 3.50 T × R 0.631 0.579 
All values are means ± SEM (n=27) T, treatment; R, repetition; Pla, Placebo. 
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5.3.3 Transcranial Doppler imaging  
There was no time, treatment or treatment × time interaction effects observed for 
cerebral blood flow velocity (P > 0.05).   
5.3.4 Near-IR spectroscopy parameters 
5.3.4.1 Total haemoglobin (Total-Hb) 
There was a significant interaction between treatment and post-treatment epoch 
on the initial ANOVA during the resting/absorption period (F = 5.234, P = 0.015).  
Reference to planned comparisons showed that there were significantly higher 
total-Hb concentrations during the last 3 10-min epochs of the resting/absorption 
period for MC concentrate.  MC concentrate also resulted in higher total-Hb 
concentrations during each epoch of task performance 1 h post consumption (F = 
16.452, P < 0.01).  Thereafter, there were no significant differences in total-Hb (P > 
0.05, Figure 19 A). 
5.3.4.2 Oxygenated haemoglobin (oxy-Hb)   
Similarly, there was a significant interaction between treatment and posttreatment 
epoch on the initial ANOVA during the resting/absorption period (F = 3.241, P = 
0.029).  Reference to planned comparisons showed that there were significantly 
higher oxy-Hb concentrations during the last 3 10-min epochs of the 
resting/absorption period for MC concentrate.  MC concentrate also resulted in 
higher oxy-Hb concentrations during each epoch of task performance 1 h post 
consumption (F = 18.535, P = 0.019).  Thereafter, there were no significant 
differences in total-Hb (P > 0.05, Figure 19). 
5.3.4.3 Deoxygenated haemoglobin (deoxy – Hb)  
There were no significant differences in terms of deoxy-Hb during either the 
resting/absorption or task performance periods (P > 0.05, Figure 20). 
5.3.4.4 Task-related differences 
There were no significant differences seen in the hemodynamic response to the 
DV, RVIP or Stroop tasks.  
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Figure 19 - A:  Mean (± SEM) changes in concentrations of oxy-haemoglobin and 
B: total haemoglobin during a 60-min absorption period and subsequent cognitive 
task assessments 1, 2, 3 and 5 h post 60mL MC concentrate or placebo.  
Significantly different from the placebo: * P < 0.05, ** P < 0.01. 
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Figure 20 - Mean (± SEM) changes in concentrations of deoxy-haemoglobin 
during a 60-min absorption period and subsequent cognitive task assessments 1, 
2, 3 and 5 h post 60mL MC concentrate or placebo. 
 
5.4 Discussion 
To the best of our knowledge, this study was the first to investigate the acute 
effects of Montmorency tart cherries consumption on cerebral blood flow variables 
and cognitive performance in a middle aged population. In support of our 
hypothesis, this study presents new information that in comparison to placebo, the 
consumption of a MC concentrate resulted in acute modulation of CBF parameters 
in the frontal cortex during task performance as indicated by the elevated 
concentration of total-Hb, with an identical pattern observed with oxy-Hb.  This 
effect was evident for the cognitive assessment 1 h post MC consumption.  These 
CBF observations were not associated with any significant modulation of cognitive 
performance or mood.   There was also a significant reduction in SBP for up to 
three hours post MC consumption relative to the placebo.   
Compromised cerebral blood flow has been suggested as a key contributor to 
cognitive function decline observed with advancing age and in a number of 
neurodegenerative diseases (Farkas et al., 2002).  The results of the current study 
demonstrate that MC concentrate can modulate aspects of brain function, this was 
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evident 1 h post consumption.  Total-Hb and oxy-Hb were increased toward the 
end of the 60-min resting/absorption period and during the cognitive assessment 1 
h post consumption.  However, there were no concomitant changes in deoxy-Hb 
across any of the time points.  These results are consistent with previous studies 
using compounds and whole foods to demonstrate a positive effect on cognitive 
function and CBF.   Kennedy and colleagues (2010) demonstrated an increase in 
total-Hb and oxy-Hb following single doses of orally administered resveratrol and 
more recently, Wightman et al., (2015) following beetroot juice ingestion.  In both 
of these studies, total-Hb was increased during the first epoch of task 
performance.  However, whilst total-Hb remained higher in the resveratrol study 
throughout the 40 minute cognitive assessment, it was decreased during the last 5 
repetitions when participants were supplemented with beetroot juice.  In the 
current study, no significant differences were seen following the first task period.  
The limitations associated with NIRS have consistently been highlighted (Murkin & 
Arango, 2009), and in the past few years, fMRI and other neuroimaging 
techniques have been used to assess the effect of a nutritional supplement on 
CBF (Isaacs, 2013; Bookheimer et al., 2013). 
In terms of higher total-Hb concentrations, the modulation seen in the current 
study may be due to the vaso-relaxatory and antihypertensive properties of some 
of the phenolic acids (vanillic and protocatechuic acid) contained in the MC 
concentrate as demonstrated in Chapters 3 and 4 of this thesis. The time points 
(~1 hour post) at which these metabolites are seen in the plasma coincide with 
improvements in vascular function (Chapter 4), and modulation in CBF in the 
current study.  Deoxy-Hb was not modulated in the current study. Furthermore, in 
the current study, task had no significant effect on cerebral modulation.  It has 
previously been speculated that “high activation” tasks such as RVIP result in a 
higher increase in CBF than does performance in “low activation” tasks, for 
example digit vigilance.  This can be largely attributed to the relative cognitive 
demands of the two tasks, with RVIP requiring the monitoring of rapidly changing 
digits along with a passive contribution from working memory.  We speculate that 
these very early on effects on CBF in the current study might  be associated with 
the sensory properties of the MC concentrate as previous studies have showed 
demonstrated that a number of sensory factors including differing taste and 
flavours are likely to modulate frontal cortex activity (Marciani et al., 2006; Smits et 
al., 2007).  Marciani and colleagues previously demonstrated that several brain 
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areas were activated immediately after swallowing particularly when supplements 
had a strong (combined) taste or aroma.  It could be argued that the MC 
concentrate was more sensory stimulating than the placebo, however this is 
speculative.  Furthermore, a full analysis of sensory properties of MC and the 
placebo was outside the remit of the current study.  In addition, NIRS only 
provides data on the relative concentration changes in each of the separate 
chromophores in response to tasks in the region of interest (the prefrontal cortex in 
the present thesis), and does not provide any information regarding the effects of 
the treatment on general cerebral blood flow.  
Although the current study highlights an acute heightened NIRS response in brain 
regions responsible for task performance, there no was effect on cognitive 
performance.  Supplementary oxygen (Moss et al., 1998) has been shown to 
positively influence cognitive performance in a healthy population.  Therefore, it 
makes the expectation tenable that increases in CBF could be beneficial to acute 
cognitive performance via increasing the delivery of oxygenated blood metabolic 
substrate to, and efflux of metabolites from the brain, which is critical for brain 
function (Attwell et al., 2010).  Importantly, despite some indication of improved 
blood flow, the current study showed no changes in cognitive task performance 
between experimental conditions. Nevertheless, these results do not stand alone; 
Caldwell et al., (2015) previously demonstrated that regardless of dose, cherry 
juice had no acute impact on cognitive function in young people, older people or 
dementia patients.  They concluded that although cherry juice may have an acute 
impact on cardiovascular function, there was no change in cognitive performance 
6 h post consumption. However, Caldwell and colleagues used sweet cherries as 
an intervention, it has been speculated that sweet cherries are not as rich in 
polyphenol compounds as tart/sour cherries (Kim et al., 2005).   
Furthermore, cognitive assessments and blood flow measures were taken at 
baseline, 2 and 6 h post consumption, the current study attempted to explore the 
time points following consumption in more detail (hourly), however it is possible 
that any potential changes might still have been missed. Contrastingly, a chronic 
study by the same group (Kent et al., 2015) reported that the daily consumption of 
sweet cherries for 12 weeks improved cognitive performance across almost all 
tasks in older adults with mild-to-moderate dementia; this group showed 
improvements for category verbal fluency and tasks relating to verbal learning and 
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memory and concluded the positive changes have clinical relevance for these 
cognitive improvements.  Therefore, it is likely that regulation of blood flow and 
cognition are extremely complex, with multiple overlapping regulatory mechanisms 
paradigms and contributing structural components (Peterson et al., 2011), and 
therefore more likely to be influenced by chronic supplementation.  This also 
accords with previous observations in similar trials, where Kelly et al., (2013) and 
Thompson et al., (2014) showed that after acute beetroot supplementation, there 
were no changes in cognitive performance for concentration, memory, attention or 
information processing ability.  However, when older type 2 diabetics were 
supplemented with beetroot juice for 14 days, they experienced a significant 
improvement in simple reaction time compared to a control group (Gilchrist et al., 
2014).  These somewhat contrasting results may be partly explained by dose 
duration.  It would seem that the cerebrovascular response required to elicit 
measurable changes in cognitive function can only be achieved with longer term 
dosing strategies that have the potential to induce sustained modifications to 
cerebrovascular function (Clifford et al., 2015).   
However, contrary to this suggestion, two recent additions to the literature have 
demonstrated positive effects on cognitive function following acute blackcurrant 
(Watson et al., 2015) and wild blueberries (WBB) supplementation (Whyte et al., 
2016).  Acute blackcurrant supplementation was shown to improve RVIP accuracy 
and reaction time on the DV task in healthy people.  Whilst, Whyte and colleagues 
demonstrated that acute cognitive benefits can be observed in 7-10-year old-
children with an anthocyanin-rich blueberry intervention. The Page’s test revealed 
the consistency and strength of this finding with WBB supplementation leading to 
significant overall improvements in cognition function, with the best change from 
baseline performance associated with 30g WBB treatment, intermediate 
performance with the 15g WBB treatment, and least effective performance with the 
vehicle treatment. Given that the protective cognitive effect of fruits is attributed to 
their high anthocyanin content, the anthocyanin dose in both of these studies was 
marginally higher than the current investigation (253 mg and 552 mg vs. 68 mg 
cyanidin-3-glucoside /L), this might go some way in explaining the inconsistent 
findings. It is also worthy to note, the cognitive tasks in the current study were 
selected on the basis of previous sensitivity to nutritional interventions (Scholey et 
al., 2010; Watson et al., 2015), however, these tasks may not be adequately 
sensitive to detect change in acute studies as perhaps this particular intervention 
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could affect different cognitive domains (i.e.. memory, recall).  The most important 
consideration in setting up a suitable framework for measuring human cognitive 
function in polyphenol or flavonoid research is to determine methods that are 
sensitive to dietary changes and repeatable over time, simple to interpret and 
specific to cognitive domains (Macready et al., 2009).  
Furthermore, all participants in the current study were healthy with no apparent 
issues pertaining to cerebral blood flow or cognitive ability. It is logical to question 
if that could mean that sufficient blood flow already exist for maximal cognitive 
performance and therefore, increasing blood flow beyond this threshold does not 
have any acute benefits on cognitive performance.   
Additionally, there was no effect of the intervention on mood. This is somewhat 
surprising as mental fatigue has been previously shown to be receptive to cocoa 
flavanols in healthy adults (Scholey et al., 2010).  However, Scholey and 
colleagues employed repeated 10-min cycles of a Cognitive Demand Battery (two 
serial subtraction tasks [Serial Threes and Serial Sevens] and RVIP), over the 
course of 1 h.  Therefore, the cognitive assessment adopted in the current study 
might not have been as taxing on the brain as the aforementioned CDB with very 
limited rest time between repetitions.  
There was a significant decrease in systolic blood pressure following MC 
supplementation when compared to placebo.  These findings are in agreement 
with the previous chapter that reported a positive modulation of SBP in early 
hypertensive males following MC ingestion. This is not surprising, as participants 
in the current study had moderately elevated systolic blood pressure above the 
published ideal values at baseline - 128/82 mmHg.  Kapil et al., (2010) noted that 
the magnitude of change in the BP response is directly related to baseline BP 
therefore, those who have a higher BP, will likely experience a greater change 
following an intervention.  The current study is particularly noteworthy as data from 
prospective, observational studies have shown a reduction in mean SBP of 5-6 
mmHg over a five year period was associated with 38% and 23% reduced risk of 
stroke and coronary heart disease, respectively (Collins et al., 1990). Here, we 
reported peak reductions in postprandial SBP of 6 ± 2 mmHg relative to the 
placebo. This finding, along with the modulation of CBF 1 h post MC consumption 
supports the growing body of evidence showing an inverse association between 
133 
the risk of chronic human diseases and the consumption of polyphenolic rich diet 
(King, 2000; Ginter & Simko, 2012). 
The findings of the current study should be interpreted with a certain degree of 
caution because of the dietary restrictions imposed on participants.  It is extremely 
unlikely that one would consume a diet that is free from polyphenol-rich foods and 
as a result, future work should attempt to demonstrate synergistic effects of MC 
supplementation within habitual dietary practices.  Furthermore, a digital automatic 
BP monitor was used in the current study.   The accuracy of this method has been 
called into question (Nelson et al., 2008).  Future studies should consider using 
ambulatory blood pressure measurements, where readings are taking at regular 
intervals.  Many studies have now confirmed that blood pressure measured over a 
24-hour period is superior to clinic blood pressure in predicting future 
cardiovascular events (Ogedegbe, 2010).   A timeframe of 5 h was utilized based 
on previous findings that phenolic compounds are quickly absorbed and/or 
excreted (Chapter 3) (Manach et al., 2005) and that any positive effects in 
vascular function are transient and return to baseline after four hours as evidenced 
in Chapter 4.   However, it is possible that this timeframe may not long enough to 
capture the absorption of potentially other bioactive phenolic compounds provided 
by cherries in the colon. 
In summary, the findings from this study suggest that MC concentrate can acutely 
modulate CBF in the prefrontal cortex characterized by increased concentrations 
of both total-Hb and oxy-Hb.  Despite this evident modulation, these results do not 
translate to improvements in cognition or mood in the hours following 
consumption.    Finally, this Chapter reaffirms previous findings that demonstrate a 
significant improvement in SBP following MC supplementation.   
 
5.5 Perspectives 
This Chapter addressed the third aim of this thesis to examine the effect of 
Montmorency tart cherry juice supplementation on cerebrovascular function and 
cognition.  In participants supplemented with Montmorency tart cherry juice, total 
and oxy-Hb levels were elevated 1 h post consumption.  Additionally, marked 
reductions in systolic blood pressure were observed following MC consumption, 
building on the findings from Chapter 4. 
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Whilst previous studies have assessed the impact of polyphenol supplementation 
on cognitive function and haemodynamics, prior to this study no attempt had been 
made to examine the haemodynamic response to tart cherries.  The results from 
this Chapter add weight to the findings from Chapter 4, showing MC 
supplementation may be an efficacious strategy in modulating vascular function.  
Indices of cerebrovascular function (specifically total-Hb and oxy-Hb) were 
consistently higher in the MC supplemented group which may be of benefit to the 
aging population when trying to maintain sufficient blood flow to counteract the 
natural cognitive decline that occurs with age, although the lack of cognition or 
mood changes in this study, make this inference speculative.  The findings from 
Chapter 4 suggest efficacy for MC in improving systolic blood pressure in those 
with early hypertension, and the results of the current Chapter provide further 
support those data. 
Given the known vascular response following MC consumption provided by the 
current and preceding Chapters, and the interest surrounding polyphenol 
supplementation and its potential to improve exercise performance, Chapter 6 will 
directly assess the effects of acute tart cherry supplementation on plasma NO2- 
concentration, blood pressure, V̇O2 kinetics, and exercise performance, compared 
with an energy-matched placebo. 
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6.1 Introduction  
As previously highlighted, tart cherries are a food source rich in polyphenols 
(Wang et al., 1999; Seeram et al., 2001; Seynour et al., 2014; Bell et al., 2014) 
that include the flavonoids isorhamnetin, kaempferol, quercetin, catechin, 
epicatechin, procyanidins, and anthocyanins (Kim et al., 2005; Kirakosyan et al., 
2009).  Anthocyanins are a flavonoid group that has been associated with benefits 
for human health through anti-inflammatory effects (Zhu et al. 2013) and AOX 
activity (De la Cruz et al. 2013) (Section 2.2.3.1.4). These effects are of interest to 
counteract the production of reactive oxygen species during exhaustive exercise 
(Viña et al. 2000), which is the primary cause of exercise-induced disturbance in 
the oxidation–reduction status (i.e. redox balance) of skeletal muscle (Powers et al. 
2004).  In addition, the previous studies of this thesis demonstrated the positive 
effects of Montmorency tart cherry concentrate on various aspects of 
cardiovascular function, specifically enhanced cell migration, improvements in 
systolic blood pressure as well as elevated levels of total and oxy-Hb have been 
demonstrated.  This may be mediated by the ability of polyphenols to increase 
nitric oxide by endothelial cells and also a reduced breakdown of nitric oxide by 
free radicals (Martin et al. 2002; Nagai et al. 2002) however this has not been 
investigated. Evidence shows that various polyphenols improve flow-mediated 
dilatation and endothelial function in humans by increasing endothelial nitric oxide 
synthesis (Nicholson et al., 2008; Ghosh & Scheepens, 2009). In sports where the 
rate of blood flow and maximum cardiac output are important determinants of 
cardiovascular performance, by acting on endothelial function, polyphenols could 
aid overall athletic performance 
The cardio-protective properties of Montmorency tart cherries highlighted in this 
thesis, and the evidence that tart cherries can reduce oxidative stress and 
inflammatory markers (Wang et al., 1999; Howatson et al., 2010; Bell et al., 2014) 
may represent a potential ergogenic affect upon exercise performance. To date, 
there have only been two other studies that have investigated the effect of tart 
cherry supplementation on exercise performance.    Clifford and colleagues (2014) 
first examined the effect of 200mg of CherryActive® capsules containing 216 mg 
of polyphenols on sub-maximal cycling and time trial performance.  Results 
showed that no significant differences between trials were found for heart rate, 
respiratory exchange ratio, gross mechanical efficiency, oxygen consumption, 
blood lactate or final 20 km TT times (P > 0.05).  In contrast, a more recent study 
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found that when participants were supplemented with powered Montmorency tart 
cherry capsules for 10-days, they averaged 13% faster half-marathon finish times 
(P= 0.001) and tended to have smaller deviations from predicted race pace (P = 
0.091) compared to their placebo counterparts.  The latter is in agreement with 
several studies reporting the significant beneficial AOX effects of natural 
polyphenols, in exercise-induced oxidative stress (Morillas-Ruiz et al., 2006; 
Panza et al., 2008).  Previous studies have highlighted the performance-
enhancing benefits of grape extract, chokeberries and blueberries (McAnulty et al., 
2011; Lafay et al., 2009; Pilaczynska – Szczesniak et al., 2005).  In one such 
study, Lafay et al (2009) supplemented handball players with a grape extract 
containing several polyphenols; the authors concluded that following grape extract 
supplementation, jump performance over 45-s significantly improved.  The authors 
suggest that the enhancement in performance might be caused, at least in part, by 
the protective action of polyphenols during physical exercise.  More recently, Cook 
et al. (2015) reported that following a seven-day intake of New Zealand 
blackcurrant extract, there was a significant improvement in cycling time-trial by 
2.4% performance, coupled with an increase in fat oxidation. The authors 
speculated that this improvement may have been as a result of improved 
endothelial function and increased peripheral blood flow.  Tart cherries have been 
shown to improve blood flow and blood pressure in earlier chapters; therefore if 
blood flow and cardiac output are important determinants of athletic performance, 
tart cherries may pose beneficial effects. 
With the role of tart cherries in exercise recovery been widely discussed 
(Howatson et al., 2010; Bowtell et al., 2011 ; Bell et al., 2013; 2014; 2016), it is 
somewhat surprising that as of yet, there has been no attempt to investigate the 
effect of acute tart cherry ingestion on exercise performance.  Therefore, this study 
addresses the specific aim of this thesis, which was to investigate the effects of 
acute tart cherry supplementation on plasma NO2- concentration ([NO2-]), a 
sensitive marker of NOS activity (Lauer et al., 2001), as well as blood pressure, 
V̇O2 kinetics, and exercise performance, compared with an energy-matched 
placebo.  We hypothesized that, compared with placebo, MC supplementation 
would elevate plasma [NO2−], reduce blood pressure, and improve V̇O2 kinetics, 
cycling efficiency, and exercise performance. 
138 
6.2 Methods 
6.2.1 Participants 
Ten healthy male trained cyclists from a local cycling club volunteered to 
participate in the study (mean ± SD age; 28 ± 7 years, stature 1.83 ± 0.06 m, body 
mass 78.0 ± 8.5 kg and V̇O2peak 59.0 ± 7.0 ml/kg/min). Exclusion criteria for the 
study were as follows: V̇O2peak < 50 ml/kg/min (determined on visit 1), smokers, 
food allergy (as discussed with research team), history of gastrointestinal, renal or 
cardiovascular disease and current use of any food supplementations. All 
participants provided written consent prior to the commencement of the study.  For 
24 h prior to and for each of the testing days, participants were asked to avoid 
strenuous exercise, alcohol, caffeine, nutritional supplements and any anti-
inflammatory drugs. Participants were also instructed to avoid polyphenol-rich 
foods and to record their dietary intake for 24 h prior to each testing day.  
Participants were asked to arrive at the laboratory in a rested and fully hydrated 
state, ≥10 h postprandial.  All tests were performed at the same time of day.  The 
study was conducted in accordance with the Helsinki Declaration and ratified by 
the University’s Research Ethics Committee. 
6.2.2 Study Design 
Participants were required to report to the laboratory on five occasions over a 4-5 
week period to complete the experimental testing (1 familiarization / V̇O2peak visit 
and 4 experimental visits).  On the first visit to the laboratory, participants 
completed a ramp incremental exercise test for determination of the gas exchange 
threshold (GET) and peak V̇O2 (V̇O2peak).  Participants were also familiarized with 
the two exercise performance tests employed in the study on this visit to avoid any 
order effect on the performance results as a consequence of a potential “learning 
effect”.  Participants then returned to the laboratory on visits 2, 3, 4 and 5 to 
complete the experimental testing.  During these tests, resting blood pressure, 
arterial stiffness, pulmonary V̇O2 kinetics, muscle oxygenation, and exercise 
performance was assessed, and venous blood samples were obtained.  The MC 
concentrate and Placebo drinks were administered orally in a randomized order as 
part of a double – blind, crossover experimental design.  Each supplementation 
day was separated by at least 3 days, but no longer than 7 days. 
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6.2.2.1 Incremental Test.   
During the first laboratory visit, participants completed a ramp incremental cycle 
test on an electronically braked cycle ergometer (Lode Excalibur Sport, Groningen, 
The Netherlands).  Initially, participants performed 3 min of baseline cycling at 0W: 
then the work rate was increased by 30 W/min until the limit of tolerance.  The 
participants cycled at a self – selected pedal rate, which, along with saddle and 
handle bar heights and configuration, was recorded and reproduced in subsequent 
tests.  Breath-by-breath pulmonary gas exchange data was collected continuously 
during the incremental tests and averaged over consecutive 10-s periods.  The 
maximum V̇O2peak was taken as the highest 30-s mean value attained prior to the 
participant’s volitional exhaustion in the test.  The GET was determined as 1) the 
first disproportionate increase in CO2 production (V̇CO2) from visual inspection of 
individual plots of V̇CO2 and V̇O2, and an increase in expired ventilation (V̇E)/ V̇O2 
with no increase in (V̇E)/ V̇CO2.  The work rate that’s would require 90% of the GET 
(moderate – intensity exercise) and 70% Δ (GET + 70% of the difference between 
the work rate at the GET and V̇O2peak; severe intensity exercise) were calculated.  
The mean response time (MRT) for V̇O2 during ramp exercise was taken into 
account, therefore two – thirds of the ramp rate was deducted from the work rate 
at GET and peak (i.e.., 20W; Whipp et al., 1981).   
 
Following the incremental test and a 45-minute rest, participants were familiarized 
with the exercise tests.  Participants completed a severe – intensity step exercise 
test finishing with an all-out sprint followed, after a 30-minute passive recovery 
period, by a severe – intensity constant-work-rate step exercise test that was 
continued until the limit of tolerance.  
 
6.2.2.2 Experimental tests.  
On all subsequent visits, participants were required to rest in a seated position for 
10 min in an isolated room.  Thereafter, baseline blood pressure of the brachial 
artery was measured using an automated sphygmomanometer (M10-IT Omron 
Healthcare, UK).  Additionally, pulse wave velocity and pulse wave analysis were 
determined by using Arterial Tonometry (SphygmoCor CPV system, ScanMed 
Medical, UK).  Three measurements were taken, and the mean of the 
measurements was calculated.  A venous blood sample was then collected into a 
lithium-heparin tube and centrifuged at 4,000 rpm at 4°C for 10 min, within 2 min of 
collection.  Lithium-heparin plasma was subsequently extracted and immediately 
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frozen at -80°C for later analysis of [NO2-] in duplicate via chemiluminescence 
(Wylie et al., 2013). 
 
Participants were then provided with breakfast.  Descriptive measures and a 
Physical Activity Level of 1.7 was used to calculate the participant’s individual 
resting energy expenditure (Schofield Equation, 1985).  This subsequently 
identified the amount of cereal (Rice Snaps, Tesco, Manchester, UK) and semi-
skimmed milk (1g/kg/bm) each individual needed to consume to meet 10% of their 
daily energy requirements.  This standardised fixed-energy breakfast meal 
consisted of a cereal: milk ratio of 30 g: 120 mL and delivered fat, protein and 
carbohydrate with a macronutrient composition of 14, 14 and 72%, respectively 
(Astbury et al., 2010).  One-hour post breakfast consumption, participants received 
the intervention drink.  Ninety minutes after ingestion of the supplement, vascular 
measures were reassessed and participants completed one of the two cycle tests 
described below, as published pharmacokinetic data have shown that this time 
frame should coincide with peak plasma concentrations of phenolic acids following 
MC supplementation according to both Chapters 3 and 4 of this thesis.  
 
The exercise protocol consisted of three “step” exercise tests including two 
moderate – intensity step tests followed by one severe-intensity exercise bout.  All 
participants performed a total of four bouts of moderate intensity exercise and two 
bouts of severe-intensity exercise for each experimental condition. This protocol 
replicated one used in a previously study by Bailey et al, (2015) when investigating 
the effect of L-Citrulline supplementation on V̇O2 kinetics and performance.  Each 
transition began with 3 min of baseline cycling at 20W before an abrupt transition 
to the target work rate.  Each moderate intensity bout lasted 6 min in duration.  A 
passive recovery of 5 min separated the transitions.  On two of the study visits 
(one occasion for each supplement), participants cycled for 6 minutes at a severe-
intensity constant work rate (70% Δ), this was then followed immediately by a 60-s 
all-out sprint at maximum effort.  The resistance on the pedals during this sprint 
was set using the linear mode of the Lode ergometer, so that each participant 
would attain the power output calculated to be 50% Δ when considering the 
participants preferred (linear factor = power/preferred cadence2).  Participants 
were provided with a 5-s countdown prior to the sprint.  On the other two study 
visits (one occasion for each supplement), the severe-intensity constant-work-rate 
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bout was continued to the limit of tolerance, this limit was recorded as a fall in 
pedal rate >10rpm below the required pedal rate. 
6.2.3 Treatments and dietary control 
Participants consumed either 60 mL of MC concentrate or fruit-flavoured cordial in 
a double blind cross-over manner.  This choice to use 60 mL was based on 
previous Chapters (Chapters 3 and 4) and work that showed a greater uptake of 
anthocyanin and phenolic acids in vivo post-consumption (Bell et al., 2014).  The 
concentrate was diluted with 100 mL of water prior to consumption.  The PLA 
supplement consisted of a commercially available, low fruit (<1%) squash (Kia Ora, 
Coca Cola Enterprises, Uxbridge, UK) cordial mixed with water, whey protein 
isolate (Arla Foods Ltd., Leeds, UK) and maltodextrin (MyProtein Ltd., Northwich, 
UK), to match the MC concentrate for volume and macronutrient content (Energy = 
204 kcal, volume = 60 mL, carbohydrates = 49 g, protein = 2.2 g and fat = 0 g). 
 
Prior to study commencement, it was explained to participants that the aim of the 
study was to investigate the effect of a fruit juice on vascular function.  As a result, 
they were unaware which beverage was the experimental drink. Participants were 
instructed to follow a low phenolic diet for 24 h prior to each arm of the trial by 
avoiding fruits, vegetables, tea, coffee, alcohol, chocolate, cereals, wholemeal 
bread, grains and spices and were asked to refrain from strenuous exercise.  
Compliance with the dietary restrictions was assessed with a standardised, self-
reported 1-day dietary record.   
6.2.4 Measurements  
During all tests, pulmonary gas exchange and ventilation were measured breath-
by-breath.  In order to do this, participants were required to wear a nose clip and 
breathe through a low-dead-space, low-resistance mouthpiece-and-impeller 
turbine assembly. The inspired and expired gas volume was continuously sampled 
at 100Hz; gas concentration signals were continuously sampled at 100 Hz using 
paramagnetic (O2) and infrared (CO2) analyzers (Oxycon, Care Fusion, Rolle, 
Switzerland). The gas analyzers were calibrated before each test using a 
calibrated 3-L syringe (Hans Rudolph Inc, Kansas City, Missouri, USA) and 
concentrations of known gases (16% O2 and 5% CO2). The breath-by-breath V̇O2 
data from each test was linearly interpolated to provide second-by-second values, 
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and, for each individual, identical repetitions were time-aligned to the start of 
exercise and ensemble-averaged.   
The oxygenation status of the vastus lateralis of the right leg was monitored using 
a commercially available using near-infrared spectroscopy (NIRS; INVOS 5100C, 
Somanetics, Troy, MI, USA).  The system emits NIR light through fiber optic 
cables at two different wavelengths (765 nm and 855 nm) to the tissue and the 
light reflected from the tissue is detected by a photomultiplier tube. For each 
wavelength, the oximeter probe contains four light emitting fibers which are 
located at 2.0, 2.5, 3.0 and 3.5 cm from the detector, allowing ∼1–2 cm 
measurement depth. The intensity of the transmitted light was continuously 
recorded at 1 Hz. Based on the absorption and scattering coefficients of light at 
each wavelength (Beer–Lambert Law), concentrations can be estimated for 
oxy(Hb + Mb), deoxy(Hb + Mb), and total(Hb + Mb).   The leg was initially cleaned 
around the belly of the muscle, and the optodes were placed 20cm above the 
fibular head.  The probes were secured to the skin surface and covered with an 
elasticized, tensor bandage to minimize the influence of extraneous light, and to 
avoid movement of the probe relative to the skin, while allowing unrestricted 
movement.  The NIRS data were acquired continuously throughout the exercise 
protocol and output every 5 s and recorded for later offline analysis.  The NIRS 
data output was time stamped at the start of each task segment to assure that 
data corresponded to the relevant period of task performance. Relative 
concentration changes in Oxy-Hb, Deoxy-Hb and Total-Hb were calculated.  
PWV and PWA were determined by using Arterial Tonometry (SphygmoCor CPV 
system, ScanMed Medical, UK).  The aortic pulse waveform and augmentation 
index were derived at the radial artery; PWV was determined between carotid and 
femoral sites.  A pencil-type probe was used for all measurements and was held at 
the base of the neck over the carotid artery and at the inguinal crease over the 
right femoral artery.  Recordings were taken when a reproducible signal was 
obtained with a high amplitude excursion.  The distance between carotid and 
femoral sites was measured and electrocardiogram gating permitted the time 
lapse between pulse waves at the carotid and femoral sites to be calculated. Inter- 
and intra-trial %CV for this method was 3.3 and 3.1% respectively. 
During the exercise trials, a blood sample was collected from a fingertip into a 
capillary tube at baseline, over the 20 s preceding the step transition in work rate, 
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the 20 s preceding the completion of 360 s of moderate- and severe – intensity 
cycling exercise, immediately following the all-out 60-s sprint and immediately after 
exhaustion during the severe-intensity constant-work-rate trial.  These whole blood 
samples were analysed to determine blood lactate (Biosen C_Line, EKF 
Diagnostic, Barleben, Germany); intra-sample coefficient of variation for this 
instrument was< 1.8%. 
6.2.5 Plasma [nitrate] and [nitrite] determination 
All glassware, utensils, and surfaces were rinsed with deionized water to remove 
residual NO intermediates prior to [NO2-] and [NO3-] analysis.  Plasma samples 
were deproteinized using zinc sulfate/sodium hydroxide precipitation prior to 
determination of [NO3-]. Firstly, 500 μL of 0.18 N NaOH was added to 100 µL of 
sample followed by 5 min incubation at room temperature.  Subsequently, samples 
were treated with 300 μL aqueous ZnSO4 (5% w/v) and vortexed for 30 seconds 
before undergoing an additional 10 min incubation period at room temperature. 
Samples were then centrifuged at 4,000 rpm for 5 min, and the supernatant was 
removed for subsequent analysis.  The [NO3-] of the deproteinized plasma sample 
was determined by its reduction to NO in the presence of 0.8 % (w/v) VCl3 in 1M 
HCl within an air-tight purging vessel.  Plasma samples were introduced to the 
vessel via 50 µL injections into the septum at the top of the vessel.  The spectral 
emission of electronically excited nitrogen dioxide, derived from the reaction of NO 
with ozone, was detected by a thermoelectrically cooled, red-sensitive 
photomultiplier tube housed in a Sievers gas-phase chemiluminescence nitric 
oxide analyzer (Sievers NOA 280i. Analytix Ltd, Durham, UK). The [NO3-] was 
determined by plotting signal (mV) area against a calibration plot of sodium nitrate 
standards.  The [NO2-] of the undiluted (non-deproteinized) plasma was 
determined by its reduction to NO in the presence of glacial acetic acid and 
aqueous NaI (4% w/v) from sodium nitrite standards.  100 µL injections were used 
for plasma [NO2-] determination.   
6.2.6 Statistical Analysis 
Statistical analysis was performed using PASW Statistics 21.0 for Windows (SPSS, 
Inc., Chicago, IL.).  All group characteristics were reported as means ± standard 
errors, unless otherwise stated.  A two–way repeated measures ANOVA was 
employed to assess between – intervention differences in V̇O2, NIRS – derived 
[oxy-Hb], [deoxy-Hb], TOI, lactate and glucose.  Mauchly’s Test of Sphericity was 
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used to check homogeneity of variance for all ANOVA analyses; where necessary, 
violations of the assumption were corrected using the Greenhouse–Geisser 
adjustment. Significant main effects were followed up using LSD post hoc analysis.  
Blood pressure, arterial stiffness, NO2− and NO3- and exercise performance were 
analysed using a paired samples t-test. Statistical significance was accepted when 
P < 0.05. 
6.3 Results  
Eleven physically active males volunteered to take part in the study, but one 
participant voluntarily withdrew after the second study day (n=10).  There were no 
adverse events reported in response to the intervention products. Subjects 
consumed all doses of the supplement for each experimental condition, and all 
participants complied with the low-polyphenolic experimental diet according to the 
food diaries. The V̇O2 peak attained in the ramp incremental test was 4.56 ± 0.3 
l/min, which equated to a relative V̇O2 peak of 59 ± 7 ml·kg−1·min−1. The work 
rates that corresponded to 90% GET and 70%Δ were 121 ± 19 and 303 ± 28 W, 
respectively. 
6.3.1 Pulmonary V̇O2 kinetics 
The pulmonary gas exchange data for the moderate- and severe intensity cycle 
tests are reported in Table 15.  There were no significant between-supplement 
differences for the baseline and end-exercise V̇O2 during the moderate-intensity 
step exercise tests (P > 0.05).  Accordingly, the fundamental V̇O2 amplitude was 
not significantly different between the conditions (0.55 ± 0.09 and 0.60 ± 0.07 l/min 
with MC concentrate and Pla respectively, P > 0.05). 
 
The baseline and end-exercise V̇O2 during severe-intensity exercise were not 
significantly impacted by the dietary interventions employed in this investigation 
(P > 0.05 for all comparisons).  The V̇O2 at exhaustion was not significantly 
different between experimental conditions and was also not significantly different 
from the V̇O2peak attained in the ramp incremental test (P > 0.05).  No significant 
change from baseline to 120 s was observed (2.43 ± 0.10 and 2.37 ± 0.09 l/min 
with MC concentrate and Pla, respectively) or V̇O2 slow component (0.27 ± 0.02 
and 0.35 ± 0.03 l/min with MC concentrate and Pla, respectively) were observed 
across the experimental conditions. There were no significant differences in V̇CO2 
between the conditions during moderate- or severe-intensity cycle exercise (P > 
0.05 for all comparisons). 
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Table 15 - Pulmonary gas exchange measures during moderate- and severe-
intensity cycle exercise after MC and Pla supplementation. 
 MC Concentrate Placebo 
 Moderate-intensity exercise 
V̇O2, l/min   
  Baseline 1.67 ± 0.09 1.68 ± 0.11 
  End-exercise 2.22 ± 0.09 2.28 ± 0.10 
Fundamental amplitude, 
l/min 
0.55 ± 0.09 0.60 ± 0.07 
 Severe – intensity exercise 
V̇O2, l/min   
  Baseline 1.72 ± 0.04 1.74 ± 0.04 
  360 s 4.42 ± 0.12 4.36 ± 0.10 
  Exhaustion 4.50 ± 0.11 4.44 ± 0.09 
Fundamental amplitude, 
l/min 
2.43 ± 0.10 2.37 ± 0.09 
Slow component amplitude 
l/min 
0.27 ± 0.02 0.35 ± 0.03 
All values are means ± SEM. 
 
6.3.2 Exercise performance  
The time to exhaustion during the severe-intensity constant-work-rate cycle trials 
(the exercise tolerance test) are shown in Figure 21, while the power profiles for 
the two experimental conditions during the 60-s all-out sprint that followed the 6-
min bout of severe intensity exercise (the exercise performance test) are shown in 
Figure 22. 
There were no significant differences in time to exhaustion during the exercise 
tolerance test between the experimental conditions (Figure 21).  There were no 
significant differences in time to exhaustion during the exercise tolerance test 
between the experimental conditions (772 ± 34 vs 733.2 ± 34 s, P > 0.05).   
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A significant main effect for supplement was observed for the peak power attained 
and total work completed during the 60-s all-out sprint that concluded the exercise 
performance test (P < 0.05) in favour of the MC concentrate.  Follow-up analyses 
demonstrated that, compared with Pla, MC concentrate supplementation 
increased the test peak power by 9.5% (363 ± 42 vs. 330 ± 26 W, P = 0.033; 
Figure 22) and the total work completed during the 60 s sprint by 10% between 
conditions (21 ± 3 vs. 19 ± 3 kJ, P = 0.021).   
Figure 21 - Time to exhaustion during severe-intensity constant –work-rate cycle 
exercise after MC concentrate and placebo with individual responses to 
supplementation included.  
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Figure 22 - Group mean power profiles during a 60-s all-out cycle sprint completed 
immediately after 6-min of severe-intensity cycle exercise following MC 
concentrate and Pla supplementation.  Note significant increase in peak and mean 
power output during the 60s- all-out sprint after MC concentrate compared to Pla. 
 
6.3.3 NIRS variables 
The NIRS- derived muscle (deoxy-Hb, oxy-Hb and TOI) data during moderate- 
and severe-intensity cycle exercise with Pla and MC supplementation are reported 
in Table 16.  There were no significant differences between the experimental 
conditions for any of the NIRS variables during the moderate or severe-intensity 
exercise (P > 0.05 for all comparisons).   
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Table 16 - Near – infrared spectroscopy measures during moderate- and severe 
intensity cycle exercise after MC and Pla supplementation. 
 MC Concentrate Placebo 
 Moderate- intensity exercise 
Muscle [deoxy-Hb], AU 
  Baseline -1 ± 1 -2 ± 1 
  120 s 4 ± 1 5 ± 2 
  End-exercise 5 ± 1 5 ± 2 
Muscle [oxy-Hb], AU 
  Baseline 4 ± 1 4 ± 1 
  120 s 4 ± 1 4 ± 1 
  End-exercise 6 ± 1 5 ± 1 
Tissue oxygenation index, % 
  Baseline 67 ± 2 67 ± 2 
  120 s 67 ± 2 66 ± 2 
  End-exercise  66 ± 3 65 ± 1 
   Severe-intensity exercise 
Muscle [deoxy-Hb], AU   
  Baseline -8 ± 1 -9 ± 1 
  120 s 15 ± 1 15 ± 1 
  End- exercise  15 ± 1 16 ± 1 
Muscle [oxy-Hb], AU   
  Baseline 10 ± 1 9 ± 1  
  120 s -7 ± 1 -7 ± 1 
  End-exercise -14 ± 2 -15 ± 1 
Tissue oxygenation 
index, % 
  
  Baseline 66 ± 3 68 ± 3 
  120 s 52 ± 4 54 ± 4 
  End- exercise 49 ± 3 48 ± 5 
All values are means ± SEM.  AU, arbitrary units.  
 
6.3.4 Vascular measures 
There was a significant main effect for supplement on SBP (P = 0.003), with 
follow-up analyses showing that SBP was lower 1.5 h post MC supplementation, 
with reductions of 5 ± 2 mmHg compared to the placebo trial.  No other vascular 
variables (DBP, mean arterial pressure, PWV, AIx and AIx corrected for HR at 75 
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bpm) were altered after consumption of the MC concentrate compared to the 
placebo treatment.  The absolute values for all variables are presented in Table 17. 
 
Table 17 - Acute effects of tart Montmorency cherry juice and Pla on vascular 
function. 
Variable Baseline 1.5 h Post 
SBP (mmHg) 
60 ml MC 
Pla 
 
118 ± 3 
119 ± 3 
 
115 ± 2* 
120 ± 3 
DBP (mmHg) 
60 ml MC 
Pla 
 
69 ± 2 
67 ± 3 
 
68 ± 3 
68 ± 2 
PWV (m/s) 
60 ml MC  
Pla 
 
6.0 ± 0.3 
6.0 ± 0.3 
 
5.9 ± 0.4 
6.0 ± 0.3 
MAP (mmHg)   
60 ml MC 85 ± 2 84 ±2 
Pla 83 ±2 85 ± 3 
AIx (%) 
60 ml MC 
Pla 
 
9.4 ± 2.0 
8.3 ± 2.0 
 
9.1 ± 1.7 
7.5 ± 1.6 
AIx @ 75bpm (%) 
60 ml MC 
Pla 
 
9.2 ± 2.3 
9.8 ± 1.8 
 
9.9 ± 2.2 
10.3 ± 2.3 
All values are means ± SEM (n=10). * Significant difference between Placebo and 
cherry concentrate treatment (2-factor repeated measures ANOVA) P < 0.05: SBP, 
systolic blood pressure; DBP, diastolic blood pressure; MAP, mean arterial 
pressure; PWV, pulse wave velocity; AIx, augmentation index; MC, Montmorency 
cherry concentrate; Pla, Placebo. 
 
6.3.5 Plasma [NO2−] [NO3−] 
The plasma concentrations [NO2−] [NO3−] for the MC and Pla conditions are 
reported in Table 18.  There were no significant changes reported for NO2− or 
NO3− in the MC supplemented trial when compared to the Placebo (P > 0.05). 
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Table 18 - Plasma [NO2−] and [NO3−] at baseline and 1.5 h following MC 
concentrate/Pla supplementation. 
 MC Concentrate Pla 
 Pre Post Pre Post 
Plasma [NO2−] nM 65 ± 9 68 ± 8 63 ± 7 63 ± 9 
Plasma [NO3−] nM 19 ± 2 18 ± 2 20 ± 2 18 ± 2 
All values are means ± SEM (n=8). MC, Montmorency Cherry; Pla, Placebo. 
6.3.6 Lactate and glucose 
There was no treatment or treatment × time interaction effect observed in blood 
[lactate], however there was a significant time effect identified during both the 
exercise performance and tolerance test (F = 168.179, P < 0.001).   Glucose 
demonstrated a significant treatment × time interaction effect in the exercise 
performance and tolerance test (F = 3.050, P = 0.029).  Glucose levels were 
significantly different between MC and placebo at time points 2 and 3 (20 s 
preceding the step transition in work rate, the 20 s preceding the completion of 
360 s of moderate intensity exercise) during the exercise performance test and at 
time point 2 (20 s preceding the step transition in work rate) during the tolerance 
test. No other differences were reported.  Absolute values are presented in Table 
19.   
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Table 19 - Acute effects of tart Montmorency cherry juice and Pla on lactate and 
glucose following exercise performance and tolerance test. 
 Time points 
 1 2 3 4 5 
Lactate 
(mmol/L) 
Exercise performance test 
 
60 ml MC 
Pla 
 
1.7 ± 0.2† 
1.7 ± 0.2† 
 
2.3 ± 0.2† 
2.2 ± 0.2† 
 
2.6 ± 0.2† 
2.9 ± 0.4† 
 
9.5 ± 0.8† 
10.0 ± 0.8† 
 
10.6 ± 0.6† 
11.6 ± 0.8† 
 Exercise tolerance test 
 
60 ml MC 
Pla 
 
2.0 ± 0.1† 
2.1 ± 0.2† 
 
2.2 ± 0.2† 
2.4 ± 0.2† 
 
2.6 ± 0.2† 
2.7 ± 0.2† 
 
9.8 ± 0.7† 
9.9 ± 0.5† 
 
12.5 ± 0.8† 
11.2 ± 0.7† 
Glucose 
(mmol/L) 
Exercise performance test 
60 ml MC 
PLA 
3.3 ± 0.3 
3.2 ± 0.3 
3.8 ± 0.3* 
3.2 ± 0.2 
4.0 ± 0.3* 
3.4 ± 0.3 
3.5 ± 0.3 
3.8 ± 0.2 
3.6 ± 0.2 
3.8 ± 0.2 
 Exercise tolerance test 
60 ml MC 
PLA 
3.6 ± 0.2 
3.4 ± 0.3 
3.9 ± 0.2* 
3.2 ± 0.2 
3.7 ± 0.2 
3.6 ± 0.2 
4.0 ± 0.2 
3.7 ± 0.2 
4.3 ± 0.2 
3.8 ± 0.3 
 
All values are means ± SEM (n=10).  † Significant difference between time points 
from baseline, * Significant difference between placebo and cherry concentrate 
treatment, P < 0.05.  
 
6.4 Discussion 
To the best of knowledge, this study was the first to investigate the effects of acute 
tart cherry supplementation on plasma NO2- concentrations, blood pressure, V̇O2 
kinetics, and exercise performance, compared with an energy-matched placebo.  
The principal novel findings from this study are that acute MC supplementation 
enhanced exercise performance in the absence of changes in V̇O2 amplitudes, 
NO2- concentrations or muscle oxygenation.  Additionally, SBP was significantly 
decreased 1.5 h post consumption in the MC trial, relative to the Pla.    
Peak power output and total work completed over a 60-s sprint was increased by 6 
and 10% respectively, during an exercise performance test following MC 
supplementation relative to the Pla.  While tart cherry supplementation has been 
shown to improve exercise recovery (Howatson et al., 2010; Bowtell et al., 2011; 
Bell et al., 2014), decrease markers of inflammation and oxidative stress (Wang et 
al., 1999; Bell et al., 2014; Howatson et al., 2010), studies investigating the effects 
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of tart cherries on exercise performance are limited and equivocal.  One recent 
addition to the literature investigated the effects of powdered Montmorency tart 
cherry supplementation on acute endurance exercise performance in aerobically 
trained individuals (Levers et al., 2016).  Results of this study revealed that short-
term supplementation of Montmorency powdered tart cherries not only attenuated 
markers of muscle damage, but also increased performance in aerobically trained 
individuals evidenced by a quicker overall race pace compared to the Pla group.   
Similar findings have been reported in other studies with whole polyphenol 
compounds (Nieman et al., 2010) and in studies where polyphenolic content of a 
fruit – derived supplement is similar to tart cherries (Kang et al., 2012). The current 
study cannot determine any physiological mechanisms behind the improved 
performance, but the significant improvement in sprint performance accompanied 
by an insignificant small trend toward lower blood lactate levels following MC 
ingestion might suggest that MC supplementation may have contributed to less 
production of or enhanced removal of lactate during intense exercise, although this 
is speculative. Although, in vitro and in vivo animal studies suggest that 
polyphenols could really play a role in improving exercise performance (Davies et 
al., 2010); on the other hand, data in favour of polyphenol supplementation in 
humans are sparse and future research is warranted to fully understand if 
polyphenol intake enhances exercise performance.  It is work commenting that MC 
supplementation could have prolonged the duration for which the participants were 
in the optimal cellular redox state for force production such that when they were 
require to produce an all-out sprint, they produced a higher peak power and 
completed more work.  Studies on intact muscle have shown that the cellular 
redox balance may have an important influence on contractile function. That is, 
optimal contractile function may depend on the redox state of some, or all the 
participating cellular elements. In accordance with this, a study by Reid et al. 
(1993) demonstrated in rat diaphragm bundles that brief exposures to H2O2 
increased twitch forces and prolonged the time to peak tension and the half-
relaxation time. However, the current study did not measure any redox markers 
and this should be explored in future work.  
Nitric oxide is a key regulator of vascular integrity.  This multifaceted physiological 
signalling molecule can be synthesized endogenously through the nitrate-nitrite 
(NO2-) – NO pathway (Lundberg & Weitzberg, 2009). Furthermore, it can be 
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generated through NOS and plasma [NO2-] has been reported to reflect NOS 
activity as well as the capacity for O2-independent NO generation (Jones et al., 
2014).  Dietary nitrate supplementation has previously been shown to increase NO 
biomarkers, prevent platelet aggregation (Webb et al, 2008), modulate cellular 
respiration (Cooper & Giulivi, 2007), reduce blood pressure (Hobbs et al., 2013) 
and improve exercise efficiency in healthy adults (Bailey et al., 2009; 2010).  No 
significant difference in NO2- concentration was reported between the MC and Pla 
trial in the current study.  This is somewhat in agreement with the findings from 
Chapter 3, where no time, treatment, or time × treatment interaction effect for 
plasma nitrate or nitrite was observed following 60mL MC supplementation using 
an ELISA kit.  The lack of a change in plasma NO2- concentrations in this study 
extends previous findings by using a sensitive method to detect plasma [NO2-] in 
the nM range and this better reflects NOS activity than plasma [NO3-].  Well 
trained cyclists were recruited in the current study as research has demonstrated a 
clear moderate improvement of performance following polyphenol 
supplementation (Somerville et al., 2017); an improvement that would prove 
advantageous in sporting situations where very little separates opponents.  
However, it is likely that eNOS is optimally functioning in this cohort and therefore 
no changes were observed. 
 Furthermore, a study (Nabrzyski & Gajewska, 1994) that investigated the content 
of nitrates and nitrites in fruits, vegetables and other foodstuffs reported relatively 
small concentrations in cherries (from 0.0 to 36.0 mg NO3/kg product).  Previous 
studies have examined the impact of processing on cherry anthocyanins and 
polyphenolics (Ferretti et al., 2010; Chaovanalikit & Wrolstad, 2004) and have 
reported that pre-harvest factors and temperature, light intensity, fruit crops 
maturity may affect the content and stability of polyphenols and the nutritional 
value in cherries.   In addition, post-harvest factors such as transport and storage 
can also influence polyphenol composition of food crops.  As a result, it makes the 
argument tenable that the little amount contained in the whole cherry as previously 
alluded to, could be further diminished or removed during processing. Therefore, it 
would appear that the health benefits associated with tart cherry consumption as 
discussed previously are not likely to be attributed to NO, at least systemically. A 
second, and perhaps more likely method by which MC supplementation improves 
exercise performance, as outlined in Chapter 2, is based on the high polyphenol 
content of cherries and the subsequent uptake of downstream metabolites.  This 
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mechanism as previously described to in Chapter 2 and 3 has been suggested to 
be at least partly responsible for acute improvements in indexes of cardiovascular 
function. 
It was hypothesized that because of the AOX properties and pro-circulatory effects 
of the polyphenols contained in tart cherries; this would lead to an overall 
improvement in aerobic metabolism during highly intense exercise.  However, in 
contrast with a recent addition to the literature concerning dietary polyphenol 
supplementation and metabolic rate (Jo et al., 2016), and our experimental 
hypothesis, acute MC supplementation did not significantly alter V̇O2 during 
moderate- or severe intensity cycle ergometry exercise. Unsurprisingly, as 
capacity of aerobic metabolism during highly intense exercise depends on efficient 
blood supply to the contracting muscle (Mortensen et al., 2008), there were no 
significant differences in any of the NIRS variables between conditions.  
Conversely, it has previously been shown that blackcurrant intake inhibited the 
decrease in total-Hb and oxy-Hb that occurred in a model of experimentally 
induced disturbances to the local circulation (i.e.. typing activity) (Matsumoto et al., 
2004). The authors speculated that this effect was largely caused by the high 
anthocyanin content of blackcurrants.  Although tart cherries have also previously 
been shown to have a high anthocyanin content [specifically cyanidin and peonidin 
(Ou et al., 2012)], these findings were not replicated in the current study.  Overall, 
there is insufficient and inconsistent evidence to conclude whether or not 
polyphenol supplementation can alter muscle oxygenation and improve oxidative 
metabolism, as a consequence of differences in experimental design including the 
type of supplementation, subjects and protocol (Malaguti, 2013). 
A primary outcome of enhanced NO synthesis is a reduction in blood pressure 
owing to NO-induced smooth muscle relaxation (Gruetter et al., 1979).  The 
current study reported a significant reduction in SBP 1.5 h post MC ingestion 
relative to placebo, however this augmented modulation occurred in the absence 
of changes in NO biomarkers.  These results do not stand alone; a recent study 
demonstrated that when participants were supplemented with L-Citrulline or L-
arginine, plasma NO2- was not increased, however significantly reduced blood 
pressure was observed (Bailey et al., 2015; Vanhatalo et al., 2013).  Previous 
Chapters have reported significant improvements in SBP following MC 
consumption in males with early hypertension [Chapter 4] and middle aged adults 
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[Chapter 5].  Chapter 4 also highlighted than an increase in downstream phenolic 
acids, protcatechuic and vanillic acid, have been reported after acute MC 
consumption, which suggests that circulating phenolic metabolites derived from 
Montmorency tart juice are, at least in part, responsible for acute improvements in 
SBP. As mentioned earlier, further work is required to elucidate if a similar 
mechanism is responsible for the improvement in exercise performance in the 
current study. 
In conclusion, the findings of the current study demonstrate that acute 
supplementation with tart cherry juice has the ability to lower SBP and improve 
exercise performance with no changes in oxidative metabolism or muscle 
oxygenation.  Further research is required to determine whether the effects 
reported would be amplified using a chronic supplementation strategy and to 
further confirm the link between cellular protective action, and performance 
enhancement effects caused by the consumption of tart cherries in elite and 
occasional athletes. 
6.5 Perspectives 
This Chapter aimed to investigate the effect Montmorency tart cherry juice 
supplementation would have on exercise performance in well-trained individuals.  
Results demonstrated that participants supplemented with Montmorency tart 
cherry juice performed better in a 60 s all-out sprint following moderate- and 
severe intensity exercise.  This was characterized by higher peak power output 
attained and total work competed over the course of the 60 s.  Additionally, SBP 
was reduced 1.5 h post MC supplementation.  Despite these changes, there were 
no differences in V̇O2 kinetics, NO2- plasma concentrations or muscle oxygenation 
between the two conditions. 
The findings from this Chapter extend the application of MC supplementation to 
wider group of individuals, specifically to athletic populations in a bid to improve 
exercise performance.   The concept of marginal gains has revolutionised many 
sports particularly if a sprint finish could potentially be the difference between 
winning and losing.  After completing exercise that was deemed both mechanically 
and metabolically stressful, when participants were supplemented with MC, they 
performed better over a 60-s sprint.   Importantly, regardless of the mechanism, 
these improvements in performance are of most interest to the athlete, applied 
coach or sports scientist. The moderate- and severe intensity exercise task used in 
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this Chapter presented as a good model to assess V̇O2 kinetics and cycling 
economy with both the presence and the absence of a V̇O2 slow component.   
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7 General Discussion 
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7.1 Experimental Chapter Synopsis  
 
The first experimental Chapter in this thesis (Chapter 3) was designed to (1) 
examine the time course of selected phenolic compounds following ingestion of a 
Montmorency cherry (MC) concentrate, and (2) identify the effects of the selected 
phenolic compounds on vascular smooth muscle cell (VSMC) behaviour in vitro.   
Previous work has suggested that the health-related benefits of tart cherries arise 
from their high anthocyanin content (Bell et al., 2015); however, given the poor 
bioavailability of whole anthocyanins it would appear that the biological 
effectiveness of Montmorency cherries might be due to the downstream 
metabolites of anthocyanins and the polyphenol interactions, which accomplish 
complementary effects. Such synergies occur when combinations of bioactive 
substances exert effects at target sites that are greater than the sum of individual 
components (Lila & Raskin, 2004).  Ou and colleagues (2012) previously 
established that the anthocyanins (in order of decreasing prevalence) in processed 
tart cherry products were cyanidin-3-glucosylrutinoside, cyanidin-3-rutinoside and 
peonidin-3-rutinoside. As a result, Chapter 3 aimed to identify the primary 
downstream metabolites of the anthocyanins, cyanidin and peonidin, in the plasma 
post ingestion.  HPLC/LCMS identified two dihydroxybenzoic acids, protocatechuic 
and vanillic acid (PCA and VA) in plasma following MC concentrate consumption. 
Both compounds were most abundant 1-2 h post-initial ingestion with traces 
detectable at 8 h post-ingestion.  In addition, VSMC migration increased when the 
cells were treated in concert with both metabolites, demonstrating that these 
metabolites, at a similar level to that seen in plasma, can alter VSMC function.  
There was no effect on cell proliferation observed.   
The second investigation (Chapter 4) aimed to identify the effects of Montmorency 
tart cherry consumption on vascular function in males with early hypertension.  
Cherry extracts have been shown, in cell and animal models, to exert a range of 
cardio-protective effects that include increasing nitric oxide production and AOX 
status, reducing lipid oxidation and inhibiting inflammatory pathways (Wang et al., 
1999; Seeram et al., 2001).  However, the potential cardio-protective effects of 
cherries have not been investigated in humans to the same degree.  Montmorency 
tart cherries are high in numerous polyphenols, such as anthocyanins, and as 
previously discussed these compounds have poor bioavailability. However as 
demonstrated in Chapter 3, it is likely that they contribute to the overall 
appearance of downstream metabolites in the plasma following MC ingestion and 
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that the resulting metabolites can alter vascular function in vitro.  As such, it makes 
the expectation tenable they would positively modulate vascular function in vivo.  
Results of Chapter 4 demonstrated that MC supplementation significantly reduced 
SBP for up to 3 hours post-prandial, with peak reductions of 7 ± 3 mm Hg at 2 h 
after MC consumption relative to the placebo.  Furthermore, findings suggested 
that circulating phenolic metabolites (PCA and VA) derived from MC juice are at 
least partly responsible for acute improvements in SBP in men with early 
hypertension.  This was the first study to demonstrate the efficacy for MC 
supplementation as an adjuvant in the management of hypertension. 
The third experimental study (Chapter 5) of this thesis was designed to build on 
the findings from Chapter 4 and further explore the health applications of tart 
cherries.  Conceptually, in light of the vaso-modualtory effects of polyphenol-rich 
foods, and the findings of Chapter 3 and 4, it was not unrealistic to speculate that 
Montmorency cherries might also be capable of conferring a positive cognitive 
effect by improving cerebral blood flow. The aim of this study was to examine the 
effects of Montmorency tart cherry consumption on cerebral blood flow and 
cognition in middle aged adults.  The results of this study demonstrated that in 
comparison to a placebo, the consumption of a MC concentrate resulted in acute 
modulation of CBF parameters in the frontal cortex during cognitive task 
performance as indicated by the elevated concentrations of total-Hb, with an 
identical pattern observed with oxy-Hb.  This effect was evident during the last 3 
10-min epochs of the 60-min resting/absorption period and for the cognitive 
assessment 1 h post MC consumption.  However, these CBF observations were 
not associated with any significant modulation of cognitive performance or mood.   
Similar to the results observed in Chapter 4, there was a significant reduction in 
SBP for up to three hours post MC consumption relative to the placebo trial.  The 
results from this Chapter add weight to the findings from Chapter 4, suggesting 
that MC supplementation may be an efficacious strategy in modulating other 
aspects of (cerebro-) vascular function. 
Given the abundance of previous literature supporting the use of MC 
supplementation as a recovery aid (Howatson et al., 2010; Bowtell et al., 2011; 
Bell et al., 2014) and previous studies that have reported improved exercise 
capacity and efficacy in association with improved vascular function (Oh et al., 
2010), the final experimental Chapter of this thesis (Chapter 6) directly assessed 
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the effects of acute Montmorency tart cherry supplementation on plasma NO2- 
concentrations, blood pressure, V̇O2 kinetics, and exercise performance, 
compared with an energy-matched placebo.  Results demonstrated that acute MC 
supplementation increased peak power by 6% (363 ± 42 vs. 341 ± 16 W) and the 
total work completed during the 60 s sprint by 10% between conditions (21 ± 3 vs. 
19 ± 3 kJ).  This improvement in performance occurred in the absence of changes 
in V̇O2 kinetics, NO2- concentrations or muscle oxygenation.  Similar to the 
previous experimental chapters, SBP was significantly decreased 1.5 h post 
consumption in the MC trial, relative to the placebo.   The findings from this 
chapter extend the application of MC supplementation to wider group of individuals, 
specifically those individuals with impaired physical mobility due to cardiovascular 
and cardiorespiratory impairment and also to athletic populations in an attempt to 
improve exercise performance 
7.2 Main findings 
 
The overall aim of this thesis was to investigate the bioavailability of compounds in 
Montmorency tart cherry juice and their potential application to modulate aspects 
of health relating to vascular function.  A number of relevant issues have been 
previously discussed throughout each of the experimental chapters, however the 
following sections discusses the main findings of this thesis in the context of 
existing literature, the limitations of the work and potential future areas of 
investigation. 
 
7.2.1 Bioavailability  
 
The initial aim of the thesis was to assess the polyphenol uptake following human 
consumption of Montmorency tart cherries.  Data from the investigational chapters 
of this thesis have identified the presence of both PCA (2.75 and 2.76 µg) and VA 
(0.29 and 0.30 µg) in the plasma post MC supplementation.  To date, the majority 
of work involving MC supplementation focuses on the absorption of primary 
anthocyanins.  Given that the bioavailability of these compounds is poor (Patras et 
al., 2010), exploring the presence and absorption time of their primary downstream 
metabolites may be more appropriate when trying to determine the compounds 
eliciting positive health benefits.  These two dihydroxybenzoic acids are the main 
degradation metabolites of cyanidin and peonidin, the most abundant 
anthocyanins present in MC concentrate (Wang et al., 1997; Kirakosyan et al., 
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2000).  Chapter 3 demonstrated that physiological concentrations of these 
phenolic acids are most bioavailable 1-2 h post MC consumption; this finding was 
further supported in Chapter 4 of this thesis. Both of these phenolic acids have 
been found to possess several health-promoting properties including chemo-
preventative, antibacterial, AOX, antidiabetic, anticancer, antiulcer, antiaging, anti-
inflammatory and anti-atherosclerotic effects (Kamat et al., 2000; Kakker & Bais, 
2014).  Chapter 3 used a 30 and 60 mL dose of MC as previous studies 
investigating the pharmacokinetics and biological effects of MC used an identical 
dosing strategy (Bell et al., 2014) or 45 and 90 whole cherries (Seymour et al., 
2014).  Doses higher than this may infer some gastrointestinal discomfort (Bell et 
al., 2014) 
 
7.2.2 Vascular function in vitro 
 
Within Chapter 3, this thesis also examined the effect of PCA and VA on VSMC 
behaviour.  VSMC are responsible for the provision of vascular tone in normal, 
healthy blood vessels, and their behaviour is critical in the development of 
atherosclerotic plaques (Ross, 1993).  Chapter 3 demonstrated that cell migration 
increased when the VSMC were exposed to both VA and PCA, demonstrating that 
these metabolites, at a similar level to that identified in the plasma following MC 
supplementation, can alter cell function.  Importantly, migration of de-differentiated 
VSMC is required for vessel remodelling which occurs from exercise and vascular 
injury. The VSMC migration in advanced atherosclerotic plaques is often 
considered to be protective as it increases stability, protecting against plaque 
rupture and ensuing vascular trauma such as myocardial infarction or stroke 
(Louis & Zahradka, 2010). By increasing VSMC migration, the metabolites may 
potentially be beneficial for blood vessel remodelling, although this would require 
further investigation. Cell proliferation was not altered over the course of this 
experiment. Noticeably, the time frames and period of investigation in this chapter 
were different for the in vivo and in vitro work i.e. 8 h vs 24 h.  This was the case 
as it takes much longer for cells to react to a particular stimulus, and thus the time 
frame was extended accordingly. 
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7.2.3 Vascular function in vivo 
 
The secondary aim of the thesis was to assess the impact of MC supplementation 
on vascular function in humans.  In the literature, there is very little evidence in 
humans to support the modulation of vascular function following cherry 
supplementation; in fact the most recent literature has reported no changes (Lynn 
et al., 2014). The current thesis advanced on the study by Lynn and colleagues by 
investigating a population with a higher CV risk and incorporating more robust 
methods for vascular assessment.  Throughout this thesis, there was an 
observable impact of MC supplementation on systolic blood pressure.  Data from 
the investigational Chapters of this thesis give some indication of an augmentation 
of vascular function in various populations following acute supplementation with 
Montmorency tart cherry concentrate.  It must be noted, that there appeared to be 
a clear pattern of modulation of blood pressure across all chapters.  In Chapter 4, 
systolic blood pressure was reduced by 7 ± 3 mm Hg in males with early 
hypertension following 60 mL MC supplementation.  Similarly, in Chapter 5, the 
MC supplement resulted in peak reductions in SBP of 6 ± 2 mmHg relative to the 
placebo in middle aged adults. Additionally in Chapter 6, SBP was significantly 
reduced 1.5 h post MC supplementation in male cyclists.  In both Chapter 4 and 5, 
SBP had returned to near baseline 5 h post supplementation, however this was 
not explored in Chapter 6.   The studies in this thesis are particularly noteworthy 
because data from prospective observational studies have shown a reduction in 
mean SBP of 5–6 mm Hg over a 5-y period was associated with 38% and 23% 
reduced risk of stroke and coronary artery disease, respectively (Collins et al., 
1990).   
An earlier study from Lynn and colleagues (2014) did not detect any changes in 
BP or any other vascular measures following tart cherry consumption, however, 
this was in normotensive subjects (~111/70 mm Hg).  Both Chapter 4 and 5 of this 
thesis found significant reductions in SBP following MC supplementation in 
individuals whose baseline BP was 137 / 82 mm Hg (Chapter 4) and 128 / 82 mm 
Hg (Chapter 5), therefore it makes the argument tenable that the magnitude of 
change in the BP response is directly related to baseline BP (Kapil et al., 2010).  In 
support of this finding, there is a plethora of data suggesting improvements in 
blood pressure following the consumption of other polyphenol-rich fruits such as 
cocoa, beetroot, and grape extract (Grassi et al., 2005; Hobbs et al., 2013; Draijer 
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et al., 2015). And although it has previously been reported and demonstrated in 
Chapter 4, that concurrent improvements in all measures of vascular function are 
not always observed (Hobbs et al., 2013), modulations of central haemodynamics 
were observed after supplementation of MC juice in Chapter 5.   
A continuous, oxygen-rich supply of blood is vital for general health. Poor 
circulation of blood and reduced oxygenation is associated with a number of 
disorders including cardiovascular disease (Zeiher et al., 2003).  Of importance 
here, blood flow and oxygenation are especially vital for neurocognitive 
performance; with research correlating reduced CBF and poorer cognitive function 
in humans (Celsis et al., 1997). Conversely, improvements to aspects of cognitive 
function can be seen with supplementary inspiration of pure oxygen in deprived 
participants (Weiskopf et al., 2002) and in young, healthy participants (Moss et al., 
1998). Changes in concentrations of either oxy-Hb and deoxy-Hb are related to 
changes in cerebral metabolic rates (Tamura et al., 1997), and the concentration 
of deoxy-Hb and to a lesser extent oxy-Hb, is strongly correlated with the fMRI 
blood-oxygenation-leveldependent (BOLD) signal (Huppert et al., 2006). 
fMRI is the most comparable neuroimaging tool to NIRS with both measuring the 
CBF response to preceding neural activation; the ‘neurovascular coupling’. Neural 
activation instigates an increase in CBF which is primarily seen as increased 
concentrations of total and oxy-Hb. This CBF response is greater than the 
metabolic rate of oxygen extraction/utilization (deoxy-Hb) and, as such, the 
concentration of deoxy-Hb can be observed to decrease during cognitive 
performance (Hasegawa et al., 2002). This relative fall in deoxy-Hb is the product 
ofthe local haemoglobin becoming more oxygenated and results in a slight 
increase in the magnetic signal; as haemoglobin is diamagnetic when oxygenated 
and paramagnetic when deoxygenated (Buxton et al., 2004). As stated above, this 
BOLD signal is strongly correlated to that measured by NIRS; indeed the two 
techniques have been converged successfully in the past, and a relative rise in 
total and oxy-Hb with a concomitant reduction in deoxy-Hb is the typical 
hemodynamic response to cognitive workload as assessed by NIRS (Tamura et al., 
1997). 
When compared to the placebo, MC consumption resulted in significant 
modulations in prefrontal cortex haemoglobin concentrations during the absorption 
period and cognitive task performance.  Increases in oxy-Hb of 0.76 µmol/L and 
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total Hb of 1.43 µmol/L were seen during the cognitive task period 1 h after 
consumption of MC juice relative to the placebo.  No effect of task type was 
evident.  These increases coincide with the appearance of phenolic acid 
concentrations highlighted in earlier chapters.  This is the first study to investigate 
the acute effects of Montmorency tart cherries on cerebral blood flow variables 
and cognitive function in a middle aged population.  The findings from this Chapter 
are in agreement with previous studies using polyphenol compounds and whole 
foods to demonstrate a positive effect on cerebral blood flow (Kennedy et al., 2010; 
Wightman et al., 2015).  Reductions in cerebral blood flow have been associated 
with natural aging (Leenders et al., 1990) and neurological diseases (Dede et al. 
2007).  Results from this thesis outline the ability of tart cherries to increase 
cerebral blood flow in a middle aged population. 
However, it must be noted that NIRS only provides data on the relative 
concentration changes in each of the separate chromophores (oxy-Hb, deoxy-Hb, 
total-Hb) in response to tasks in the region of interest (the prefrontal cortex in the 
present thesis), and does not provide any information regarding the effects of the 
treatment on general cerebral blood flow. In addition, a disadvantage of the NIRS 
imaging technique is that it has low spatial resolution in comparison to other 
methods; however it does have the benefit of providing high temporal resolution 
(Obrig & Villringer, 2003).  Therefore, although the results presented in Chapters 5 
are promising, the paradigm could be improved in future interventions.   
In Chapter 4 and 5 of this thesis, the greatest improvements in SBP occurred in 
association with peak plasma PCA and VA as highlighted in earlier Chapters, 
indicating that both of these metabolites could be partly responsible for the effects 
observed, particularly given that these hydroxybenzoic acids were shown in the 
Chapter 3 to modulate vascular smooth muscle cell behaviour in vitro. 
Furthermore, we speculate that these very early on effects on CBF in the current 
study might  be associated with the sensory properties of the MC concentrate as 
previous studies have showed demonstrated that a number of sensory factors 
including differing taste and flavours are likely to modulate frontal cortex activity 
(Marciani et al., 2006; Smits et al., 2007).  Marciani and colleagues previously 
demonstrated that several brain areas were activated immediately after swallowing 
particularly when supplements had a strong (combined) taste or aroma.  It could 
be argued that the MC concentrate was more sensory stimulating than the 
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placebo; however this is speculative as full analysis of sensory properties of MC 
and the placebo was outside the remit of the current study. 
To conclude the vascular function findings from this thesis; initial findings would 
suggest that MC supplementation can reduce SBP.  The pattern of evidence from 
the subsequent studies in this thesis supports this modulation of systole. This 
finding, along with the modulation of CBF post MC consumption supports the 
growing body of evidence showing an inverse association between the risk of 
chronic human diseases and the consumption of polyphenolic rich diets (Pandey & 
Rizvi, 2009; Lima et al., 2014). 
7.2.4 Cognitive function  
Although Chapter 5 highlights an acute heightened NIRS response in brain 
regions responsible for task performance (increases in oxy-Hb of 0.76 µmol/L and 
total Hb of 1.43 µmol/L respectively), this modulation of shallow pre-frontal cortical 
haemodynamics was not associated with any improvement or decrement to 
measured behavioural parameters.  Supplementary oxygen has been shown to 
positively influence cognitive performance (Moss et al., 1998).  However, to the 
best of the author’s knowledge, there are no studies that show that this pattern of 
CBF modulation following polyphenol supplementation is associated with cognitive 
improvements in middle aged adults.  Yet, the results of this study do not stand 
alone.  Kennedy et al., (2010) showed that resveratrol supplementation increased 
pre-frontal cerebral blood flow in a similar pattern to Chapter 5, with no change in 
cogntion. In addition, other berry studies (Krikorial et al., 2012) have shown that 
although polyphenol supplementation results in changes in haemodynamics, 
which are particularly evident during cognitive demand, this does not necessarily 
manifest into improved cognitive performance.   
Conceivably, all participants in the current study were healthy with no apparent 
issues pertaining to cerebral blood flow or cognitive ability. It is logical to question 
if that could mean that sufficient blood flow already exist for maximal cognitive 
performance and therefore, increasing blood flow beyond this threshold does not 
have any acute benefits on cognitive performance.  Therefore it is more likely that 
regulation of blood flow and cognition are extremely complex, with multiple 
overlapping regulatory mechanisms paradigms and contributing structural 
components and are not easily affected by nutritional interventions.  
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7.2.5 Exercise performance 
 
A secondary aim of this thesis was to assess the effect of MC supplementation on 
exercise performance.  While tart cherry supplementation has been shown to 
improve exercise recovery (Howatson et al., 2010; Bowtell et al., 2011; Bell et al., 
2014), decrease markers of inflammation and oxidative stress (Wang et al., 1999; 
Bell et al., 2014; Howatson et al., 2010), studies investigating the effects of tart 
cherries on exercise performance are limited and equivocal. Chapter 6 of this 
thesis demonstrates that MC supplementation could improve exercise 
performance in trained male cyclists.   
Peak power output and total work completed over a 60-s sprint was increased by 6 
and 10% respectively, during an exercise performance test following MC 
supplementation relative to the Pla.  This study is in agreement with a recent 
addition to the literature where the effects of powdered Montmorency tart cherry 
supplementation on acute endurance exercise performance in aerobically trained 
individuals was investigated (Levers et al., 2016).  Results of this study revealed 
that short-term supplementation of Montmorency powdered tart cherries not only 
attenuated markers of muscle damage, but also increased performance in 
aerobically trained individuals evidenced by a quicker overall race pace compared 
to the Pla group.  Similar findings have been reported in other studies with whole 
polyphenol compounds (Nieman et al., 2010) and in studies where polyphenolic 
content of a fruit – derived supplement is similar to tart cherries (Kang et al., 2012).   
Although physiological mechanisms for this observation are unclear, previous 
studies have shown that L-citrulline and beetroot supplementation resulted in 
improvements in skeletal muscle oxygenation and performance during endurance 
exercise in healthy subjects (Bailey et al., 2015; Suzuki et al., 2015).  These 
improvements are paralleled by increases in nitric oxide production, decreases in 
blood pressure and flow mediated vasodilation.  However, improvements in 
exercise performance in Chapter 6 occurred in the absence of changes in V̇O2 
kinetics, NO2- plasma concentrations or muscle oxygenation, however there was 
an overall reduction in SBP post MC supplementation.  Both Chapters 3, 4 and 5 
highlighted than an increase in PCA and VA might, at least in part, be responsible 
for acute improvements in vascular function. In agreement with this theory, 
previous studies have reported that improvements in performance may be due to 
the ability of polyphenol flavonoids to exert a vasodilatory effect which may 
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promote blood flow to the working muscle (Pietta, 2000; Oh et al., 2010)  However, 
these possibilities need to be verified in the future.  
 
7.3 Clinical applications 
 
Although the focus of this thesis was to investigate the efficacy of MC 
supplementation on various aspects of health and exercise performance in healthy 
participants, these studies have highlighted the potential clinical application of 
Montmorency tart cherries. Section 2.6 of the literature review discussed some of 
the previous work where MC supplementation was used in a more clinical setting 
i.e.. gout and sleep disturbance.  Furthermore, it was highlighted in both section 
2.5 and 2.6 that supplementation with MC significantly decreased markers of 
inflammation and oxidative stress and this in itself may have implications for the 
management of clinical pathologies associated with high levels of inflammation 
and oxidative stress and suggests that MC consumption may have the potential to 
reduce cardiovascular or chronic diseases in humans.  In support of this, the 
results from all of the studies in this thesis demonstrate the potential cardio-
protective benefits of Montmorency tart cherries.  In Chapter 3, cell migration of 
vascular smooth muscle cell was increased post MC supplementation.  Migration 
of de-differentiated VSMC is required for vessel remodelling which occurs from 
exercise but also following vascular injury which may be of clinical relevance.  
Additionally, in Chapter 4, 5 and 6, it was reported that MC supplementation 
significantly lowered systolic blood pressure in (1) males with early hypertension (2) 
middle aged adults (3) trained cyclists, suggesting application to those with 
diagnosed hypertension, a major risk factor of several cardiac diseases.  Further 
to this, in Chapter 5 the consumption of a MC concentrate resulted in acute 
modulation of CBF parameters in the frontal cortex during task performance as 
indicated by the elevated concentrations of total-Hb, with an identical pattern 
observed with oxy-Hb.  Compromised cerebral blood flow has been suggested as 
a key contributor to cognitive function decline.  Therefore, the application of tart 
cherries in groups who experience natural decrements in CBF and oxygenation 
would be worthwhile i.e.. cohorts experiencing natural age-associated reductions 
in CBF and/or cognitive function and. neurodegenerative or stroke patients. 
Naturally, cardiovascular variables are inextricably linked to cerebral blood flow 
and metabolism in the brain, and therefore, they covary with the incidence of age-
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related cognitive decline, dementia, and mood disorders. Notably, polyphenol-
related increases in vasodilation, cerebral blood flow, and NO synthesis are also 
implicated in hippocampal angiogenesis and neurogenesis, processes that are 
implicated in learning, memory, and neuroprotection. Lastly, the findings from 
Chapter 6 extend the application of MC supplementation to wider group of 
individuals, specifically those individuals with impaired physical mobility due to 
cardiovascular and cardiorespiratory impairment.  
 
7.4 Limitations of findings 
 
A number of limitations exist in the interpretation of the findings from this thesis 
which have been discussed in each chapter.  The controls put in place allow for 
targeted analyses, however in most instances, this is at the expense of a degree 
of ecological validity.  The following over-arching limitations are potential issues 
and criticisms of the work.  
The strict dietary restrictions imposed on participants throughout the thesis are a 
particular limitation and as a result, findings should be interpreted with a certain 
degree of caution. In order to examine the true efficacy of tart cherry 
supplementation on various aspects of cardiovascular function and exercise 
performance, it was important that participants were restricted from consuming 
any other foods rich in polyphenols that might affect results.  This approach 
allowed for greater confidence when interpreting the influence of tart cherries on 
various health and exercise parameters.  However, it is extremely unlikely that one 
would consume a diet that is free from polyphenol-rich foods and as a result, 
future work should attempt to demonstrate synergistic effects of MC 
supplementation within habitual dietary practices.  In Chapters 3, 4 and 5, dietary 
restrictions were imposed 48 h prior to the visit; however this was shortened to just 
24 h in the final experimental chapter.  The reason for this was twofold, the 
population in Chapter 6, well trained cyclists had five visits to the laboratory (twice 
as many as other studies), in addition they also found the diet far more difficult to 
maintain.  Secondly, and more importantly, it became apparent in Chapter 3 and 4 
that the compounds of interest were either absorbed or excreted 5 h post 
consumption.  In order to take into account enterohepatic metabolism which is not 
limited to a few hours, a 24 h restriction was imposed.   
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An acknowledged limitation of the current study is that the analysis was not 
exhaustive and so not every polyphenol was analysed; instead, the focus was on 
the degradation products of two of the main anthocyanins reported in the MC juice 
(Ou et al., 2012; Kirakosyan et al., 2009) that could exert a positive effect on 
vascular function. In addition, we did not investigate compounds with poor 
bioavailability due to their instability, large molecular weight or quick excretion. 
Conceivably, these compounds might also contribute to any potential physiological 
effects exerted by MC and cannot be excluded. Furthermore, enterohepatic 
metabolism could predict that the absorption of polyphenols and their metabolites 
are not limited to just a few hours after intake (Seymour et al., 2014; de Ferrars et 
al., 2014).  As a result, the timeframe of all the studies (≤ 8 hours) might not have 
been long enough to fully capture the entire absorption profile of the selected 
phenolic acids. 
As previously described in section 2.3.2, there are several factors that affect the 
polyphenol content of foods.  The batch-to-batch variation in MC supplement is a 
further limitation of this work.  Unfortunately due to the resource available, it was 
not possible to analyse each batch for individual polyphenol or polyphenol content.  
However in an attempt to counteract this, total anthocyanins, total phenolic content 
and Trolox equivalent AOX capacity was identified for all studies. 
 
7.5 Future research directions  
 
The aims of this thesis have been addressed in the 4 experimental Chapters, and 
more importantly have contributed to the existing literature.  The data from this 
thesis has provided an insight into the application of Montmorency tart cherry 
supplementation in both health and exercise settings. Consequently, a number of 
potential avenues for future research have been identified.   
Chapters 3 and 4 of this thesis have previously established the time course at 
which some polyphenolic compounds are most bioavailable (peak absorption) 
following acute doses of tart cherry juice.  Following chronic consumption of MC, it 
makes the expectation tenable that continued or elevated bioavailability could 
increase a number of health parameters, particularly in relation to markers of 
vascular reactivity (Jin et al., 2011) and consequently a more pronounced effect on 
blood flow and vasodilation following a longer period of consumption. 
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If continuing with samples from young, healthy participants, future studies may 
want to bear in mind the difficulty in observing vascular improvements and 
cognitive enhancement in this population.  These participants are likely to have 
good cognition (Ronnlund et al., 2005); as a result any treatment-related 
improvements would undoubtedly be small.  More recently, there has been 
emphasis on the use of functional foods and cherries to improve the prognosis in 
clinical populations such as those with cardiovascular disease and neurological 
disorders.   
Foods such as Montmorency cherries contain hundreds of polyphenolic 
compounds that give rise to a myriad of different metabolites present in biological 
samples in a wide range of concentrations.  Until quite recently, this complexity 
has meant that it was virtually impossible to identify how supplements influence 
metabolism and how these changes can be related to health effects.  However, 
through the developments in technology this is changing and there have been 
numerous reports describing the use of ‘omics’ technology to investigate aspects 
of human nutrition (Primrose et al., 2011).  As a result, we can comprehensively 
analyse the whole metabolome (all metabolites synthesized by an organism) 
(Fiehn, 2002) and focus on the measurements of metabolite concentrations and 
secretions in cells and tissues. This will allow for the identification of small 
molecules that make the difference between the effects of different diets and, in so 
doing, deepen our knowledge of human health and the interacting and regulatory 
roles of nutrition. 
Furthermore, it appears different compounds get metabolised and absorbed at 
different time points in the colon.  The enterohepatic circulation of colonic 
metabolites requires further investigation and hepatic metabolism of colonic 
metabolites of plant phenolic compounds should be addressed in the future.  
Additionally, one of the major gaps in the literature at present, is the lack of 
knowledge concerning hepatic conversion of small colon-derived phenolic acids, 
which may be missed in analyses of human body fluids or cell lines due to their 
hydrophilic nature.  Finally, the influence of consuming a mixed diet i.e.. “real” 
complex meals, on bio-accessibility absorption is poorly understood.  Future work 
should attempt to investigate the potential synergistic effects of MC 
supplementation within habitual dietary practices. 
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In conclusion, the series of investigations in this thesis have provided the first 
evidence that a commercially available Montmorency tart cherry concentrate is 
rich in polyphenols and has potential to modulate aspects of vascular function and 
improve exercise performance.  These findings are of importance as they highlight 
a natural, alternative solution to pharmacological interventions in managing blood 
pressure and enhancing performance in diverse populations. As Wersching (2011) 
points out, the direct interplay between nutrients in whole Montmorency tart 
cherries may be more important than the unique nutrients on their own in the 
reduction of risk in cardiovascular disease and performance improvement.  With 
that said, it is critically important that future work focus on the bioavailability and 
kinetics of absorption with the goal to find the combinatorial mix that acts 
synergistically upon the various targets, to then as a whole reduce the economic 
burden of cardiovascular disease and to promote healthy aging. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
172 
 
 
 
 
 
 
8 Reference List 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
173 
Aaslid, R., Markwalder, T.M., & Nornes, H. (1982) Non-invasive transcranial 
Doppler ultrasound recording of flow velocity in basal cerebral arteries.  Journal of 
Neurosurgery, 57, 769-774. 
Aggarwal, B. B., Prasad, S., Reuter, S., Kannappan, R., Yadev, V. R., Park, B., 
Kim, J. H., Gupta, S.C., Phromnoi, K., Sundaram, C., Chaturvedi, M. M. & Sung, B. 
(2011) Identification of Novel Anti-inflammatory Agents from Ayurvedic Medicine 
for Prevention of Chronic Diseases: "Reverse Pharmacology" and "Bedside to 
Bench" Approach. Current Drug Targets, 12(11), 1595-1653. 
Ajmani, R.S., Metter, E.J., Jaykumar, R., Ingram, D.K., Spangler, E.L., Abugo, 
O.O., & Rifkind, J.M. (2000) Hemodynamic changes during aging associated with 
cerebral blood flow and impaired cognitive function. Neurobiology of Aging, 21, 
257-269. 
Alhola, P., & Polo-Kantola, P. (2007).  Sleep deprivation: Impact on cognitive 
performance. Neuropsychiatric Disease and Treatment, 3, 553-567. 
Allen, D.G., Lamb, G.D., & Westerblad, H. (2008). Skeletal muscle fatigue: Cellular 
mechanisms. Physiological Reviews, 88, 287–332. 
Allender, S., Scarborough, P., Peto, V., Rayner., M. L. J., & Luengo-Fernandez, R. 
European cardiovascular disease statistics. Brussels: European Heart Network 
2008. 
Allgrove, J., Farrell, E., Gleeson, M., Williamson, G., & Cooper, K. (2011) Regular 
dark chocolate consumption’s reduction of oxidative stress and increase of free-
fatty-acid mobilization in response to prolonged cycling. International Journal of 
Sport Nutrition and Exercise Metabolism, 21(2), 113–123. 
Arakawa, O. (1993). Effect of ultraviolet light on anthocyanin synthesis in light-
colored. sweet cherry, cv. Sato Nishiki. Journal of the Japanese Society for 
Horticultural Science, 62, 543–546. 
Armah, C.K., Jackson, K.G., Doman, I., James, L., Cheghani, F., & Minihane, A.M. 
Fish oil fatty acids improve postprandial vascular reactivity in healthy men. Clinical 
Science 2008, 114,679-686. 
Arranz, S., Chiva-Blanch, G., Valderas-Martinez, P., Medina-Remon, A., Lamuela-
Raventos, R.M., & Estruch, R. (2012) Wine, beer, alcohol and polyphenols on 
174 
cardiovascular disease and cancer. Nutrients, 4(7), 759–781. 
doi:10.3390/nu4070759 
Arts, I.C.W., van de Putte, B., & Hollman, P.C.H. (2000). Catechin contents of 
foods commonly consumed in the Netherlands. 2. Tea, wine, fruit juices, and 
chocolate milk. Journal of Agricultural and Food Chemistry, 48, 1752–1757 
Astbury, N.M., Stevenson, E.J., Morris, P., Taylor, M.A., Macdonald, I.A. (2010). 
Dose-response effect of a whey protein preload on within-day energy intake in 
lean subjects. British Journal of Nutrition, 104, 1858–1867. doi: 
10.1017/S000711451000293X. 
Ataie-Jafari, A., Hosseini, S., Karimi, F., and Pajouhi, M. (2008).  Effects of sour 
cherry juice on blood glucose and some cardiovascular risk factors improvements 
in diabetic women: a pilot study.  Nutrition and Food Science, 238(4), 355-360. 
Attwell, D., Buchan, A.M., Charpak, S. Luritzen, M., MacVicar, B.A., & Newman, 
E.A. (2010) Glial and neuronal control of brain blood flow. Nature, 468, 232-243. 
Aura, A.M., Martin-Lopez, P., O’Leary, K.A., Williamson, G., Oksman-Caldentey, 
K.M., Poutanen, K. and Santos-Buelga, C. (2005). In vitro metabolism of 
anthocyanins by human gut flora. European Journal of Nutrition, 44:133-142. 
Aura, A.Microbial metabolism of dietary phenolic compounds in the colon 
Phytochem. Rev. 2008, 7, 407– 429 
Azuma, K., Ippoushi, K., Nakayama, M., Ito, H., Higashio, H., & Terao, J. (2000) 
Absorption of chlorogenic acid and caffeic acid in rats after oral administration. 
Journal of Agriculture and Food Chemistry, 48(11), 5496–5500. 
doi:10.1021/jf000483q 
Azzi, A., Davies, K.J.A., & Kelly, F. (2004) Free radical biology: terminology and 
critical thinking. Federation of European Biochemical Societies, 558, 3–6. 
Azzini, E., Vitaglione, P., Intorre, F., Napolitano, A., Durazzo, A., Foddai, M.S., 
Fumagalli, A., Catasta, G., Rossi, L., Venneria, E., Raguzzini, A., Palomba, L., 
Fogliano, V., & Maiani, G. (2010) Bioavailability of strawberry AOXs in human 
subjects. British Journal of Nutrition, 104(8), 1165–1173. 
doi:10.1017/s000711451000187x 
175 
Bailey, S.J., Blackwell, J.R., Lord, T., Vanhatalo, A., Winyard, P.G., & Jones, A.M. 
(2015). L-citrulline supplementation improves O2 uptake kinetics and high-intensity 
exercise performance in humans. Journal of Applied Physiology, 19(4), 385–95. 
doi:10.1152/japplphysiol.00192.2014. 
Bailey, S.J., Fulford, J., Vanhatalo, A., Winyard, P.G., Blackwell, J.R., Dimenna, 
F.J., Wilkerson, D.P., Tarr, J., Benjamin, N & Jones, A.M. (2010). Dietary nitrate 
supplementation enhances muscle contractile efficiency during knee-extensor 
exercise in humans. Journal of Applied Physiology, 109, 135-148. 
Bailey, S.J., Fulford, J., Vanhatalo, A., Winyard, P.G., Blackwell, J.R., Dimenna, 
F.J., Wilkerson, D.P., Tarr, J., Benjamin, N & Jones, A.M. (2009b). Dietary nitrate 
supplementation reduces the O2 cost of low-intensity exercise and enhances 
tolerance to high-intensity exercise in humans. Journal of Applied Physiology, 107, 
1144-1155. 
Baskin, C.R., Hinchcliff, K.W., DiSilvestro, R.A., Reinhart, G.A., Hayek, M.G., 
Chew, B.P., et al. (2000). Effects of dietary AOX supplementation on oxidative 
damage and resistance to oxidative damage during prolonged exercise in sled 
dogs. American Journal of Veterinary Research, 61, 886–891. 
Baur, J.A., Pearson, K.J., Price, N.L., Jamieson, H.A., Lerin, C., Kalra, A., Prabhu, 
V.V., Allard, J.S., Lopez-Lluch, G., Lewis, K., Pistell, P.J., Poosala, S., Becker, 
K.G., Boss, O., Gwinn, D., Wang, M., Ramaswamy, S., Fishbein, K.W., Spencer, 
R.G., Lakatta, E.G., Le Couter, D., Shaw, R.J., Navas, P., Puigserver, P., Ingram, 
D.K., de Cabo, R., & Sinclair, D.A. (2006). Resveratrol improves health and 
survival of mice on a high-calorie diet. Nature, 444(7117), 337-342. 
Bazzano, L.A., He, J., Ogden, L.G., Loria, C.M., Vupputuri, S., Myers, L., & 
Whelton, P.K. (2002). Fruit and vegetable intake and risk of cardiovascular 
disease in US adults: the first National Health and Nutrition Examination Survey 
Epidemiologic Follow-up Study. American Journal of Clinical Nutrition, 76, 93-99. 
Bell, L., Lamport, D., Butler, L. & Williams, C. (2015). A review of the cognitive 
effects observed in humans following acute supplementation with flavonoids, and 
their associated mechanisms of action. Nutrients, 7(12), 0290-10306. ISSN 2072-
6643 doi: 10.3390/nu7125538 
176 
Bell, P.G., Gaze, D.C., Davison, G.W., George, T.W., Scotter, M.J., & Howatson, 
G. (2014) Montmorency tart cherry (Prunus Cerasus L.) concentrate lowers uric 
acid, independent of plasma cyanidin-3-O-glucosiderutinoside. Journal of 
Functional Foods, 11, 82-90. 
Bell, P.G., McHugh, M.P., Stevenson, E., & Howatson, G. (2013) The role of 
cherries in exercise and health. Scandinavian Journal of Medicine and Science, 
24(3), 477-490. doi:10.1111/sms.12085 
Bell, P.G., Walshe, I.H., Davison, G.W., Stevenson, E., & Howatson, G. (2014) 
Montmorency cherries reduce the oxidative stress and inflammatory responses to 
repeated days high-intensity stochastic cycling. Nutrients, 6(2), 829–843. 
doi:10.3390/nu6020829 
Beyer, P., Al-Babili, S., Ye, X.D., Lucca, P., Schaub, P., Welsch, R., & Potrykus, I. 
(2002). Golden rice: introducing the beta-carotene biosynthesis pathway into rice 
endosperm by genetic engineering to defeat vitamin A deficiency. Journal of 
Nutrition, 132, 506–510. 
Bialonska, D., Ramnani, P., Kasimsetty, S.G., Muntha, K.R., Gibson, G.R., & 
Ferreira, D. (2010).  The influence of pomegranate by-product and punicalagins on 
selected groups of human intestinal microbiota, International Journal of Food 
Microbiology, 140, 175–182. 
Birks, J., & Evans, J.G. (2009) Ginkgo biloba for cognitive impairment and 
dementia. Cochrane Database of Systematic Reviews, 4, CD003120. 
Blando, F., Gerardi, C., & Nicoletti, I. (2004).  Sour Cherry (Prunus Cerasus L.) 
Anthocyanins as Ingrediants for Functional Foods.  Journal of Biomedicine and 
Biotechnology, 1(5), 253 – 258.   
Blau, L.W. (1950). Cherry diet control for gout and arthritis. Texas Reports on 
Biology and Medicine, 8, 309–311. 
Bohm, B.A. (1994). The minor flavonoids, in book The flavonoids: Advances in 
research since 1986, Eds Harborne JB, published by Chapman & Hall, London, 
UK, page 387-440. 
Bohm, B.A. (1998) Introduction to Flavonoids.  Amsterdam: Harwood Academic 
Publishers. 
177 
Bookheimer, S.Y., Renner, B.A., Ekstrom, A., Zhaoping, L., Henning, S.M., Brown, 
J.A., Jones, M., Moody, T., & Small, G.W. (2013) Pomegranate Juice Augments 
Memory and fMRI Activity in Middle-Aged and Older Adults with Mild Memory 
Complaints. Evidence-Based Complementary and Alternative Medicine. Vol. 2013, 
Article ID 946298, 14 pages. http://dx.doi.org/10.1155/2013/946298 
Bors, W., Michel, C., & Stettmaier, K. (1997). AOX effects of flavonoids. Biofactors, 
6, 399-402. 
Bowtell, J.L., Sumners, D.P., Dyer, A., Fox, P., Mileva, K.N. (2011) Montmorency 
Cherry Juice Reduces Muscle Damage Caused by Intensive Strength Exercise. 
Medicine and Science in Sports & Exercise, 43, 1544-1551. 
Brand-Williams, W., Cuvelier, M.E., & Berset, C. (1995) Use of a free radical 
method to evaluate AOX activity. Food Science and Technology, 28(1), 25–30. 
doi:10.1016/s0023-6438(95)80008-5 
Brayne, C., Gill, C., Huppert, F.A., Barkley, C., Gehlhaar, E., Girling, D.M., 
O'Connor, D.W., & Paykel, E.S. (1995). Incidence of clinically diagnosed subtypes 
of dementia in an elderly population. Cambridge Project for Later Life. British 
Journal of Psychiatry, 167(2), 255–262. 
Broncel, M., Kozirog, M., Duchnowicz, P., Koter-Michalak, M., Sikora, J., & 
Chojnowska-Jezierska, J. (2010) Aronia melanocarpa extract reduces blood 
pressure, serum endothelin, lipid, and oxidative stress marker levels in patients 
with metabolic syndrome. Medical Science Monitor, 16(1), 28–34. 
Buckow, R., Kastell, A., Terefe, N.S., & Versteeg, C. (2010) Pressure and 
temperature effects on degradation kinetics and storage stability of total 
anthocyanins in blueberry juice. Journal of Agriculture and Food Chemistry, 58(18), 
10076–10084. doi:10.1021/jf1015347 
Buxton, R. B., Uluda, K., Dubowitz, D. J., & Liu, T. T. (2004). Modeling the 
hemodynamic response to brain activation. Neuroimage, 23, 220-233. 
Caldwell, K.C.K., Roodenrys, S., & Jenner, A. (2015) Anthocyanin-rich cherry juice 
does not improve acute cognitive performance on RAVLT. Nutritional 
Neuroscience, 19(9), 423-424. 
178 
Celsis, P., Agniel, A., Cardebat, D., Demonet, J., Ousset, P., & Puel, M. (1997). 
Age related cognitive decline: a clinical entity? A longitudinal study of cerebral 
blood flow and memory performance. Journal of Neurology, Neurosurgery & 
Psychiatry, 62(6), 601- 608. 
Centers for Disease Control and Prevention, National Center for Health Statistics. 
Underlying Cause of Death 1999-2013 on CDC WONDER Online Database, 
released 2015. Data are from the Multiple Cause of Death Files, 1999-2013, as 
compiled from data provided by the 57 vital statistics jurisdictions through the Vital 
Statistics Cooperative Program: http://wonder.cdc.gov/ucd-icd10.html. Accessed 
on May 3, 2015 
Chan, Y.C., Hosoda, K., Tsai, C.J. Yamamoto, S., & Wang, M.F. (2006) Favorable 
effects of tea on reducing the cognitive deficits and brain morphological changes in 
senescence-accelerated mice. Journal of Nutritional Science and Vitaminology, 52, 
266-273. 
Chandra, A., Nair, M.G., & Iezzoni, A. (1992). Evaluation and characterization of 
the anthocyanin pigments in tart cherries (Prunus Cerasus L.). Journal of 
Agricultural and Food Chemistry, 40, 976-969. 
Chandra, A., Nair, M.G., & Iezzoni, A. (1993). Isolation and stabilization of 
anthocyanins from tart cherries (Prunus Cerasus L.). Journal of Agricultural and 
Food Chemistry, 41, 1062-1065. 
Chang, W.H., Chen, C.M., Hu, S.P., Kan, N.W., Chiu, C.C., & Liu, J.F. (2007) 
Effect of purple sweet potato leaves consumption on the modulation of the 
immune response in basketball players during the training period. Asia Pacific 
Clinical Nutrition Society, 16, 609-615. 
Chang, W.H., Hu, S.P., Huang, Y.F., Yeh, T.S., & Liu, J.F. (2010). Effect of purple 
sweet potato leaves consumption on exercise-induced oxidative stress and IL-6 
and HSP72 levels. Journal of Applied Physiology, 109, 1710-1715. 
Chaovanalikit, A., & Wrolstad, R.E. (2004). Total anthocyanins and total phenolics 
of fresh and processed cherries and their AOX properties. Journal of Food 
Science, 69, 67-72. 
Chiang, L.C., Ng, L.T., Chiang, W., Chang, M.Y., & Lin, C.C. (2003) 
Immunomodulatoryactivities of flavonoids, monoterpenoids, triterpenoids, iridoid 
179 
glycosides and phenolic compounds of plantago species. Planta Medica, 69(7), 
600–604 
Chiva-Blanch, G., & Visioli, F. (2012).  Polyphenols and health: Moving beyond 
AOXs.  Journal of Berry Research, 2, 63-71. 
Choi, C.U., Park, E.B., Suh, S.Y., Kim, J.W., Kim, E.J., Rha, S.W., Seo. H.S., Oh, 
D.J., & Park, C.G. (2007) Impact of aortic stiffness on cardiovascular disease in 
patients with chest pain - Assessment with direct intra-arterial measurement. 
American Journal of Hypertension, 20, 1163-1169. 
Chong, M.F.F., MacDonald, R., & Lovegrove, J.A. (2010).  Fruit polyphenols and 
CVD risk: a review of human intervention studies. British Journal of Nutrition, 
103(3), 28–39. 
Clifford, M.N. (2000). Anthocyanins – nature, occurrence and dietary burden. 
Journal of Science and Food Agriculture, 7, 1063–1072. 
Clifford, T., Howatson, G., West, D.J. & Stevenson, E.J. (2015) The Potential 
Benefits of Red Beetroot Supplementation in Health and Disease. Nutrients, 7, 
2801-2822. 
Clifford, T., Scott, A., and Mitchell, N. (2013). The influence of different sources of 
polyphenols on submaximal cycling and time trial performance.  International 
Journal of Sport Nutrition and Exercise Metabolism, 2(6), S10. 
Collins, R., Peto, R., Macmahon, S., Hebert, P., Fiebach, N.H., Eberlein, K.A., 
Godwin, J., Qizilbash, N., Taylor, J.O., Hennekens, C.H. (1990). Blood - pressure, 
stroke and coronary heart disease.2. short term reductions in blood pressure- 
overview of randomized drug trials in their epidemiologic context. Lancet, 335, 
827-838. 
Connolly, D.A.J., Mchugh, M.P., & Padilla-Zakour, O.I. (2006b). Efficacy of a tart 
cherry juice blend in preventing the symptoms of muscle damage. British Journal 
of Sports Medicine, 40, 679-683. 
Cook, M.D., Myers, S.D., Blacker, S.D.,  & Willems, M.E.T. (2015). New Zealand 
Blackcurrant Extract Improves Cycling Performance and Fat Oxidation in Cyclists. 
European Journal of Applied Physiology 115(11), 2357-2365. 
180 
Cooper, CE., & Giulivi, C. (2007). Nitric oxide regulation of mitochondrial oxygen 
consumption II: molecular mechanism and tissue physiology. American Journal of 
Physiology-Cell Physiology, 292, 1993-2003. 
Coull, J.T., Frith, C.D., Frackowiak, R.S.J., & Grasby, P.M. (1996) A fronto-parietal 
network for rapid visual information processing: A PET study of sustained attention 
and working memory. Neuropsychologia, 34, 1085-1095. 
Croteau, R., Kutchan, T.M. & Lewis, N.G. (2000). Natural products (secondary 
metabolites). In B.B. Buchannan, W. Gruissem and R.L. Jones (eds), Biochemistry 
and Molecular Biology of Plant. American Society of Plant Physiology, Rockville, 
MD, pp.1250- 1318. 
Crozier, A. (2003). Classification and biosynthesis of secondary plant products: an 
overview. In Plants: Diet and Health. British Nutrition Foundation. Blackwell 
Science Ltd., London pp. 107-146. 
Crozier, A., Jaganath, I. & Clifford, M.N. (2006). In Plant Secondary metabolites. 
Occurance, structure and role in the human diet. A. Crozier, M.N. Clifford and H. 
Ashihara (eds) Blackwell Publishing Ltd. Oxford, UK. pp.1-22. 
Cruickshank, K.R.L., Anderson, S.G., Wright, J.S., Dunn, G., & Gosling, R.G.(2002) 
Aortic pulse-wave velocity and its relationship to mortality in diabetes and glucose 
intolerance: an integrated index of vascular function? Circulation, 106, 2085–2090. 
Czyżowska, A., & Pogorzelski, E. (2004). Changes to polyphenols in the process 
of production of must and wines from blackcurrants and cherries. Part II. 
Anthocyanins and flavanols. European Food Research and Techology, 218,355–
359. Doi: 10.1007/s00217-003-0857-2 
D’Archivio, M., Filesi, C., Di Benedetto, R., Gargiulo, R., Giovannini, C., and 
Masella, R. (2007).  Polyphenols, dietary sources and bioavailability.  Ann Ist 
Super Sanita, 43,4, 348-361. 
D’Archivio, M., Filesi, C., Varí, R., Scazzocchio, B., and Masella, R. (2010).  
Bioavailability of the polyphenols: Status and Controversies.  International Journal 
of Molecular Science, 11,4. 
Dal-Ros, S., Zoll, J., Lang, A., Auger, C., Keller, N., Bronner, C., Geny, B., & 
Valérie, S.K.B. (2011). Chronic intake of red wine polyphenols by young rats 
181 
prevents aging-induced endothelial dysfunction and decline in physical 
performance: role of NADPH oxidase. Biochemical and Biophysical Research 
Communications, 404(2), 743–749 
Davies, K.J., Quintanilha, A.T., Brooks, G.A., & Packer, L. (1982). Free radicals 
and tissue damage produced by exercise. Biochemical and Biophysical Research 
Communications, 107(4), 1198-1205. 
Davies, M.J., Baer, D.J., Judd, J.T., Brown, E.D., Campbell, W.S., & Taylor, P.R. 
(2002) Effects of moderate alcohol intake on fasting insulin and glucose 
concentrations and insulin sensitivity in postmenopausal women - A randomized 
controlled trial. Journal of the American Medical Association, 287, 2559-2562. 
Day, A.J., Mellon, F., Barron, D., Sarrazin, G., Morgan, M.R., & Williamson, G. 
(2001). Human metabolism of dietary flavonoids: identification of plasma 
metabolites of quercetin. Free Radical Research, 35, 941-952. 
de Ferrars, R.M., Czank, C., Zhang, Q., Botting, N.P., Kroon, P.A., Cassidy, A., & 
Kay, C.D. (2014) The pharmacokinetics of anthocyanins and their metabolites in 
humans. British Jouranl of Pharmacology 171(13):3268– 3282. 
doi:10.1111/bph.12676 
De La Cruz, A.A., Hilbert, G., Mengin, V., Rivière, C., Ollat, N., Vitrac, C., 
Bordenave, L., Decroocq, S., Delaunay, J.C., Mérillon, J.M., Monti, J.P., Gomès, 
E., & Richard, T. (2013) Anthocyanin polyphenol profiles and anti-oxidant 
activities of Vitis candicans and Vitis doaniana. Polyphenol Analysis, 24, 446–
452. 
de Pascual-Teresa, S., Moreno, D.A., & Garcia-Viguera, C. (2010). Flavanols and 
anthocyanins in cardiovascular health: a review of current evidence. International 
Journal of Molecular Science, 11(4), 1679-1703. 
Dean, S., Braakhuis, A., & Paton, C. (2009). The effects of EGCG on fat oxidation 
and endurance performance in male cyclists. International Journal of Sport 
Nutrition and Exercise Metabolism, 19(6), 624–644. 
Dede, D.S., Yavus, B., Yavus, B.B., Cankuratan, M. Halil, M. Ulger, Z., 
Cankurtaran, E.S. Aytemir, K., Kabakci, G. and Ariogul, S. (2007).  Assessment of 
endothelial function in Alzheimer’s disease: Is Alzheimer’s disease a vascular 
182 
disease?  Journal of American Geriatrics Society, 55(10), 1613-1617. doi: 
10.1111/j.1532-5415.2007.01378.x 
Del Rio, D., Rodriguez-Mateos, A., Spencer, J.P.E., Tognolini, M., Borges, G., & 
Crozier, A. (2013). Dietary (Poly)phenolics in Human Health: Structures, 
Bioavailability, and Evidence of Protective Effects Against Chronic Diseases. AOX 
Redox Signaling, 18, 1818-1892. 
Deorukhkar, A., Krishnan, S., Sethi, G., & Aggarwal, B. B. (2007). Back to basics: 
how natural products can provide the basis for new therapeutics. Expert Opinion 
on Investigational Drugs, 16, 1753-1773. 
Dewick, P.M. (2002). Medicinal natural products. A biosynthetic approach. 2nd 
edition. John Wiley & Sons Ltd. England. 
Dhalla, N.S., Temsah, R.M., & Netticadan, T.  (2000)  Role of oxidative stress in 
cardiovascular diseases. Journal of Hypertension, 18(6), 655–673. 
Dodd, F.L., Kennedy, D.O., Riby, L.M., & Haskell-Ramsay, C.F. (2015) A double-
blind, placebo-controlled study evaluating the effects of caffeine and L-theanine 
both alone and in combination on cerebral blood flow, cognition and mood. 
Psychopharmacology, 232, 2563-2576. 
Dohadwala, M.M., Holbrook, M., Hamburg, N.M., Shenouda, S.M., Chung, W.B., 
Titas, M., Kluge, M.A., Wang, N., Palmisano, J., Milbury, P.E., Blumberg, J.B., & 
Vita, J.A. (2011). Effects of cranberry juice consumption on vascular function in 
patients with coronary artery disease. American Journal of Clinical Nutrition, 93, 
934-940. 
Draijer, R., de Graaf, Y., Slettenaar, M., de Groot, E., & Wright, C.I. (2015) 
Consumption of a Polyphenol-Rich Grape-Wine Extract Lowers Ambulatory Blood 
Pressure in Mildly Hypertensive Subjects. Nutrients, 7, 3138-3153. 
Drummond, S.P.A., Brown, G.G., Stricker, J.L. Buxton, R.B., Wong, E.C., & Gillin, 
J.C. (1999). Sleep deprivation-induced reduction in cortical functional response to 
serial subtraction. NeuroReport, 10, 3745-3748. 
Ducharme, N.G., Fortier, L.A., Kraus, M.S., Hobo, S., Mohammed, H.O., McHugh, 
M.P., Hackett, R.P., Soderholm, L.V., & Mitchell, L.M. (2009).  Effect of a tart 
183 
cherry juice blend on exercise-induced muscle damage in horses. American 
Journal of Veterinary Research, 70, 758-763. 
Dulloo, A.G, Duret, C., Rohrer, D., Girardier, L., Mensi, N., Fathi, M., Chantre, P., 
& Vandermander, J. (1999). Efficacy of a green tea extract rich in catechin 
polyphenols and caffeine in increasing 24-h energy expenditure and fat oxidation 
in humans. American Journal of Clinical Nutrition, 70(6), 1040–1045. 
Eichenberger, P., Colombani, P.C., & Mettler, S. (2009). Effects of 3-week 
consumption of green tea extracts on whole-body metabolism during cycling 
exercise in endurance-trained men. International Journal for Vitamin and Nutrition 
Research, 79(1), 24–33. 
Eichenberger, P., Mettler, S., Arnold, M., & Colombani, P.C. (2010).. No effects of 
three-week consumption of a green tea extract on time trial performance in 
endurance-trained men. International journal for vitamin and nutrition research, 80, 
54-64. 
Eisen, B., Ungar, Y. & Shimoni, E. 2003. Stability of isoflavones in soy milk stored 
at elevated and ambient temperatures. Journal of Agricultural and Food Chemistry, 
51, 2212 - 2215. 
Epriliati, I., & Ginjom, I. (2012).  Bioavailability of Polyphenols. In: A Global 
Perspective of Their Role in Nutrition and Health. InTech, pp. 401-429. ISBN 978-
953-51-0296-0. 
Eynon, N., Alves, A.J., Sagiv, M., Yamin, C., Sagiv, M., & Meckel, Y. (2010). 
Interaction between SNPs in the NRF2 gene and elite endurance performance. 
Physiological Genomics, 41(1),78–81. 
Fang, J. (2014). Bioavailability of anthocyanins. Drug Metabolism Reviews, 46(4), 
508–520. doi:10.3109/03602532.2014.978080 
Farah, A., & Donangelo, C.M. (2006). Phenolic compounds in coffee. Brazilian 
Journal of Plant Physiology, 18(1), 23–36. 
Farah, A., Monteiro, M., Donangelo, C.M., & Lafay, S. (2008). Chlorogenic acids 
from green coffee extract are highly bioavailable in humans. Journal of Nutrition, 
138(12), 2309–2315. doi:10.3945/jn.108.095554 
184 
Farkas, E., de Wilde, M.C., Kiliaan, A.J. & Luiten, P.G. (2002). Chronic cerebral 
hypoperfusion-related neuropathologic changes and compromised cognitive status: 
Window of treatment. Drugs of Today, 38, 365-376. 
Feng, R., Ni, H.M., Wang, S.Y., Tourkova, I.L., Shurin, M.R., Harada, H., & Yin, 
X.M. (2007). Cyanidin-3-rutinoside, a natural polyphenol AOX, selectively kills 
leukemic cells by induction of oxidative stress. Journal of Biological Chemistry, 
282(18), 13468-13476. 
Ferracane, R., Pellegrini, N., Visconti, A., Graziani, G., Chiavaro, E., Miglio, C., & 
Fogliano, V. (2008). Effects of different cooking methods on AOX profile, AOX 
capacity, and physical characteristics of artichoke. Journal of Agriculture and Food 
Chemistry, 56, 8601–8608. 
Ferreira, L.F., & Behnke, B.J. (2010). A toast to health and performance! Beetroot 
juice lowers blood pressure and the O2 cost of exercise. Journal of Applied 
Physiology, 110, 585-586. 
Fiehn, O. (2002). Metabolomics – the link between genotypes and phenotypes.  
Plant Molecular Biology, 48, 155-171. 
Filippin, L. I., Vercelino, R., Marroni, N. P., & Xavier, R. M. (2008). Redox 
signalling and the inflammatory response in rheumatoid arthritis. Clinical and 
Experimental Immunology, 152(3), 415–422. doi: 10.1111/j.1365-
2249.2008.03634.x 
Fleschhut, J., Kratzer, F., Rechkemmer, G., & Kulling, S.E. (2006). Stability and 
biotransformation of various dietary anthocyanins in vitro. European Journal of 
Nutrition, 45(1), 7-18. 
Forman, H.J., Torres, M., Fukuto, J. (2002). Redox signaling. Molecular Cell 
Biochemistry, 49(62), 234 –235. 
Francis, S.T., Head, K., Morris, P.G. & Macdonald, I.A. (2006). The effect of 
flavanol-rich cocoa on the fMRI response to a cognitive task in healthy young 
people. Journal of Cardiovascular Pharmacology, 47, 215-220. 
Freemont, L. (2000). Biological effect of resveratrol. Life Sciences, 66, 663-673. 
Frigo, D.E., Duong, B.N., Melnik, L.I., Schief, L.S., Collins-Burow, B.M., Pace, D.K., 
McLachlan, J.A., & Burow, M.E. (2002). Flavonoid polyphenols regulate activator 
185 
protein-1 signal transduction pathways in endometrial and kidney stable cell lines. 
Journal of Nutrition, 132, 1848-1853. 
Geibel, M. (1995). Sensitivity of the fungus Cytospora personii to the flavonoids of 
Prunus Cerasus. Phytochemistry, 38, 599- 601. 
Geibel, M., & Feucht, W. (1991). Flavonoid 5-glucosides from Prunus Cerasus 
bark and their characteristic weak glucosidic bonding. Phytochemistry, 30, 1519-
1521. 
Geibel, M., Geiger, H., & Treuter, D. (1990). Tectochrysin 5- and genistein 5-
glucosides from the bark of Prunus Cerasus. Phytochemistry, 29, 1351-1353 
George, T.W., Niwat, C., Waroonphan, S., Gordon, M.H., & Lovegrove, J.A. (2009). 
Effects of chronic and acute consumption of fruit- and vegetable-puree-based 
drinks on vasodilation, risk factors for CVD and the response as a result of the 
eNOS G298T polymorphism. Proceedings of the Nutrition Society, 68, 148-161. 
George, T.W., Paterson, E., Waroonphan, S., Gordon, M.H., & Lovegrove, J.A. 
(2012). Effects of chronic consumption of fruit and vegetable puree-based drinks 
on vasodilation, plasma oxidative stability and AOX status. Journal of Human 
Nutrition and Dietetics, 25, 477-487. 
George, T.W., Waroonphan, S., Niwat, C., Gordon, M.H., & Lovegrove, J.A. (2012). 
The Glu298Asp single nucleotide polymorphism in the endothelial nitric oxide 
synthase gene differentially affects the vascular response to acute consumption of 
fruit and vegetable puree based drinks. Molecular Nutrition & Food Research, 56, 
1014-1024. 
Ghosh, D. &Scheepens, A. (2009). Vascular action of polyphenols. Molecular 
Nutrition & Food Research, 53(3), 322–31. 
Gilchrist, M., Winyard, P.G., Fulford, J., Anning, C., Shore, A.C., & Benjamin, N. 
(2014). Dietary nitrate supplementation improves reaction time in type 2 diabetes: 
Development and application of a novel nitrate-depleted beetroot juice placebo. 
Nitric Oxide-Biology and Chemistry, 40, 67-74. 
Ginter, E., & Simko, V. (2012) Plant polyphenols in prevention of heart disease. 
Bratislava Medical Journal, 113, 476-480. 
186 
Goel, A., Kunnumakkara, A.B. & Aggarwal, B.B. (2008). Curcumin as “Curecumin”: 
from kitchen to clinic. Biochemical Pharmacology, 75, 787-809. 
Goldberg, G. (2003).  Plants: Diet and Health, Blackwell Publishing, Oxford, UK. 
Gomez-Cabrera, M.C., Martinez, A., Santangelo, G., Pallardo, F.V., Sastre, J., & 
Vina, J. (2006). Oxidative stress in marathon runners: interest of AOX 
supplementation. British Journal of Sports Nutrition, 96 (1), 31-33. 
Gonçalves, B., Landbo, A.K., Knudsen, D., Silva, A.P., Moutinho-Pereira, J., Rosa, 
E., & Meyer, A.S. (2004). Effect of Ripeness and Postharvest Storage on the 
Phenolic Profiles of Cherries (Prunus avium L.). Journal of Agriculture and Food 
Chemistry, 52, 523-530. 
Grassi, D., Necozione, S., Lippi, C., Croce, G., Valeri, L., Pasqualetti, P., Desideri, 
G., Blumberg, J.B., & Ferri, C. (2005). Cocoa reduces blood pressure and insulin 
resistance and improves endothelium-dependent vasodilation in hypertensives. 
Hypertension, 46, 398-405. 
Grayer R.J., Veitch N.C. Flavanones and dihydroflavonols. In: Anderson O.M., 
Markham K.R., editors. Flavonoids: Chemistry, Biochemistry and Applications. 
CRC Press/Taylor & Francis Group; Boca Raton, FL, USA: 2006. pp. 918–1002 
Habauzit, V., & Morand, C. (2012) Evidence for a protective effect of polyphenols-
containing foods on cardiovascular health: an update for clinicians. Therpeutic 
Advances in Chronic Disease, 3(2), 87–106. doi:10.1177/2040622311430006 
Haidari, F., Mohammad, S.M., Keshavarz, S., Rashidi, M. (2009). Inhibitory Effects 
of Tart Cherry (Prunus Cerasus) Juice on Xanthine Oxidoreductase Activity and its 
Hypouricemic and AOX Effects on Rats. Malaysian Journal of Nutrition, 15, 53–64. 
Halliwell, B., Rafter, J., Jenner, A. (2005). Health promotion by flavonoids, 
tocopherols, tocotrienols, and other phenols: direct or indirect effects? AOX or not? 
American Journal of Clinical Nutrition, 81, 268–276. 
Halson, S.L. (2008).  Nutrition, sleep and recovery. European Journal of Sport 
Science, 8, 119-126. 
Harborne, J.B. (1993). The Flavonoids: Advances in Research Since 1986, 
Chapman & Hall (ed.), London, UK. 
187 
Hasegawa, M., Carpenter, P. A., & Just, M. A. (2002). An fMRI study of bilingual 
sentence comprehension and workload. Neuroimage, 15(3), 647-660. 
Heldt, H.W. (2005). Plant Biochemistry Third Edition, Elsevier Academic Press, 
California.   
Higdon, J. (2007). An Evidence-Based Approach to Dietary Polyphenols. Thieme 
Medical Publishers, Inc, New York 
Hobbs, D.A., Goulding, M.G., Nguyen, A., Malaver, T., Walker, C.F., George, T.W., 
Methven, L., & Lovegrove, J.A. (2013). Acute Ingestion of Beetroot Bread 
Increases Endothelium-Independent Vasodilation and Lowers Diastolic Blood 
Pressure in Healthy Men: A Randomized Controlled Trial. Journal of Nutrition, 143, 
1399-1405. 
Hobbs, D.A., Kaffa, N., George, T.W., Methven, L., and Lovegrove, J.A. (2012).  
Blood pressure-lowering effects of beetroot juice and novel beetroot-enriched 
bread products in normotensive male subjects.  British Journal of Nutrition, 1-9. 
doi:10.1017/S0007114512000190 
Hofer, S.M., Berg, S., & Era, P. (2003) Evaluating the interdependence of aging-
related changes in visual and auditory acuity, balance, and cognitive functioning. 
Psychology and Aging, 18, 285-305. 
Holst B, Williamson G. (2004). A critical review of the bioavailability of 
glucosinolates and related compounds. Nat Prod Rep, 21, 425–447. 
Homack, S., & Riccio, C.A. (2004) A meta-analysis of the sensitivity and specificity 
of the Stroop Color and Word Test with children. Archives of Clinical 
Neuropsychology, 19, 725-743. 
Howatson, G., Bell, P.G., Tallent, J., Middleton, B., McHugh, M.P., & Ellis, J. 
(2012a).  Effect of tart cherry juice (Prunus Cerasus) on melatonin levels and 
enhanced sleep quality. European Journal of Nutrition, 51, 909-916. 
doi:10.1007/s00394-011-0263-7 
Howatson, G., McHugh, M.P., Hill, J.A., Brouner, J., Jewell, A.P., Van Someren, 
K.A., Shave, R.E., & Howatson, S.A. (2010) Influence of tart cherry juice on 
indices of recovery following marathon running. Scandinavian Journal of Medicine 
& Science in Sports, 20(6), 843–852. doi:10.1111/j.1600-0838.2009.01005. 
188 
Hu, F.B., Rimm, E.B., Stampfer, M.J., Ascherio, A., Spiegelman, D., & Willett, W.C. 
(2000). Prospective study of major dietary patterns and risk of coronary heart 
disease in men. American Journal of Clinical Nutrition, 72(4), 912-921. 
Hung, H.C., Joshipura, K.J., Jiang, R., Hu, F.B., Hunter, D., Smith-Warner, S.A., 
Colditz, G.A., Rosner, B., Spiegelman, D., & Willett, W.C. (2004) Fruit and 
vegetable intake and risk of major chronic disease. Journal of the National Cancer 
Institute, 96, 1577-1584. 
Huppert, T. J., Hoge, R. D., Diamond, S. G., Franceschini, M. A., & Boas, D. A. 
(2006). A temporal comparison of BOLD, ASL, and NIRS hemodynamic responses 
to motor stimuli in adult humans. Neuroimage, 29(2), 368-382. 
Ice, C.H. & Wender, S.H. (1953) Quercetin and its glycosides in leaves of 
Vaccinium myrtilus. Journal of the American Chemical Society, 75, 50-52. 
Ichiyanagi, T., Rahman, M.M., Hatano, Y., Konishi, T., & Ikeshiro, Y. (2007). 
Protocatechuic acid is not the major metabolite in rat blood plasma after oral 
administration of cyanidin 3-O-[beta]-d-glucopyranoside. Food Chemistry, 105(3), 
1032-1039. 
Irwin, M.R., Wang, M., Ribeiro, D., CHO, H.J., Olmstead, R., Breen, E.C., 
Martinez-Maza, O., & Cole, S. (2008).  Sleep loss activates cellular inflammatory 
signaling. Biol Psychiatry, 64, 538-540. 
Isaacs, E.B. (2013) Neuroimaging, a new tool for investigating the effects of early 
diet on cognitive and brain development. Frontiers in Human Neuroscience, 7, 445. 
Jacob, R.A., Spinozzi, G.M., Simon, V.A., Kelley, D.S., Prior, R.L., Hess-Pierce, B., 
Kaddar, A.A. (2003). Consumption of cherries lowers plasma urate in healthy 
women. Journal of Nutrition, 133, 1826–1829. 
Jädert, C., Petersson, J., Massena, S., Ahl, D., Grapensparr, L., Holm, L., & 
Phillipson, M. (2012). Decreased leukocyte recruitment by inorganic nitrate and 
nitrite in microvascular inflammation and NSAID-induced intestinal injury. Free 
Radical Biology and Medicine, 52(3), 683-692. 
Jakobek, L., Serung, M., Novak, I., & Medvidovic-Kosanovic, M. (2007).  Flavanols, 
Phenolic Acids, and AOX Activity of Some Red Fruits.  Deulsche Lebensmittel-Ru, 
103, 369-378. 
189 
Jin, Y., Alimbetov, D., George, T., Gordon, M.H., & Lovegrove, J.A. (2011). A 
randomised trial to investigate the effects of acute consumption of a blackcurrant 
juice drink on markers of vascular reactivity and bioavailability of anthocyanins in 
human subjects. European Journal of Clinical Nutrition, 65, 849-856. 
Jo, E., Lewis, K.L., Higuera, D., Hernandez, J., Osmond, A.D., Directo, D.J., & 
Wong, M. (2016).  Dietary Caffeine and Polyphenol Supplementation Enhances 
Overall Metabolic Rate and Lipid Oxidation at Rest and After a Bout of Sprint 
Interval Exercise.  Journal of Strength and Conditioning Research, 30(7), 1871-
1879. 
Joseph, J.A., Bartus, R.T., Clody, D., Morgan, D., Finch, C., Beer, B., & Sesack, S. 
(1983) Psychomotor performance in the senescent rodent - reduction of deficits 
via striatal dopamine receptor up-regulation. Neurobiology of Aging, 4, 313-319. 
Joshipura, K.J., Ascherio, A., Manson, J.E., Stampfer, M.J., Rimm, E.B., Speizer, 
F.E., Hennekens, C.H., Spiegelman, D., & Willett, W.C. (1999). Fruit and 
vegetable intake in relation to risk of ischemic stroke. Journal of the American 
Medical Association, 282, 1233-1239. 
Jówko, E., Sacharuk, J., Balasinka, B., Ostaszewski, P., Charmas, M., & Charmas, 
R. (2011).  Green tea extract entation gives protection against exercise-induced 
oxidative damage in healthy men. Nutrition Research, 31, 813-821. 
Jówko. E,, Sacharuk, J., Balasinska, B., Wilczak, J., Charmas, M., Ostaszewski, 
P., & Charmas, R. (2012). Effect of a single dose of green tea polyphenols on the 
blood markers of exercise-induced oxidative stress in soccer players. International 
Journal of Sport Nutrition and Exercise Metabolism, 22(6), 486–496. 
Justice, J. N., Gioscia-Ryan, R. A., Johnson, L. C., Battson, M. L., de Picciotto, N. 
E., Beck, H. J., & Seals, D. R. (2015). Sodium nitrite supplementation improves 
motor function and skeletal muscle inflammatory profile in old male mice. Journal 
of Applied Physiology, 118(2), 163-169. 
K.D., Brown, N.M., & Lydeking-Olsen, E. (2002). The clinical importance of the 
metabolite equol-a clue to the effectiveness of soy and its isoflavones. Journal of 
Nutrition,132:3577–3584. 
Kakkar, S., & Bais, S. (2014). A review on protocatechuic Acid and its 
pharmacological potential. ISRN pharmacology, 952943-952943. 
190 
Kamat, J.P., Ghosh, A., & Devasagayam, T.P.A. (2000) Vanillin as an AOX in rat 
liver mitochondria: inhibition of protein oxidation and lipid peroxidation induced by 
photosensitization. Molecular and Cellular Biochemistry, 209(1–2), 47–53. 
doi:10.1023/a:1007048313556 
Kang, S.W., Hahn, S., Kim, J.K., Yang, S.M., Park, B.J., & Lee, S.C. (2012) 
Oligomerized lychee fruit extract (OLFE) and a mixture of vitamin C and vitamin E 
for endurance capacity in a double blind randomized controlled trial. Journal of 
Clinical Biochemistry and Nutrition, 50, 106-113. 
Kang, S.Y., Seeram, N.P., Nair, M.G., & Bourquin, L.D. (2003). Tart cherry 
anthocyanins inhibit tumor development in Apc(Min) mice and reduce proliferation 
of human colon cancer cells. Cancer Letters, 194, 13–19. 
Kapil, V., Milsom, A.B., Okorie, M., Maleki-Toyserkani, S., Akram, F., Rehman, F., 
Arghandawi, S., Pearl, V., Benjamin, N., Loukogeorgakis, S., Macallister, R., 
Hobbs, A.J., Webb, A.J., & Ahluwalia, A. (2010). Inorganic Nitrate 
Supplementation Lowers Blood Pressure in Humans Role for Nitrite-Derived NO. 
Hypertension, 56, 274-281. 
Kay, C.D., Kroon, P.A., & Cassidy, A. (2009). The bioactivity of dietary 
anthocyanins is likely to be mediated by their degradation products. Molecular 
Nutrition Food Research, 53(S1), 92-101. 
Kelley, D.S., Adkins, Y., Reddy, A., Woodhouse, L.R., Mackey, B.E., & Erickson, 
K.L. (2013).  Sweet Bing cherries lower circulating concentrations of markers for 
chronic inflammatory diseases in healthy humans. Journal of Nutrition, 143, 340-
344. 
Kelly. J., Fulford, J., Vanhatalo, A. Blackwell, J.R., French, O., Bailey, S.J., 
Gilchrist, M., Winyard, P.G., & Jones, A.M. (2013) Effects of short-term dietary 
nitrate supplementation on blood pressure, O-2 uptake kinetics, and muscle and 
cognitive function in older adults. American Journal of Physiology-Regulatory 
Integrative and  Comparative Physiology, 304, 73-83. 
Kennedy, D.O., Wightman, E.L., Reay, J.L. Lietz, G., Okello, E.J., Wilde, A., & 
Haskell, C.F. (2010) Effects of resveratrol on cerebral blood flow variables and 
cognitive performance in humans: a double-blind, placebo-controlled, crossover 
investigation. American Journal of Clinical Nutrition, 91, 1590-1597. 
191 
Kent, K., Charlton, K., Roodenrys, S., Batterham, M., Potter, J., Traynor, V., 
Gilbert, H., Morgan, O., & Richards, R. (2015) Consumption of anthocyanin-rich 
cherry juice for 12 weeks improves memory and cognition in older adults with mild-
to-moderate dementia. European Journal of Nutrition, 56(1), 333-341. 
Keppler, K., & Humpf, H.U. (2005). Metabolism of anthocyanins and their phenolic 
degradation products by the intestinal microflora. Bioorganic and Medicinal 
Chemistry, 13(17), 5195- 5205. 
Kesse-Guyot, E., Fezeu, L., Andreeva, V.A., Touvier, M., Scalbert, A., Hercberg, 
S., and Galan, P. (2012).  Total and specific polyphenol intakes in midlife are 
associated with cognitive function measured 13 years later.  Journal of Nutrition, 
142(1), 76-83. 
Kim, D.O., Heo, H.J., Kim, Y.J. Yang, H.S. & Lee, C.Y. (2005) Sweet and sour 
cherry phenolics and their protective effects on neuronal cells. Journal of 
Agricultural and Food Chemistry, 53, 9921-9927. 
King, R.A. (2000). The role of polyphenols in human health, Tannins in Livestock 
and Human Nutrition.  Research Publications Repository , 92, 75-81. 
Kirakosyan, A., Seymour, E.M., Llanes, D.E.U., Kaufman, P.B., & Bolling, S.F. 
(2009) Chemical profile and AOX capacities of tart cherry products. Food 
Chemistry, 115(1), 20–25. doi:10.1016/j. foodchem.2008.11.042 
Kirakosyan, A., Seymour, E.M., Wolforth, J., McNish, R., Kaufman, P.B., & Bolling, 
S.F. (2015). Tissue bioavailability of anthocyanins from whole tart cherry in healthy 
rats. Food Chemistry, 171, 26–31. doi:10.1016/j.foodchem.2014.08.114 
Koenig, W., Lowel, H., Baumert, J., & Meisinger, C. (2004). C-reactive protein 
modulates risk prediction based on the Framingham score: implications for future 
risk assessment: results from a large cohort study in southern Germany. 
Circulation, 109, 1349–1353. 
Koli, R., Erlund, I., Jula, A., Marniemi, J., Mattila, P., & Alfthan, G. Bioavailability of 
various polyphenols from a diet containing moderate amounts of berries. Journal 
of Agriculture and Food Chemistry, 58, 3927–3932. doi: 10.1021/jf9024823 
192 
Kressler, J., Millard-Strafford, M., & Warren, G.L. (2011).  Quercetin and 
endurance exercise capacity: a systematic review and meta-analysis. Medicine 
and Science in Sport and Exercise, 43(12), 2396 – 2404. 
Krikorian, R., Boespflug, E.L., Fleck, D.E., Stein, A.L., Wightman, J.D., Shidler, 
M.D., & Sadat-Hossieny, S. (2012) Concord Grape Juice Supplementation and 
Neurocognitive Function in Human Aging. Journal of Agricultural and Food 
Chemistry, 60, 5736-5742. 
Kroon, P.A., Clifford, M.N., Crozier, A., Day, A.J., Donovan, J.L., Manach, C., & 
Williamson, G. (2004). How should we assess the effects of exposure to dietary 
polyphenols in vitro? American Journal of Clinical Nutrition, 80,15-21. 
Kuehl, K., Perrier, E., Elliot, D., & Chesnutt, J. (2010). Concord Grape Juice 
Supplementation and Neurocognitive Function in Human Aging. Journal of the 
International Society of Sports Nutrition, 7, 17, 5736-5742. 
Kyaw, M., Yoshizumi, M., Tsuchiya, K., Izawa, Y., Kanematsu, Y., Fujita, Y., Ali, N., 
Ishizawa, K., Yamauchi, A., &Tamaki, T. (2004). AOX effects of stereoisomers of 
N-acetylcysteine (NAC), L-NAC and D-NAC, on angiotensin II-stimulated MAP 
kinase activation and vascular smooth muscle cell proliferation. Journal of 
Pharmacology Science, 95, 483-486. 
Lafay, S., Jan, C., Nardon, K., Lemaire, B., Ibarra, A,, Roller, M., Houvenaeghel, 
M., Juhel, C., & Cara, L. (2009). Grape extract improves AOX status and physical 
performance in elite male athletes. Journal of Sports Science and Medicine, 8(3), 
468. 
Lambert, J.D., Hong, J., Yang, G.Y., Liao, J., & Yang, C.S. (2005). Inhibition of 
carcinogenesis by polyphenols: evidence from laboratory investigations. American 
Journal of Clinical Nutrition, 81, 284-291. 
Lampe, J.W. (2003).  Isoflavonoid and lignin phytoestrogens as dietary biomarkers.  
Journal of Nutrition, 133, 956-964. 
Lamport, D., Dye, L., Wightman, J. D. & Lawton, C. L. (2012) The effects of 
flavonoid and other polyphenol consumption on cognitive performance: A 
systematic research review of human experimental and epidemiological studies. 
Nutrition and Aging, 1(1)., 5-25. ISSN 1879-7725 doi: 10.3233/NUA-2012-0002 
193 
Lamport, D.J., Pal, D., Macready, A.L., Barbosa-Boucas,S., Fletcher, J.M., 
Williams, C.M., Spencer, J.P.E., & Butler, L.T. (2017).  The Effects of Flavanone-
Rich Citrus Juice on Cognitive Function and Cerebral Blood Flow: An Acute, 
Randomised, Placebo-Controlled Cross-Over Trial in Healthy, Young Adults.  
British Journal of Nutrition, 116(12), 2160 – 2168. 
Lansley, K.E., Winyard, P.G., Bailey, S.J., Vanhatalo, A., Wilkerson, D.P., 
Blackwell, J.R., Gilchrist, M., Benjamin, N., & Jones, A.M. (2011a).  Acute Dietary 
Nitrate Supplementation Improves Cycling Time Trial Performance. Medicine & 
Science in Sports & Exercise, 43, 1125-1131. Doi: 
10.1249/MSS.0b013e31821597b4. 
Lansley, K.E., Winyard, P.G., Fulford, J., Vanhatalo, A., Bailey, S.J., Blackwell, 
J.R., Dimenna, F.J., Gilchrist, M., Benjamin, N., & Jones, A.M. (2011b).  Dietary 
nitrate supplementation reduces the O2 cost of walking and running: a placebo-
controlled study. Journal of Applied Physiology, 110, 591-600. 
Lau, F.C., Shukitt-Hale, B., & Joseph, J.A. (2005). The beneficial effects of fruit 
polyphenols on brain aging. Neurobiology of Aging, 26(1), 128-132. 
Laurent, C., Besancon, P., & Caporiccio, B. (2007) Flavonoids from a grape seed 
extract interact with digestive secretions and intestinal cells as assessed in an in 
vitro digestion/Caco-2 cell culture model. Food Chemistry, 100, 1704– 1712. 
Lawrence, N.S., Ross, T.J., & Stein, E.A. (2002) Cognitive mechanisms of nicotine 
on visual attention. Neuron, 36, 539-548. 
Lee, H.C., Jenner, A.M., Low, C.S., & Lee, Y.K. (2006).  Effect of tea phenolics 
and their aromatic fecal bacterial metabolites on intestinal microbiota, Research in  
Microbiology, 157, 876–884. 
Lee, K. W., Bode, A. M., & Dong, Z. (2011) Molecular targets of polyphenols for 
cancer prevention. Nature Reviews Cancer, 11, 211-218. 
Leenders, K.L., Perani, D., Lammertsma, A.A., Heather, J.D., Buckingham, P., 
Jones, T., Healy, M.J.R., Gibbs, J.M., Wise, R.J.S., Hatazawa, J., Herold, S., 
Beany, R.P., Brooks, D.J., Spinks, T., Rhodes, C. & Fracowiak, R.S.J. (1990).  
Cerebral blood flow, blood volume and oxygen utilization: Normal values and 
effect of age.  Brain, 113(1), 27-47. Doi:10.1093/brain/113.1.27. 
194 
Levers, K., Dalton, R., Galvan, E., O’Connor, A., Goodenough, C., Simbo, S., 
Mertens-Talcott, S.U., Rasmussen, C., Greenwood, M., Riechman, S., Crouse, S., 
& Kreider, R.B. (2016) Effects of powdered Montmorency tart cherry 
supplementation on acute endurance exercise performance in aerobically trained 
individuals. Journal of the International Society of Sports Nutrition, 13(22), Epub.  
Doi:  10.1186/s12970-016-0133-z 
Lewington, S., Clarke, R., Qizilbash, N., Peto, R., & Collins, R. (2002). Prospective 
Studies C: Age-specific relevance of usual blood pressure to vascular mortality: a 
meta-analysis of individual data for one million adults in 61 prospective studies. 
Lancet, 360, 1903-1913. 
Lila, M.A., & Raskin, I. (2005) Health-related interactions of polyphenols. Journal 
of Food Science, 70(1), 20–27. 
Lima, G.P.P., Vianello, F., Corrêa, C.R., da Silva Campos, R.A. & Borguini, M.G. 
(2014).  Polyphenols in fruits and vegetables and its effect on human health.  Food 
and Nutrition Sciences, 5, 1065-1082. 
Lin, H., Chen, J.H., Chou, F.P., & Wang, C.J. (2011) Protocatechuic acid inhibits 
cancer cell metastasis involving the down-regulation of Ras/Akt/NF-κB pathway 
and MMP-2 production by targeting RhoB activation. British Journal of 
Pharmacology, 162(1), 237–254. 
Lirdprapamongkol, K., Kramb, J.P., Suthiphongchai, T., Surarit, R., Srisomsap, C., 
Dannhardt, G., & Svasti, J. (2009) Vanillin suppresses metastatic potential of 
human cancer cells through PI3K inhibition and decreases angiogenesis in vivo. 
Journal of Agriculture and Food Chemistry, 57(8), 3055–3063. 
doi:10.1021/jf803366f 
Liu, M. L. & L. C. Yu (2008). Potential protection of green tea polyphenols against 
ultraviolet irradiationͲinduced injury on rat cortical neurons." Neuroscience Letters, 
444(3), 236-239. 
Liu, R.H. (2003). Health benefits of fruit and vegetables are from additive and 
synergistic combinations of polyphenols. American Journal of Clinical Nutrition, 78, 
517-520. 
Loren, D. J., Seeram, N.P., Schulman, R.N., & Holtzman, D.M. (2005). Maternal 
dietary supplementation with pomegranate juice is neuroprotective in an animal 
195 
model of neonatal hypoxic  ischemic brain injury. Pediatric Research, 57(6), 858-
864. 
Lotito, S.B., & Frei, B. (2006). Consumption of flavonoid-rich foods and increased 
plasma AOX capacity in humans: cause, consequence, or epiphenomenon? Free 
Radical Biology and Medicine, 41, 1727-1746. 
Louis, S.F., & Zahradka, P. (2010) Vascular smooth muscle cell motility: from 
migration to invasion. Experimental and Clinical Cardiology, 15(4), 75–85. 
Lundberg, J.O., & Weitzberg, E. (2009). NO generation from inorganic nitrate and 
nitrite: role in physiology, nutrition and therapeutics. Archives of Pharmacal 
Research, 32, 1119–1126. 
Lynn, A., Mathew, S., Moore, C.T., Russell, J., Robinson, E., Soumpasi, V., & 
Barker, M.E. (2014). Effect of a Tart Cherry Juice Supplement on Arterial Stiffness 
and Inflammation in Healthy Adults: A Randomised Controlled Trial. Plant Foods 
for Human Nutrition, 69, 122-127. 
Machefer, G., Groussard, C., Rannou-Bekono, F., Zouhal, H., Faure, H., Vincent, 
S., et al. (2004). Extreme running competition decreases blood AOX defense 
capacity. Journal of the American College of Nutrition, 23, 358–364Macheix, J.J., 
Fleuriet, A., & Billot, J. (1990). Fruit Phenolics. CRC Press; Boca Raton, FL, USA, 
pp. 101–126. 
Macready, A.L., George, T.W., Chong, M.F., Alimbetov, D.S., Jin, Y., Vidal, A., 
Spencer, J.P.E., Kennedy, O.L.B., Tuohy, K.M., Minihane, A.M., Gordon, M.H., & 
Lovegrove, J.A. (2014). Flavonoid-rich fruit and vegetables improve microvascular 
reactivity and inflammatory status in men at risk of cardiovascular disease-
FLAVURS: a randomized controlled trial. American Journal of Clinical Nutrition, 99, 
479-489. 
Macready, A.L., Kennedy, O.B., Ellis, J.A., Williams, C.M., Spencer, J.P., & Butler, 
L.T. (2009) Flavonoids and cognitive function: a review of human randomized 
controlled trial studies and recommendations for future studies. Genes and 
Nutrition, 4, 227-242. 
Malaguti, M., Angeloni, C., & Hrelia, S. (2013).  Polyphenols in exercise 
performance and prevention of exercise-induced muscle damage. Oxidative 
Medicine and Cellular Longevity, 825928. doi:  10.1155/2013/825928 
196 
Manach, C., Williamson, G., Morand, C., Scalbert, A., & Rémésy, C. (2005) 
Bioavailability and bioefficacy of polyphenols in humans. I. Review of 97 
bioavailability studies. American Journal of Clinical Nutrition, 81, 230-242. 
Marchal, G., Rioux, P., Petittaboue, M.C., Seete, G., Travere, J.M., Le Poec, C., 
Courtheoux, P., Derlon, J.M., & Baron, J.C. (1992).  Regional cerebral oxygen-
consumption, blood flow and blood volume in healthy human aging. Archives of 
Neurology, 49, 1013-1020. 
Marchal, G., Rioux, P., Petit-Taboué, M.C., Sette, G., Travére, J.M., Le Poec, C., 
Courtheoux, P., Derlon, J.M., and Baron, J.C. (1992).  Regional cerebral oxygen 
consumption, blood flow, and blood volume in healthy human aging. Arch Neurol, 
49(10), 1013-1020. 
Marciani, L., Pfeiffer, J.C., Hort, J., Head, K., Bush, D., Taylor, A.J., Spiller, R.C., 
Francis, S., & Gowland, P.A. (2006). Improved methods for fMRI studies of 
combined taste and aroma stimuli. Journal of Neuroscience Methods, 158, 186-
194. 
Margaritis, I., Palazzetti, S., Rousseau, A.S., Richard, M.J., & Favier, A. (2003). 
AOX supplementation and tapering exercise improve exercise-induced AOX 
response. Journal of the American College of Nutrition, 22, 147–156 
Martin, S., Andriambeloson, E., Takeda, K., & Andriantsitohaina, R. (2002). Red 
wine polyphenols increase calcium in bovine aortic endothelial cells: a basis to 
elucidate signalling pathways leading to nitric oxide production. British Journal of 
Pharmacology, 135, 1579–1587. 
Mazza, G., Cacace, J.E., & Kay, C.D. (2004).  Methods of analysis for 
anthocyanins in plants and biological fluids.  Journal of AOAC International, 87(1), 
129-145. 
McAnulty, L.S., Nieman, D.C., Dumke, C.L., Shooter, L.A., Henson, D.A., Utter, 
A.C., Milne, G., & McAnulty, S.R. (2011). Effect of blueberry ingestion on natural 
killer cell counts, oxidative stress, and inflammation prior to and after 2.5 h of 
running. Applied Physiology, Nutrition, and Metabolism, 36, 976-984. 
McCall, D.O., McGartland, C.P., McKinley, M.C., Sharpe, P., McCance, D.R. 
Young, I.S., & Woodside, J.V. (2011). The effect of increased dietary fruit and 
vegetable consumption on endothelial activation, inflammation and oxidative 
197 
stress in hypertensive volunteers. Nutrition, Metabolism and Cardiovascular 
Disease, 21, 658-664. 
Miglio, C., Chiavaro, E., Visconti, A., Fogliano, V., & Pellegrini, N. (2008). Effects 
of different cooking methods on nutritional and physicochemical characteristics of 
selected vegetables. Journal of Agriculture and Food Chemistry,. 56, 139–147. 
Mitchell, G.F., Parise, H., Benjamin, E.J., Larson, M.G., Keyes, M.J., Vita, J.A., 
Vasan, R.S., & Levy, D. (2004). Changes in arterial stiffness and wave reflection 
with advancing age in healthy men and women - The Framingham Heart Study. 
Hypertension, 43, 1239-1245. 
Mithen, R. (2006). Sulphur containing compounds. In Plant Secondary Metabolites. 
Occurence, Structure and Role in the Human Diet. A. Crozier, M.N. Clifford and H. 
Ashihara (eds) Blackwell Publishing Ltd. Oxford, UK. pp. 25-41. 
Moncada, S.P.R., & Higgs, E.A. (1991). Nitric oxide: physiology, pathophysiology, 
and pharmacology. Pharmacological Reviews, 43, 109-142. 
Morand, C., Crespy, V., Manach, C., Besson, C., Demigne, C., & Remesy, C. 
(1998). Plasma metabolites of quercetin and their AOX properties. American 
Journal of Physiology, 275, 212-219. 
Morillas-Ruiz, J.M., Villegas García, J.A., López, F.J., VidalGuevara, M.L., & 
Zafrilla, P. (2006). Effects of polyphenolic AOXs on exercise-induced oxidative 
stress. Clinical Nutrition (Edinburgh, Scotland), 25, 444–453. 
Mortensen, S.P., Damsgaard, R., Dawson, E.A., Secher, N.H., & González-Alonso, 
J. (2008). Restrictions in systemic and locomotor skeletal muscle perfusion, 
oxygen supply and V̇O2 during high-intensity whole-body exercise in humans. The 
Journal of Physiology, 586, 2621–2635. 
Morton, M.S., Arisaka, O., Miyake, N., Morgan, L.D., & Evans, B.A. (2002). 
Phytoestrogen concentrations in serum from Japanese men and women over forty 
years of age. Journal of Nutrition, 132, 3168–3171. 
Moskaug, J.Ø., Carlsen, H., Myhrstad, M.C.W., Blomhoff, R. (2005). Polyphenols 
and glutathione synthesis regulation. American Journal of Clinical Nutrition, 81, 
277– 283. 
198 
Moss, M.C., Scholey, A.B., & Wesnes, K. (1998) Oxygen administration selectively 
enhances cognitive performance in healthy young adults: a placebo controlled 
double blind crossover study. Psychopharmacology, 138, 27-33. 
Mougin, F., Simon-Rigaud, M., Davenne, D., Renaud, A., Garnier, A., Katelip, J., & 
Magnin, P. (1991). Effects of sleep disturbances on subsequent physical 
performance. European Journal of Applied Physiology and Occupational 
Physiology, 63, 77-82. 
Mountzouris, K.C., Tsirtsikos, P., Kalamara, E., Nitsch, S., Schatzmayr, G., 
Fegeros, K. (2007).   Evaluation of the efficacy of a probiotic containing 
lactobacillus, bifidobacterium, enterococcus, and pediococcus strains in promoting 
broiler performance and modulating cecal microflora composition and metabolic 
activities. Poultrey Science, 86(2), 309–317. 
MRC trial of treatment of mild hypertension: principal results, Medical Research 
Council Working Party (1985). British Medical Journal, (Clinical research ed), 291, 
97-104. 
Mudnic, I., Budimir, D., Modun, D., Gunjaca, G., Generalic, I., Skroza, D., Katalinic, 
V., Ljubenkov, I.,&  Boban, M. (2012) AOX and vasodilatory effects of blackberry 
and grape wines.  Journal of Medicinal Food, 15(3), 315–321. 
doi:10.1089/jmf.2011.0129 
Mulat, D.G., Latva-Maenpaa, H., Koskela, H., Saranpaa, P., & Wahala, K. (2014). 
Rapid chemical characterisation of stilbenes in the root bark of Norway spruce by 
off-line HPLC/DAD-NMR. Polyphenol Analysis, 25, 529–536. doi: 
10.1002/pca.2523 
Mullen, W., Edwards, C.A. & Crozier, A. (2006). Absorption, excretion and 
metabolite profiling of methyl-, glucuronyl-, glucosyl- and sulpho-conjugates of 
quercetin in human plasma and urine after ingestion of onions. British Journal of 
Nutrition, 96, 107-116 
Murase, T., Haramizu, S., Shimotoyodome, A., Nagasawa, A., & Tokimitsu, I.  
(2005).  Green tea extract improves endurance capacity and increases muscle 
lipid oxidation in mice. American Journal of Physiology: Regulatory, Integrative 
and Comparative Physiology, 288(3), 708–715. 
199 
Murkin, J.M., &  Arango, M. (2009) Near-infrared spectroscopy as an index of 
brain and tissue oxygenation. British journal of anaesthesia, 103(1), 3-13. 
Myburgh, K. H. (2014). Polyphenol supplementation: benefits for exercise 
performance or oxidative stress? Sports Medicine, 44(1), 57-70. 
Nabrzyski, M., & Gajewska, R. (1994).  The content of nitrates and nitrites in fruits, 
vegetables and other foodstuffs.  Annals of the National Institute of Hygiene, 45(3), 
167- Gruetter CA, Barry BK, McNamara DB, Gruetter DY, Kadowitz PJ, Ignarro L. 
Relaxation of bovine coronary artery and activation of coronary arterial guanylate 
cyclase by nitric oxide, nitroprusside and a carcinogenic nitrosoamine. Journal of 
cyclic nucleotide research, 180(5), 211–224. 
Nagai, K., Jiang, M.H., Hada, J., Nagata, T., Yajima, Y., Yamamoto, S., & 
Nishizaki, T. (2002) (−)-Epigallocatechin gallate protects against NO stress-
induced neuronal damage after ischemia by acting as an anti-oxidant. Brain 
Research, 956, 319–322. 
Naghavi, M., Wang, H., Lozano, R., Davis, A., Liang, X., Zhou, M., Vollset, S.E., 
Ozgoren, A.A., Abdalla, S., Abd-Allah, F., et al. (2015). Global, regional, and 
national age-sex specific all-cause and cause-specific mortality for 240 causes of 
death, 1990-2013: a systematic analysis for the Global Burden of Disease Study 
2013. Lancet, 385, 117-171. 
Narita, K., Hisamoto, M., Okuda, T., & Takeda, S. (2011). Differential 
neuroprotective activity of two different grape seed extracts. PLoS One, 6(1), 
e14575. doi: 10.1371/journal.pone.0014575 
Nelms, M., Sucher, K., Lacey, K., & Long Roth, S. (2011).  Nutritional therapy & 
pathophysiology. Second ed. Wadsworth Cengage Learning. 
Nelson, D.K.B., Regnerus, C., & Schweinle, A. (2008) Accuracy of Automated 
Blood Pressure Monitors. Journal of Dental Hygiene, 82(4), 35. 
Nicholson, S.K., Tucker, G.A., & Brameld, J.M. (2008). Effects of dietary 
polyphenols on gene expression in human vascular endothelial cells. Proceedings 
of the Nutrition Society, 67(01), 42–47. 
Nieman, D.C., Williams, A.S., Shanely, R.A., Jin, F., McAnulty, S.R., Triplett, N.T., 
Austin, M.D., & Henson, D.A. (2010). Quercetin's influence on exercise 
200 
performance and muscle mitochondrial biogenesis. Medicine and Science in 
Sports and Exercise. 42, 338–345. 
Nikolaidis, M., Kerksick, C., Lamprecht, M., & McAnulty, S. (2012a). Does vitamin 
C and E supplementation impair the favourable adaptations of regular exercise? 
Oxidative Medicine and Cellular Longevity, 707941. doi: 10.1155/2012/707941. 
Nikolaidis, M.G., Paschalis, V., Giakas, G., Fatouros, I.G., Koutedakis, Y., 
Kouretas, D., & Jamurtas, A.Z. (2007). Decreased blood oxidative stress after 
repeated muscle-damaging exercise. Medicine in Science in Sport and Exercise,, 
39, 1080-1089. 
Nishizawa, M., Hara, T., Miura,T., Fujita, S., Yoshigai, E., Ue, H., Hayashi, Y., 
Kwon, A.H., Okumara, T., & Isaka, T. (2011). Supplementation with a Flavanol-rich 
Lychee Fruit Extract Influences the Inflammatory Status of Young Athletes. 
Phytotherapy Research, 25, 1486-1493. 
Nogata, Y., Sakamoto, K., Shiratsuchi, H., Ishii, T., Yano, M., & Ohta, H. (2006).  
Flavonoid composition of fruit tissues of citrus species.  Bioscience Biotechnology 
Biochemistry, 70(1), 178-192. 
Nogueira, L., Ramirez-Sanchez, I., Perkins, G.A., Murphy, A., Taub, P.R., 
Ceballos, G., Villarreal, F.J., Hogan, M.C., & Malek, M.H. (2011). (-)-Epicatechin 
Enhances Fatigue Resistance and Oxidative Capacity in Mouse Muscle. Journal of 
Physiology, 589(18), 4615-4631. 
Nurmi, T., Mursu, J., Heinonen, M., Nurmi, A., Hiltunen, R., & Voutilainen, S. (2009) 
Metabolism of berry anthocyanins to phenolic acids in humans. Journal of 
Agriculture and Food Chemistry, 57(6),2274–2281. doi:10.1021/jf8035116 
Obrig, H., & Villringer, A. (2003). Beyond the visible—imaging the human brain 
with light. The Journal of Cerebral Blood Flow & Metabolism, 23(1), 1-18. 
Ogedegbe, G., & Pickering, T. (2010). Principles and techniques of blood pressure 
measurement. Cardiology Clinics, 28, 571-586. 
Oh, J.K., Shin, Y.O., Yoon, J.H., Kim, S.H., Shin, H.C., & Hwang, H.J. (2010) 
Effect of Supplementation With Ecklonia cava Polyphenol on Endurance 
Performance of College Students. International Journal of Sport Nutrition and 
Exercise Metabolism, 20, 72-79. 
201 
Ooghe, W.C., Ooghe, S.J., Detaverier, C.M., & Huyghebaert, A. (1994).  
Characterization of orange juice (Citrus sinensis) by polymethoxylated flavones.  
Journal of Agriculture and Food Chemistry, 42, 2191-2195. 
Opp, M.R. (2004). Cytokines and sleep: the first hundred years. Brain Behaviour 
Immunology, 18, 295–297. 
Ou, B., Bosak, K.N., Brickner, P.R., Iezzoni, D.G., & Seymour, E.M. (2012) 
Processed tart cherry products-comparative polyphenol content, in vitro AOX 
capacity and in vitro anti-inflammatory activity. Journal of Food Science, 77(5), 
105–112. doi:10.1111/j.1750-3841.2012.02681.x 
Owens, G. (1995) Regulation of differentiation of vascular smooth muscle cells. 
Physiological Reviews, 75(3), 487–517 
Oyebode, O., Gordon-Dseagu, V., Walker, A., & Mindell, J.S. (2014). Fruit and 
vegetable consumption and all-cause, cancer and CVD mortality: Analysis of 
health survey for England data. Journal of Epidemiology and Community Health, 
68(9), 856-862. 
Pandey, K.B., &  Rizvi, S.I. (2009). Plant polyphenols as dietary AOXs in human 
health and disease. Oxidative Medicine and Cellular Longevity , 2(5), 270-278. 
Panza, V.S., Wazlawik, E., Ricardo Schütz, G., Comin, L., Hecht, K.C., & da Silva, 
E.L. (2008). Consumption of green tea favorably affects oxidative stress markers 
in weight-trained men. Nutrition (Burbank, Los Angeles County, Calif.), 24, 433–
442. 
Parkar, S.G., Stevenson, D.E., & Skinner, M.A. (2008).  The potential influence of 
fruit polyphenols on colonic microflora and human gut health, International Journal 
of Food Microbiology, 124, 295–298 
Parkins, M.D. (2001) Pharmacological practices of ancient Egypt. In: Proceedings 
of the 10th Annual Conference on History of Medicine Days. W.A. Whitelaw, 
Parkinson, A. (1996).  Toxicology the basic science of poisons, McGraw-Hill, New 
York, USA. 
Patras, A., Brunton, N.P., O’Donnell, C., & Tiwari, B.K. (2010) Effect of thermal 
processing on anthocyanin stability in foods; mechanisms and kinetics of 
202 
degradation. Trends in Food Science and Technology, 21(1), 3–11. 
doi:10.1016/j.tifs.2009.07.004 
Peri, L., Pietraforza, D., Scorza, G., Napolitano, A., Fogliano, V., & Minetti, M. 
(2005). Apples increase nitric oxide production by human saliva at the acidic pH of 
the stomach: a new biological function for polyphenols with a catechol group? Free 
Radical Biology and Medicine, 39, 668-681 
Peterson, E.C., Wang, Z., & Britz, G. (2011) Regulation of cerebral blood flow. 
International Journal of Vascular Medicine, 30-39. 
Pietta, P. (2000). Flavonoids as AOXs. Journal of Natural Products, 63, 1035–
1042. 
Pigeon, W.R., Carr, M., Gorman, C., & Perlis, M.L. (2010) Effects of a tart cherry 
juice beverage on the sleep of older adults with insomnia: a pilot study. Journal of 
Medicinal Food, 13(3), 579–583. doi:10.1089/ jmf.2009.0096 
Pilaczynska-Szczesniak, L., Skarpanska-Steinborn, A.,  Deskur, E., Basta, P., 
Horoszkiewicz-Hassan, M. (2005). The influence of chokeberry juice 
supplementation on the reduction of oxidative stress resulting from an incremental 
rowing ergometer exercise. International Journal of Sport Nutrition and Exercise 
Metabolism, 15(1), 48–58. 
Poll, L., Petersen, M B. & Nielsen, G. S. (2003). Influence of harvest year and 
harvest time on soluble solids, titrateable acid, anthocyanin content and aroma 
components in sour cherry (Prunus Cerasus L. cv. “Stevnsbær”).European Food 
Research and Technology, 216, 212–216. 
Powers, S.K., & Hamilton, K. (1999). AOXs and exercise. Clinics in Sports 
Medicine, 18, 525–536. 
Powers, S.K., & Jackson, M.J. (2008). Exercise-Induced Oxidative Stress: Cellular 
Mechanisms and Impact on Muscle Force Production. Physiological Reviews, 88, 
1243-1276. 
Powers, S.K., Deruisseau, K.C., Quindry, J., & Hamilton, K.L. (2004) Dietary AOXs 
and exercise. Journal of Sports Science, 22, 81–94. 
Primrose, S,. Draper, J.. Elsom R, Kirkpatrick, V., Mathers, J.C., Seal, C., 
Beckmann, M., Halder, S., Beattie, J.H., Lodge, J.K., Jenab, M., Keun, H., & 
203 
Scalbert, A. Metabolomics and human nutrition. British Journal of Nutrition, 105, 
1277–1283. 
Quiñones, M., Miguel, M. & Aleixandre, A.,(2013). Beneficial effects of polyphenols 
on cardiovascular disease. Pharmacological Research, 68(1),125–31. 
Rahman, I., Biswas, S.K., & Kirkham, P.A. (2006).  Regulation of inflammation and 
redox signaling by dietary polyphenols.  Biochemical Pharmacology, 72, 1439 – 
1452.  
Ramassamy, C. (2006). Emerging role of polyphenolic compounds in the 
treatment of neurodegenerative diseases: A review of their intracellular targets. 
European Journal of Pharmacology, 545(1), 51-64. 
Ramirez, M.R., Izquierdo, I., Raseira, M. d. C. B., Zuanazzi, J. A., Barros, D., & 
Henriques, A.T. (2005).  Effect of lyophilised vaccinium berries on memory, 
anxiety and locomotion in animal rats.  Pharmacological Research, 52(6), 457 – 
462.  Doi: 10.1016/j.phrs.2005.07.003. 
Rechner, A.R., Kuhnle, G., Bremner, P., Hubbard, G.P., Moore, K.P., Rice-Evans, 
C.A. (2002). The metabolic fate of dietary polyphenols in humans. Free Radical 
Bioogy Medicine, 33, 220-235. 
Reference Values for Arterial Stiffness C (2010). Determinants of pulse wave 
velocity in healthy people and in the presence of cardiovascular risk factors: 
'establishing normal and reference values'. European Heart Journal, 31, 2338-
2350. 
Reid, M.B., Khawli, F.A., & Moody, M.R. (1993). Reactive oxygen in skeletal 
muscle III. Contractility of unfatigued muscle. Journal of Applied Physiology, 75, 
1081–1087. 
Rein, M.J., Renouf, M., Cruz-Hernandez, C., Actis-Goretta, L., Thakkar, S.K., & da 
Silva Pinto, M. (2013). Bioavailability of bioactive food compounds: A challenging 
journey to bioefficacy. British Journal of Clinical Pharmacology, 75, 588–602. 
Rendeiro, C., Vauzour, D., Rattray, M., Waffo-Téguo, P., Mérillon, J.M., Bulter, 
L.T., Williams, C.M., & Spencer, J.P.E. (2013).  Dietary levels of pure flavonoids 
improve spatial memory performance and increase hippocampal brain – derived 
neurotropic factor.  Plos ONE, 8(5), e63535.  Doi: 10.1371/journal.pone.003535. 
204 
Reshef, N., Hayari, Y., Goren, C., Boaz, M., Madar, Z. & Knobler, H. (2005), 
‘‘Antihypertensive effect of sweetie fruit in patients with stage I hypertension’’, 
American Journal of Hypertension, 18(10), 1360-1363. 
Richards, J.C, Lonac, M.C, Johnson, T.K, Schweder, M.M., & Bell, C. (2010). 
Epigallocatechin-3-gallate increases maximal oxygen uptake in adult humans. 
Medicine and Science in Sport and Exercise, 42(4), 739–44. 
Rodriguez-Mateos, A., Rendeiro, C., Bergillos-Meca, T., Tabatabaee, S., George, 
T.W. Heiss, C., & Spencer, J.P.E. (2013).  Intake and time dependence of 
blueberry flavonoid–induced improvements in vascular function: a randomized, 
controlled, double-blind, crossover intervention study with mechanistic insights into 
biological activity.  The American Journal of Clinical Nutrition.  
10.3945/ajcn.113.066639. 
Rönnlund, M., Nyberg, L., Bäckman, L., & Nilsson, L.G. (2005). Stability, growth, 
and decline in adult life span development of declarative memory: Cross-sectional 
and longitudinal data from a population-based study. Psychology and aging, 20(1), 
3-18. 
Ross, R. (1993) The pathogenesis of atherosclerosis: a perspective for the 1990s. 
Nature, 362(6423), 801–809. doi:10.1038/362801a0 
Salimi, A., Motharitabar, E., Goudarzi, M., Rezaie, A., and Kalantari, H. 
(2014).Toxicity Evaluation of Microemulsion (Nano Size) of Sour Cherry Kernel 
Extract for the Oral Bioavailability Enhancement.  Jundishapur Journal of Natural 
Pharmaceutical Products, 9,1 16-23. 
Sanchez-Moreno, C., Kimler, V.A., Cordts, F.L., Cady, J.A., Weller, M.A., Dumper, 
J.W., Williams, P., Pink, F.E., Rasmussen, H.M., Jimenez-Escring, A., Martin, A., 
Joseph, J.A., & Marks, C.R.C. (2008). Effect of a blueberry nutritional supplement 
on macronutrients, food group intake, and plasma vitamin E and vitamin C in US 
athletes. International Journal of Food Sciences and Nutrition, 59, 327-338. 
Scalbert, A., Johnson, I.T., & Saltmarsh M. (2005) Polyphenols: AOXs and beyond. 
American Journal of Clinical Nutrition, 81(1), 215–217. 
Scalbert, A., Morand, C., Manach, C., Rémésy, C. (2002). Absorption and 
metabolism of polyphenols in the gut and impact on health. Biomedicine & 
Pharmacotherapy, 56, 276-282. 
205 
Scalbert, A., Williamson, G. (2000). Dietary intake and bioavailability of 
polyphenols. Journal of Nutrition,130, 2073–2085. 
Schaller, D.R., & Von Elbe, J.H. (1970). Polyphenols in montmorency cherries. 
Journal of Food Science, 35, 762-765. 
Schecklmann, M., Ehlis, A.C., Plichta, M.M., & Fallgatter, A.J. (2008) Functional 
near-infrared spectroscopy: A long-term reliable tool for measuring brain activity 
during verbal fluency. Neuroimage, 43, 147-155. 
Scholey, A.B., French, S.J., Morris, P.J., Kennedy, D.O., Milne, A.L., & Haskell, 
C.F. (2010). Consumption of cocoa flavanols results in acute improvements in 
mood and cognitive performance during sustained mental effort. Journal of 
Psychopharmacology, 24, 1505-1514. 
Seeram, N.P., Momin, R.A., Nair, M.G., & Bourquin, L.D. (2001) Cyclooxygenase 
inhibitory and AOX cyanidin glycosides in cherries and berries. Phytomedicine, 
8(5), 362–369. doi:10.1078/0944-7113-00053 
Serrano, M., Guille’n, F., Martınez-Romero, D., Castillo, S., & Valero, D. (2005 
Chemical constituents and AOX activity of sweet cherry at different ripening stages. 
Journal of Agriculture and Food Chemistry, 53, 2741-2745. 
Seymour, E.M., Warber, S.M., Kirakosyan, A., Noon, K.R., Gillespie, B., Uhley, 
V.E., Wunder, J., Urcuyo, D.E., Kaufman, P.B. &, Bolling, S.F. (2014). 
Anthocyanin pharmacokinetics and dose-dependent plasma AOX 
pharmacodynamics following whole tart cherry intake in healthy humans.  Journal 
of Functional Foods, 11, 509-516. 
Seymour, E.M., Wolforth, J., Bosak, K., Kondoleon, M., Mehta, V., Brickner, P., & 
Bolling, S.F. (2013) Effect of tart cherry versus PPAR agonist pioglitazone on 
stroke-related phenotypes and inflammation. FASEB Journal, 27(1). 
Shahidi, F. HCT (2007) AOX measurement and applications. In: ACS Symposium 
Series 956 American Chemical Society, Washington, DC 
Shimizu, M., & Kario, K. (2008).  Role of the augmentation index in hypertension. 
Therapeutic Advances in Cardiovascular Disease, 2, 25-35. 
Shrikhande, A.J., Francis, F.J. (1973). Flavone glycosides of sour cherries. 
Journal of Food Science, 38, 1035-1037 
206 
Shukitt-Hale, B., Carey, A., Simon, L., Mark, D.A., & Joseph, J.A. (2006). Effects 
of Concord grape juice on cognitive and motor deficits in aging. Nutrition, 22, 295-
302. 
Shukitt-Hale, B., Lau, F.C., & Joseph, J.A. (2008) Berry fruit supplementation and 
the aging brain. Journal of Agricultural and Food Chemistry, 56, 636-641. 
Shukitt-Hale, B., Mouzakis, G., & Joseph, J.A. (1998) Psychomotor and spatial 
memory performance in aging male Fischer 344 rats. Experimental Gerontology, 
33, 615-624. 
Smits, M., Peeters, R.R., van Hecke P & Suneart, S.(2007) A 3 T event-related 
functional magnetic resonance imaging (fMRI) study of primary and secondary 
gustatory cortex localization using natural tastants. Neuroradiology, 61-71. 
Smoliga, J.M., Baur, J.A., & Hausenblas, H.A. (2011). Resveratrol and health a 
comprehensive review of human clinical trials. Molecular Nutrition & Nutrition 
Research, 55, 1129–41. 
Somerville, V., Bringans, C., & Braakhuis, A. (2017).  Polyphenols and 
Performance: A Systematic Review and Meta-Analysis.  Sports Medicine [Epub 
ahead of print].  DOI 10.1007/s40279-017-0675-5 
Sorond, F.A.,  Lipsitz, L. Hollenberg, N.K., Fisher, N.D.L. (2008) Cerebral blood 
flow response to flavanol-rich cocoa in healthy elderly humans. Neurophychiatric 
Disease and Treatment, 4, 433-440. 
Sosulski, F., Krygier, K., & Hogge, L. (1982). Free, esterified, and insoluble-bound 
phenolic acids 3 composition of phenolic acids in cereal and potato flours. Journal 
of Agriculture and Food Chemistry, 30(2), 337-340. 
Sousa, M., Teixeira, V. H., & Soares, J. (2014). Dietary strategies to recover from 
exercise-induced muscle damage. International Journal of Food Sciences and 
Nutrition, 65(2), 151-163. 
Stalmach, A., Mullen, W., Barron, D., Uchida, K., Yokota, T., Cavin, C., Steiling, H., 
Williamson, G., & Crozier, A. (2009). Metabolite Profiling of Hydroxycinnamate 
Derivatives in Plasma and Urine after the Ingestion of Coffee by Humans: 
Identification of Biomarkers of Coffee Consumption. Drug Metabolism and 
Disposition, 37, 1749-1758. 
207 
Stalmach, A., Williamson, G., & Crozier, A. (2014) Impact of dose on the 
bioavailability of coffee chlorogenic acids in humans. Journal of Functional Foods, 
5(8),1727–1737. doi:10.1039/c4fo00316k 
Stein, J.H., Keevil, J.G., Wiebe, D.A., Aeschlimann, S., & Folts J.D. (1999). Purple 
grape juice improves endothelial function and reduces the susceptibility of LDL 
cholesterol to oxidation in patients with coronary artery disease. Circulation, 
100:1050–1055. doi: 10.1161/01.CIR.100.10.1050. 
Stevenson, D.E. (2012). Polyphenols as adaptogens–the real mechanism of the 
antioxidant effect? In: Anonymous. Croatia: InTech Rijeka, p. 143–62. 
Stonehouse, W., Conlon, C.A., Podd, J., Hill, S.R., Minihane, A.M., Haskell, C., & 
Kennedy, D. (2013) DHA supplementation improved both memory and reaction 
time in healthy young adults: a randomized controlled trial. American Journal of 
Clinical Nutrition, 97, 1134-1143. 
Strack (1997) Phenolic metabolism.  In: Plant Biochemistry (eds. P Dey, J. 
Harborne), pp. 387-416.  London: Academic Press. 
Strack, D., & Wray, V. (1994) Anthocyanins.  In: The Flavonoids: Advances in 
research since 1986 (ed. J Harborne), pp. 1-22.  London:  Chapman and Hall. 
Sugamura, K., & Keaney J. F (2011).. Reactive oxygen species in cardiovascular 
disease. Free Radical Biology and Medicine, 51(5):978–992. doi: 
10.1016/j.freeradbiomed.2011.05.004. 
Sun, B.S., Pinto, T., Leandro, M.C., Ricardo-de-Silva, J.M., & Spranger, M.I. 
(1999). Transfer of catechins and proanthocyanidins from solid parts of the grape 
cluster into wine. American Journal of Enology & Viticulture, 50(2), 179-184. 
Suzuki, T., Morita, M., Kobayashi, Y., Kamimura, A. (2016) Oral L-citrulline 
supplementation enhances cycling time trial performance in healthy trained men: 
Double-blind randomized placebo-controlled 2-way crossover study. Journal of the 
International Society of Sports Nutrition, 19(13). 
Swamy, M.S.L., Naveen, S., Singsit, D., Naika, M.,&  Khanum,  F. (2011). Anti-
fatigue effects of polyphenols extracted from pomegranate peel. International 
Journal of Integrative Biology, 11(2), 69–72. 
208 
Tall, J.M., Seerman, N.P., Zhao, C., Nair, M.G., Meyer, R.A., & Raja, S.N. (2004). 
Tart cherry anthocyanins suppress inflammation-induced pain behavior in rat. 
Behavioural Brain Research, 153, 181-188. 
Tamura, M., Hoshi, Y., & Okada, F. (1997). Localized near–infrared spectroscopy 
and functional optical imaging of brain activity. Philosophical Transactions of the 
Royal Society of London. Series B: Biological Sciences, 352(1354), 737-742. 
Tangney, C.C. & Rasmussen, H.E., (2013). Polyphenols, inflammation, and 
cardiovascular disease. Current Atherosclerosis Reports, 15(5), 324. 
Taubert, D., Roesen, R., Lehmann, C., Jung, N., & Schoemig, E. (2007). Effects of 
low habitual cocoa intake on blood pressure and bioactive nitric oxide - A 
randomized controlled trial.  The Journal of the American Medical Association, 298, 
49-60. 
Thangthaeng, N.P., Gomes, S.M., Miller, M.G.., Bielinski, D.F., & Shukitt-Hale, B. 
(2016). Tart cherry supplementation improves working memory, hippocampal 
inflammation, and autophagy in aged rats. Age (Dordr), 38(5-6), 393-404. 
Thomasset, S.C., Berry, D.P., Garcea, G., Marczylo, T., Steward, W.P., & Gescher, 
A.J. (2007). Dietary polyphenolic polyphenols promising cancer chemopreventive 
agents in humans?. A review of their clinical properties. International Journal of 
Cancer, 120, 451-458. 
Thompson, K.G., Turner, L., Prichard, J., Dodd, F., Kennedy, D.O., Haskell, C., 
Blackwell, J.R., & Jones, A.M. (2014) Influence of dietary nitrate supplementation 
on physiological and cognitive responses to incremental cycle exercise. 
Respiratory Physiology & Neurobiology, 193, 11-20. 
Tomas-Barberan, F., & Espin, J.C. (2001) Phenolic compounds and related 
enzymes as determinants of quality in fruits and vegetables. Journal of the 
Science of Food and Agriculture, 81(9):853–876. doi:10.1002/jsfa.885 
Toutain, P.L., & Bousquet-Mélou A. (2004). Bioavailability and its assessment. 
Journal of Veterinary Pharmacology and Therapeutics, 27, 455–466. doi: 
10.1111/j.1365-2885.2004.00604.x. 
Trombold, J.R., Barnes, J.N., Critchley, L., & Coyle, E.F. (2010).  Ellagitannin 
Consumption Improves Strength Recovery 2-3 d after Eccentric Exercise. 
209 
Medicine & Science in Sports & Exercise, 42, 493-498 
10.1249/MSS.0b013e3181b64edd. 
Trombold, J.R., Reinfeld, A.S., Casler, J.R., & Coyle, E.F. (2011). The Effect of 
Pomegranate Juice Supplementation on Strength and Soreness after Eccentric 
Exercise. The Journal of Strength & Conditioning Research, 25, 1782-1788 
10.1519/JSC.0b013e318220d992. 
Turner, J., Belch, J.J.F., & Khan, F. (2008). Current concepts in assessment of 
microvascular endothelial function using laser Doppler imaging and iontophoresis. 
Trends Cardiovascular Medicine, 18, 109-116. 
Uhley,, V.E., Seymour, E.M., Wunder, J., Kaufman, P., Kirakosyan, A., Al-Rawi, S., 
a& Warber, S. (2009).  Pharmacokinetic study of the absorption and metabolism of 
Montmorency tart cherry anthocyanins in human subjects.  The FASEB Journal, 
23,1, 
Upadhyay, S., & Dixit, M. (2015).  Role of Polyphenols and Other Polyphenols on 
Molecular Signaling.  Oxidative Medicine and Cellular Longevity, 504253. doi: 
10.1155/2015/504253 
Urso, M. L. (2013). Anti-inflammatory interventions and skeletal muscle injury: 
Benefit or detriment? Journal of Applied Physiology, 115(6), 920–928. 
Urso, M.L., & Clarkson, P.M. (2003). Oxidative stress, exercise, and AOX 
supplementation. Toxicology, 189, 41-54. 
Vacek, J., Ulrichová, J., & Klejdus, nek, V. (2010).  Analytical methods and 
strategies in the study of plant polyphenolics in clinical samples.  Analytical 
Methods, 2, 604-613. 
Vanhatalo, A., Bailey, S.J., Blackwell, J.R., Dimenna, F.J., Pavey, T.G., Wilkerson, 
D.P., Benjamin, N., Winyard, P.G., & Jones, A.M. (2010b).  Acute and chronic 
effects of dietary nitrate supplementation on blood pressure and the physiological 
responses to moderate-intensity and incremental exercise. American Journal of 
Physiology - Regulatory, Integrative and Comparative Physiology, 299, 1121-1131. 
Vanhatalo, A., Bailey, S.J., DiMenna, F.J., Blackwell, J.R., Wallis, G.A., & Jones, 
A.M. No effect of acute l-arginine supplementation on O2 cost or exercise 
tolerance. European Journal of Applied Physiology, 113: 1805–1819. 
210 
Venables, M.C., Hulston, C.J., Cox, H.R., &  Jeukendrup A.E. (2008). Green tea 
extract ingestion, fat oxidation, and glucose tolerance in healthy humans. 
American Journal of Clinical Nutrition, 87(3), 778–784. 
Viña, J., Gomez-Cabrera, M.C., Lloret, A., Marquez, R., Miñana, J.B., Pallardó, 
F.V., & Sastre, J. (2000) Free radicals in exhaustive physical exercise: mechanism 
of production, and protection by AOXs. IUBMB Life, 50, 271–277. 
Vinson, J.A., Su, X.H., Zubik, L., & Bose, P. (2001) Phenol AOX quantity and 
quality in foods: fruits. Journal of Agriculture & Food Chemistry, 49(11), 5315–
5321. doi:10.1021/jf0009293 
Vitaglione, P., Donnarumma, G., Napolitano, A., Galvano, F., Gallo, A., Scalfi, L., 
& Fogliano, V. (2007) Protocatechuic acid is the major human metabolite of 
cyanidin-glucosides. Journal of Nutrition, 137(9):2043–2048 
Walle, T. (2004).  Absorption and metabolism of flavonoids. Free Radical Biology 
and Medicine, 36, 829-837. 
Walsh, N.P., Gleeson, M., Pyne, D.B., Nieman, D.C., Dhabhar, F.S., Shephard, 
R.J., Oliver, S.J., Bermon, S., & Kajeniene, A. (2011).  Position statement. Part 
two: Maintaining immune health. Exercise Immunology Reviews, 17, 64-103. 
Wang, H., Liu, T.Q., Guan, S., Zhu, Y.X., Cui, Z.F. (2008).  Protocatechuic acid 
from Alpinia oxyphylla promotes migration of human adipose tissue-derived 
stromal cells in vitro. European Journal of Pharmacology, 599(1–3), 24–31. 
doi:10.1016/j.ejphar.2008.09.030 
Wang, H., Nair, M.G., Strasburg, G.M., Chang, Y.C., Booren, A.M., Gray, J.I., 
DeWitt, D.L. (1999) AOX and anti-inflammatory activities of anthocyanins and their 
aglycon, cyanidin, from tart cherries. Journal of Natural Products, 62(2), 294–296. 
doi:10.1021/np980501m 
Wang, H.B., Nair, M.G., Iezzoni, A.F., Strasburg, G.M., Booren, A.M., & Gray, J.I. 
(1997) Quantification and characterization of anthocyanins in Balaton tart cherries. 
Journal of Agriculture and Food Chemistry, 45(7), 2556– 2560. 
doi:10.1021/jf960896k 
Wang, Q.X., Liu, M., Guo, H., Ye, Q., Hu, Y., Zhang, Y., Hou, M., Zhu, H., Ma, J., 
& Ling, W. (2008).  Cyanidin-3-O-β-glucoside inhibits iNOS and COX-2 expression 
211 
by inducing liver X receptor alpha activation in THP-1 macrophages. Life Sciences, 
83, 176-184. 
Wang, S.Y.(2006).  Effect of Pre-harvest Conditions on AOX Capacity in Fruits.  
Acta Horticulturae, 712. Doi: 10.17660/ActaHortic.2006.712.33 
Watson, A.W., Haskell-Ramsay, C.F., Kennedy, D.O., Cooney, J.M., Trower, A., 
Scheepens, A. (2015) Acute supplementation with blackcurrant extracts modulates 
cognitive functioning and inhibits monoamine oxidase-B in healthy young adults. 
Journal of Functional Foods,17, 524-539. 
Watson, R.R., Preedy, V.R., & Zibadi, S. (2014).  Polyphenols in human health 
and disease.  Vol 1. Elsevier Inc, Oxford, UK 
Webb, A.J, Patel, N., Loukogeorgakis, S., Okorie, M., Aboud, Z., Misra, S., Rashid, 
R., Miall, P., Deanfield, J., Benjamin, N., Macallister, R., Hobbs, A.,J., & Ahluwalia, 
A. (2008a).  Acute Blood Pressure Lowering, Vasoprotective, and Antiplatelet 
Properties of Dietary Nitrate via Bioconversion to Nitrite. Hypertension, 51, 784-
790. 
Weiskopf, R. B., Feiner, J., Hopf, H. W., Viele, M. K., Watson, J. J., Kramer, J. H., 
Ho, R., & Toy, P. (2002). Oxygen reverses deficits of cognitive function and 
memory and increased heart rate induced by acute severe isovolemic anemia. 
Anesthesiology, 96(4), 871. 
Wersching, H. (2011).  An apple a day keeps stroke away? Consumption of white 
fruits and vegetables is associated with lower risk of stroke. Stroke, 42, 3001–
3002. doi: 10.1161/STROKEAHA.111.626754 
West, T., Atzeva, M., & Holtzman, D.M. (2007) Pomegranate polyphenols and 
resveratrol protect the neonatal brain against hypoxic ischemic injury. 
Developmental Neuroscience, 29(4-5), 363 - 372. 
Whipp, B.J., Davis, J.A., Torres, F. & Wasserman, K. (1981). A test todetermine 
parameters of aerobic function during exercise. Journal of Applied Physiology, 50, 
217–221 
Whyte, A.R., Schafer, G., & Williams, C.M. (2016) Cognitive effects following acute 
wild blueberry supplementation in 7-to 10-year-old children. European Journal of 
Nutrition, 55, 2151-2162. 
212 
Wightman, E.L., Haskell, C.F., Forster, J.S., Veasey, R.C., & Kennedy, D.O. (2012) 
Epigallocatechin gallate, cerebral blood flow parameters, cognitive performance 
and mood in healthy humans: a double-blind, placebo-controlled, crossover 
investigation. Human Psychopharmacology-Clinical and Experimental, 27, 177-
186. 
Wightman, E.L., Haskell-Ramsay, C.F., Thompson, K.G., Blackwell, J.R., Winyard, 
P.G., Forster, J., Jones, A.M., & Kennedy, D.O. (2015) Dietary nitrate modulates 
cerebral blood flow parameters and cognitive performance in humans: A double-
blind, placebo-controlled, crossover investigation. Physiology & Behaviour, 149, 
149-158. 
Wightman, E.L., Reay, J.L., Haskell, C.F., Williamson, G., Dew, T.P., Kennedy, 
D.O. (2014). Effects of resveratrol alone or in combination with piperine on 
cerebral blood flow parameters and cognitive performance in human subjects: a 
randomised, double-blind, placebo-controlled, cross-over investigation. British 
Journal of Nutrition, 112, 203-213. 
Wilkinson, I.B., Fuchs, S.A., Jansen, I.M., Spratt, J.C., Murray, G.D., Cockcroft, 
J.R., & Webb, D.J. (1998). Reproducibility of pulse wave velocity and 
augmentation index measured by pulse wave analysis. Journal of Hypertension, 
16, 2079-2084. 
Williams, C.A., & Harborne, H.B. (1992). Flavone and flavonol glycosides.  In: The 
Flavonoids.  Advances in Research Since 1986 (ed. J. Harborne), pp. 337-385.  
London: Chapman and Hall.  
Williams, R.J., Spencer, J.P., & Rice-Evans, C. (2004). Flavonoids: AOXs or 
signalling molecules? Free Radical Biology and Medicine, 36, 838-849. 
Wollenweber, E. (199) FlaVOnes and flaVOnols. In: The Flavonoids: Advances in 
Research Since 1986 (ed. J. Harborne), pp. 259-335.  London: Chapman and Hall. 
Woodward, G., Kroon, P., Cassidy, A., & Kay, C. (2009). Anthocyanin stability and 
recovery: Implications for the analysis of clinical and experimental samples. 
Journal of Agriculture and Food Chemistry, 57(12), 5271-5278. 
Wu, J., Xia, S., Kalionis, B., Wan, W., & Sun, T. (2014).  The role of oxidative 
stress and inflammation in cardiovasuclar aging.  Biomedical Research 
International, 615312 doi:  10.1155/2014/615312 
213 
Wylie, L.J., Mohr, M., Krustrup, P., Jackman, S.R., Kelly, E.G., Black, M.I., Bailey, 
S.J., Vanhatalo, A., & Jones, A.M. (2013).  Dietary nitrate supplementation 
improves team sport-specific intense intermittent exercise performance. 
European Journal of Applied Physiology, 113(7), 1673-1684. 
Xu, B., & Chang, S.K. (2009). Polyphenol profiles and health-promoting effects of 
cool-season food legumes as influenced by thermal processing. Journal of 
Agriculture and Food Chemistry, 57, 10718–10731 
Xu, J.W., Ikeda, K., & Yamori, Y. (2004). Upregulation of endothelial nitric oxide 
synthase by cyanidin-3-glucoside, a typical anthocyanin pigment. Hypertension, 44, 
217-222. 
Yang, C.S., Landau, J.M., Huang, M.T., & Newmark, H.L. (2001). Inhibition of 
carcinogenesis by dietary polyphenolic compounds. The Annual Review of 
Nutrition, 21,381–406. 
Ye, E.Q., Chacko, S.A., Chou, E.L., Kugizaki, M., & Liu, S. (2012). Greater whole-
grain intake is associated with lower risk of type 2 diabetes, cardiovascular 
disease, and weight gain. Journal of Nutrition, 42(7), 1304-1313. 
Yoshizumi, M., Tsuchiya, K., Suzaki, Y., Kirima, K., Kyaw, M., Moon, J.H., Terao, J, 
& Tamaki T. (2002). Quercetin glucuronide prevents VSMC hypertrophy by 
angiotensin II via the inhibition of JNK and AP-1 signaling pathway. Biochemical 
and Biophysical Research Communications, 293, 1458-1465. 
Zeiher, A. M., Drexler, H., Saurbier, B., & Just, H. (1993). Endothelium-mediated 
coronary blood flow modulation in humans. Effects of age, atherosclerosis, 
hypercholesterolemia, and hypertension. Journal of Clinical Investigation, 92(2), 
652. 
Zhang, K., Zuo, Y. (2004). GC-MS determination of flavonoids and phenolic and 
benzoic acids in human plasma after consumption of cranberry juice. Journal of 
Agriculture and Food Chemistry, 52, 222-227. 
Zhang, Y., Neogi, T., Chen, C., Chaisson, C., Hunter, D., & Choi, H.K. (2012).  
Cherry consumption and the risk of recurrent gout attacks. Arthritis & 
Rheumatology, 64(12), 4004-4011. 
214 
Zhu, Y., Ling, W., Guo, H., Song, F., Ye, Q., Zou, T., Li, D., Zhang, Y., Li, G., Xiao, 
Y., Liu, F., Li, Z., Shi, Z., & Yang, Y. (2013) Anti-inflammatory effect of purified 
dietary anthocyanin in adults with hypercholesterolemia: a randomized controlled 
trial. Nutrition, Metabolism & Cardiovascular Disease, 23, 843–849. 
Zulak, K.G., Liscombe, D.K., Ashihara, H. & Fachini, P.J. (2006). Alkaloids. In 
Plant Secondary metabolites. Occurance, Structure and Role in the Human Diet. A. 
Crozier, M.N. Clifford and H. Ashihara (eds) Blackwell Publishing Ltd. Oxford, UK. 
pp.102-231. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
215 
 
 
 
9 Appendices 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
216 
8.1 Appendix 1: Example informed consent document  
 
INFORMED CONSENT FORM 
Project title: 
Participant ID:  
Principal Investigator: Karen Keane 
Investigator contact details:  karen.keane@northumbria.ac.uk 
Please tick where appropriate 
 
I have read and understood the Participant Information Sheet.  
 
I have had an opportunity to ask questions and discuss this study and I 
have received satisfactory answers. 
 
 
I understand I am free to withdraw from the study at any time, without 
having to give a reason for withdrawing, and without prejudice. 
 
 
I agree to take part in this study.  
 
I would like to receive feedback on the overall results of the study at the 
email address given below.  I understand that I will not receive individual 
feedback on my own performance. 
 
Email address…………………………………………………………………… 
 
 
 
 
Signature of participant...................................................    Date.....……………….. 
 
(NAME IN BLOCK LETTERS)....................................................………………. 
 
 
 
Signature of researcher...................................................    Date.....……………….. 
(NAME IN BLOCK LETTERS)         
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INFORMED CONSENT FOR REMOVAL AND STORAGE OF TISSUE 
Project Title: 
Participant ID:   
Principal Investigator: Karen Keane  
Investigator contact details:  karen.keane@northumbria.ac.uk 
I agree that the following tissue or other bodily material may be taken and used for 
the study:  
Tissue/Bodily 
material 
Purpose Removal Method 
   
 
I understand that if the material is required for use in any other way than that 
explained to me, then my consent to this will be specifically sought. I understand 
that I will not receive specific feedback from any assessment conducted on my 
samples, but should any kind of abnormality be discovered then the investigator 
will contact me.  
I understand that the University may store this tissue in a Licensed Tissue 
Bank only for the duration of the study, it will then be destroyed. 
 
Method of disposal:    
Clinical Waste               
 
Other                            
 
If other please 
specify........................................................... 
 
I consent to the University distributing this tissue to partners in this research study, 
outside of the University, for further testing (please tick the box if you agree).                                                                     
                                    
Signature of participant.......................................................    Date.....……………….. 
 
Signature of researcher.......................................................    Date.....……………….. 
 
x 
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8.2 Appendix 2: Example Health Questionnaire Document (Ch 3, 5 and 6) 
 
 
Health Questionnaire 
STRICTLY CONFIDENTIAL 
Participant Code:       
Height: 
Weight: 
Please answer these questions truthfully and completely.  The sole purpose of this 
questionnaire is to ensure that you are fit and healthy to follow the proposed 
research programme. 
 
1. How would you describe your present level of activity? 
Vigorous activity:  
Less than 1x per month    Once a month 
Once a week      Two/three times a week 
Four/five times a week    More than five times a week 
 
2. Are you currently taking any form of medication? If yes, please give brief 
details. 
    Yes  No 
 
3. Have you suffered from a bacterial or viral infection in the last two weeks? 
Yes  No 
 
4. Have you had cause to suspend physical activity in the last two weeks for any 
reason? 
Yes  No 
 
5. If you currently suffer from or have previously suffered from any of the following 
conditions you will be unable to take part in the study.  Please inform the 
researcher (without specifics) if as a result you will now be unable to take part 
in the study. 
 heart complaint/condition  
 asthma 
 diabetes (Type 1 or 2) 
 high blood pressure 
 blood borne disease or infection 
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6. Is there any reason why you should not embark on the proposed research 
programme?   
 
 
 
You are not required to provide specifics of any condition that precludes you from 
taking part in the study.  However, if you are not sure if any such condition will 
affect your ability to participate, please feel free to discuss this with the research 
team, although you are not obliged to do so. 
 
Signature: 
Date: 
 
Sports Scientist: 
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8.3 Appendix 3: Example Health Questionnaire Document (Ch 4) 
 
 
Health Questionnaire 
STRICTLY CONFIDENTIAL 
Participant Code:       
Height: 
Weight: 
Please answer these questions truthfully and completely.  The sole purpose of this 
questionnaire is to ensure that you are fit and healthy to follow the proposed 
research programme. 
 
7. How would you describe your present level of activity? 
Vigorous activity:  
Less than 1x per month    Once a month 
Once a week      Two/three times a week 
Four/five times a week    More than five times a week 
 
8. Are you currently taking any form of medication? If yes, please give brief 
details. 
    Yes  No 
 
9. Have you suffered from a bacterial or viral infection in the last two weeks? 
Yes  No 
 
10. Have you had cause to suspend physical activity in the last two weeks for any 
reason? 
Yes  No 
 
11. If you currently suffer from or have previously suffered from any of the following 
conditions you will be unable to take part in the study.  Please inform the 
researcher (without specifics) if as a result you will now be unable to take part 
in the study. 
 heart complaint/condition  
 asthma 
 diabetes (Type 1 or 2) 
 blood borne disease or infection 
 
12. Is there any reason why you should not embark on the proposed research 
programme?   
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You are not required to provide specifics of any condition that precludes you from 
taking part in the study.  However, if you are not sure if any such condition will 
affect your ability to participate, please feel free to discuss this with the research 
team, although you are not obliged to do so. 
 
Signature: 
Date: 
 
Sports Scientist: 
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8.4 Appendix 4: Example Diet Record and Instructions Document 
 
 
 
CONFIDENTIAL 
Participant Code: _____________________ 
FOOD RECORD DIARY 
 
Please record everything you eat and drink for 1/2 days (depending on study) 
prior to your trial and throughout the trial (96 hours). You will then be asked to 
consume identical amounts of the same food and drink prior to and during the 
second trial.  Please avoid consuming the foods listed at the back of this 
document throughout the 1/2 days prior to and during the trial periods.  This 
is vitally important to the results of the study so please adhere to this strictly.  
Instructions and examples are given inside. 
 
Information about your diet will be treated in confidence. 
If you have problem, please contact: Karen (Karen.keane@northumbria.ac.uk) 
Department of Sport Exercise and Rehabilitation 
Faculty of Health and Life Sciences 
Northumbria University 
Newcastle Upon Tyne 
NE1 8ST 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
223 
INSTRUCTION FOR USING THE FOOD DIARY 
 
 Everything that you eat and drink over the course of the day should be 
recorded. 
 Do not forget to record second helpings and between meal snacks. 
 Eating Out – Most people eat foods away from home each day, please do 
not forget to record these. Take your diary with you where ever it is 
possible. If this is too inconvenient just record the type of food eaten. 
 Names and descriptions of foods should be as detailed as possible, 
including the brand name and any other information available.  
 
e.g. Cheese – is insufficient information. 
 Cheese, cheddar (Shape reduced fat) – is sufficient information. 
 
Start a new page in your diary for each day, and record each item on a separate 
line. Record the time of day in the first column of each line. 
e.g. 10:30 am  McVities  Digestive Biscuits (2)  50g 
            
The space provided at the foot of each page for general comments is for you to 
give any further information about your diet and your training/activity for that day. 
 
e.g. Steady run, morning 1 hour. 
 Missed lunch due to stomach pains 
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DAY 1 (96 hours pre-trial 1)     
Date:        /              /  
 
Please use a separate line for each item eaten; write in weight of Plate; leave a line 
between different ‘Plate’ entries. 
A B C D E F 
Office 
Use   
Ti
m
e 
Food eaten Brand 
name of 
each item 
(except 
fresh food) 
Full description of each 
item including: 
-whether fresh, frozen, 
dried, canned 
-cooked: boiled, grilled, 
fried, roasted. 
-what type of fat food 
fried in 
Wei
ght 
Serv
ed 
Weight 
of 
Leftov
ers 
Actual 
Weight 
a
m/
p
m 
ho
me 
away  
(gms
) 
 
(gms) 
 
(gms) 
        
        
        
        
        
        
        
        
        
GENERAL COMMENTS and ACTIVITY UNDERTAKEN: 
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DAY 2 (72 hours pre-trial 1)     
Date:        /              /  
 
Please use a separate line for each item eaten; write in weight of Plate; leave a 
line between different ‘Plate’ entries. 
A B C D E F 
Office 
Use   
Tim
e 
Food 
eaten 
Brand 
name of 
each item 
(except 
fresh 
food) 
Full description of 
each item including: 
-whether fresh, frozen, 
dried, canned 
-cooked: boiled, 
grilled, fried, roasted. 
-what type of fat food 
fried in 
Wei
ght 
Serv
ed 
Weigh
t of 
Leftov
ers 
Actual 
Weight 
am/
pm 
ho
me 
aw
ay 
   
(gm
s) 
 
(gms) 
 
(gms) 
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GENERAL COMMENTS and ACTIVITY UNDERTAKEN: 
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Dietary Restrictions 
Please see below for foods that you can/cannot eat during the period 1/2 days 
prior to the experimental trial.  It is vitally important that you strictly follow these 
restrictions in order to make sure any changes we see in your blood samples are 
directly as a result of the supplements you are provided with.  The foods on the 
‘should NOT’ eat list are those are high in polyphenols (AOXs), if you come across 
foods not listed there but you know are high in AOXs, please aV̇Oid these also. 
Foods that should NOT be eaten during the diet 
 Tea, coffee, drinking chocolate, alcohol (especially red wine and apple cider), 
fruit juice 
 Fruits and Vegetables 
 Chocolate and chocolate products 
 Cereals / wholemeal bread / grains 
 Spices (such as curry) and herbs 
 
Foods that you may eat 
 White bread 
 Butter, vegetable oil (aV̇Oid olive oil) 
 Pasta, rice 
 Meat, eggs, fish 
 Peeled potatoes (mash, crisps, French fries) 
 Mushrooms 
 Digestive biscuits 
 Milk and milk products (Plain yogurts, cheese) 
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EXAMPLES OF DIET FOR THE DAYS PRIOR THE STUDY 
Breakfast: 
 Toast (white bread) with butter (NO jam) 
 Glass of milk or Plain yogurt (or Greek yogurt but without Honey) 
 Scrambled eggs 
 Bacon and sausages (NO tomato sauce) 
 Croissant, pastries (NO jam or chocolate coated) 
 Waffles, pancakes 
 Rice Krispies 
Lunch: 
 Sandwich (white bread, white bagels, white pitta bread, or panini) 
with any of the following fillings (NO lettuce, or tomatoes): 
- Chicken 
- Cheese 
- Bacon, Ham, Corned beef 
- Tuna 
- Prawns 
- Butter 
- Mayonnaise 
 Sausage roll, pork pies 
 Pack of crisps (Ready salted) 
 Burger and chips 
Dinner: 
 Fish and chips with salt and vinegar (NO tomato sauce) 
 Chicken with mushrooms and mash potatoes or chips (NO 
vegetable or peas) 
 Chicken and fried rice / fried noodles with eggs, and oyster sauce 
(NO peas and NO soya sauce) 
 Macaroni and cheese (cream cheese sauce) 
 Tuna, salmon, cod, with rice or pasta (NO tomato-based or 
vegetable-based sauce) 
 Steak, pork chops 
 Spaghetti carbonara (cream cheese sauce, bacon) 
Snacks: 
 Digestive biscuits (NO chocolate coated) 
 Short breads 
 Custard rice pudding 
 Crisps (Ready salted) 
 Ice cream (vanilla flaV̇Our) 
 Vanilla flaV̇Our milk-shake 
 Plain scones with butter, clotted cream 
 
You can drink water at any time. 
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WHAT YOU MUST NOT EAT OR DRINK 
 Coffee 
 Tea 
 Alcohol (especially red/white wine, apple cider, beer) 
 Fruits (especially apples, pears, apricots, prunes, plums, cherries, peaches, 
blueberries, grapes) 
 Vegetables (especially tomatoes, spinach, asparagus, cabbage, carrots, 
peppers, onions, broccoli, cauliflower) 
 Fruits juices (especially Ribena), soft drinks (coca cola, irn bru…) 
 Chocolate / chocolate products (biscuits, cakes, chocolate bars) / drinking 
chocolate 
 Wholemeal bread, granary bread, brown bread 
 Wholegrain cereals (such as Weetabix, bran flakes, Corn flakes, oat cakes, 
porridge, Muesli) 
 Wholemeal food (such as wholemeal pasta, wholemeal rice…) 
 Beans (such as baked beans, green beans), lentils, peas 
 Curry dishes, curry spice, chilli, paprika 
 Herbs (such as basil, parsley, coriander, chives…) 
 Tomato sauce (such as Ketchup, ready-made pasta sauce in jar…) 
 
We are aware that this may be difficult for you to follow such a diet, as it may be 
really different from your usual diet. The reason we ask you to change your normal 
diet is that the foods listed above contain similar components that we want to be 
testing in the fruit juice. Therefore, if you do eat the foods above, this may interfere 
with the study. 
We recommend that you eat plenty of pasta or rice the night before the any of the 
trial days, to avoid being too hungry in the morning of the study and provide a 
good energy source. 
Thank you for your co-operation. 
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8.5 Appendix 5: Time course of systolic blood pressure in Chapter 4 
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Figure 23 - Time course of systolic blood pressure (mean ± SEM) response after 
consumption of MC concentrate- and macronutrient – matched control (n=15).  
Significantly different from the placebo drink: * P < 0.05 
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8.6 Appendix 6: Baseline NIRS data collected in Chapter 5 
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Figure 24 Baseline data for oxy-Hb and total-Hb, by treatment visit.  Mean values 
over the course of the baseline assessment for oxy-Hb are 0.59 µmol/L (MC) and 
0.62 µmol/L (Placebo).  Mean values for total-Hb are 0.35 µmol/L (MC) and 0.46 
µmol/L (Placebo). 
